false
--02-28
0000788611
0000788611
2024-12-31
2024-12-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): December 31, 2024
NextTrip,
Inc.
(Exact
name of Registrant as Specified in Its Charter)
Nevada |
|
001-38015 |
|
27-1865814 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
3900 Paseo del Sol |
|
|
Santa Fe, New Mexico |
|
87507 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrant’s
Telephone Number, Including Area Code: (505) 438-2576
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
☐ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
☐ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
☐ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
☐ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading
Symbol(s) |
|
Name of each exchange on which registered |
Common
Stock, par value $0.001 per share |
|
NTRP |
|
The
Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
1.01 Entry into a Material Definitive Agreement
On
December 31, 2024, NextTrip, Inc., a Nevada corporation (the “Company”), consummated a series of separate securities transactions
as described below.
Series
J Preferred Stock Offering
On
December 31, 2024, the Company entered into a securities purchase agreement (the “Series J Purchase Agreement”) with certain
accredited investors (the “Purchasers”), pursuant to which the Company issued and sold an aggregate of 297,788 restricted
shares of newly designated Series J Nonvoting Convertible Preferred Stock of the Company (the “Series J Preferred”), (the
“Series J Offering”) at a purchase price of $3.02 per share.
The
Series J Preferred shall be convertible into the Company’s common stock (the “Common Stock”) on such date that the
Company obtains stockholder approval to remove the Exchange Cap (as described below).
The
Series J Purchase Agreement contains customary representations, warranties, conditions to closing, indemnification rights and obligations
of the parties and termination provisions.
See
Item 5.03 below for a description of the terms of the Series J Preferred, which is incorporated by reference herein.
Series
K Preferred Stock, Warrant and Unsecured Promissory Note Offering
On
December 31, 2024, the Company entered into a series of agreements whereby an investor agreed to loan the Company up to $1,000,000 against
an unsecured promissory note (the “$1M Note”). The $1M Note is payable in full on the earlier date of one (1) year from issuance
or the date the Company completes a financing of $5 million or greater, is unsecured and has no prepayment penalty.
In
connection with the $1 million Note,
the investor received fifteen percent (15%) guaranteed prepaid interest issued in the form of Series K Nonvoting Convertible Preferred
Stock of the Company (the “Series K Preferred Stock”) as well as 100% warrant coverage, as follows: (1) a warrant exercisable
in cash to purchase up to 500,000 shares of Common Stock (the “Cash Warrant”) and (2) a cashless warrant (the “Cashless
Warrant”) to purchase up to 500,000 shares of Common Stock, each at an exercise price of $4.00 per share for a period of three
years which is exercisable six (6) months from the issuance date.
Concurrently,
on December 31, 2024, the Company entered into a series of agreements whereby additional investors agreed to loan the Company $220,000
against an unsecured promissory note (the “$220k Note”). The $220k Note has a maturity date of one (1) year from the date
thereof, is unsecured and has no prepayment penalty.
In
connection with the $220k Note, the investors also received fifteen percent (15%) guaranteed prepaid interest issued in the form of Series
K Preferred Stock as well as a warrant on to purchase up to 220,000 shares of the Company’s common stock. The warrant has
an exercise price of $4.00 per share and is exercisable for a period of three years, beginning the issuance date. If at the time of any
exercise of the warrant, there is no effective registration statement registering, or no current prospectus available for, the issuance
or resale of the shares by the investor, then such investor may elect to exercise up to 50% of the warrant on a cashless basis. In connection
with the $220k Note, the Company entered into a registration rights agreement with respect to the shares of Common Stock underlying the
Series K Preferred Stock and Half Cashless Warrant (the “Registration Rights Agreement”).
Each
Series K investor entered into a securities purchase agreement (the “Series K Purchase Agreement”) whereby an aggregate of
60,595 restricted shares of Series K Preferred, (the “Series K Offering”) at a purchase price of $3.02 per share.
The
Series K Preferred shall be convertible into the Company’s common stock (the “Common Stock”) on such date that the
Company obtains stockholder approval to remove the Exchange Cap (as described below).
The
Series K Purchase Agreement contains customary representations, warranties, conditions to closing, indemnification rights and obligations
of the parties and termination provisions.
See
Item 5.03 below for a description of the terms of the Series K Preferred, which is incorporated by reference herein.
Conversion
of Related Party Loans into Series L Preferred Stock
On
December 31, 2024, the Company entered into debt conversion agreements (the “Related Party Debt Conversion Agreements”) with
its chief executive officer William Kerby and chairman of the board Donald P. Monaco (the “Related Parties”) whereby the
Related Parties and the Company agreed to convert $1.75 million in existing unsecured promissory notes owed to the Related Parties for
monies advanced to the Company into an aggregate of 579,469 restricted shares of newly designated Series L Nonvoting Convertible Preferred
Stock of the Company (the “Series L Preferred”), (the “Series L Offering”) at a purchase price of $3.02 per share.
The
Series L Preferred shall be convertible into the Company’s common stock (the “Common Stock”) on such date that the
Company obtains stockholder approval to remove the Exchange Cap (as described below), subject to beneficial ownership limitations.
See
Item 5.03 below for a description of the terms of the Series L Preferred, which is incorporated by reference herein.
Series
M Preferred Stock Offering and Debt Conversion
On
December 31, 2024, the Company entered into a securities purchase agreement (the “Series M Purchase Agreement,” and together
with the Series J Purchase Agreement and Series K Purchase Agreement, the “Purchase Agreements”) with certain accredited
investors (the “Purchasers”), pursuant to which the Company may issue and sell up to $500,000
of restricted shares of newly designated Series
M Nonvoting Convertible Preferred Stock of the Company (the “Series M Preferred”), (the “Series M Offering,”
and together with the Series J Offering, Series K Offering and Series L Offering, the “Offerings”) at a purchase price of
$3.02 per share.
In
addition, as part of the Series M Offering, on December 31, 2024, the Company entered into a debt conversion agreement (the “Debt
Conversion Agreement,” and together with the Related Party Debt Conversion Agreements, the “Debt Conversion Agreements”)
with an existing lender whereby the lender and the Company agreed to convert $350,000 in existing unsecured promissory notes owed to
the lender for monies advanced to the Company into Series M Preferred.
The
Series M Preferred shall be convertible into the Company’s Common Stock on such date that the Company obtains stockholder approval
to remove the Exchange Cap (as described below).
The
Series M Purchase Agreement contains customary representations, warranties, conditions to closing, indemnification rights and obligations
of the parties and termination provisions.
See
Item 5.03 below for a description of the terms of the Series M Preferred, which is incorporated by reference herein.
Each
of the foregoing Offerings include conversion or exercise limitations which provide that the Company shall not issue or sell any shares
of Common Stock pursuant to the conversions of preferred stock or exercises of warrants to the extent that after giving effect thereto,
the aggregate number of shares of Common Stock that would be issued would exceed 19.99% of the shares of Common Stock outstanding on
the date of each such Offering (which number of shares shall be reduced, on a share-for-share basis, by the number of shares of Common
Stock issued or issuable pursuant to any transaction or series of transactions that may be aggregated with the transactions contemplated
by each such separate Offering under applicable rules of the Nasdaq Capital Market) (the “Exchange Cap”) unless and until
the Company elects to solicit stockholder approval of the issuance of Common Stock as contemplated by the Purchase Agreements and the
stockholders of the Company have in fact approved such issuance in accordance with the applicable rules and regulations of the Nasdaq
Capital Market.
The
Company intends to use the net proceeds from the Offerings as working capital for general corporate purposes.
The
foregoing summaries of the Purchase Agreements, Warrants, Unsecured Promissory Notes, Debt Conversion Agreements and Registration Rights
Agreement do not purport to be complete and are subject to, and qualified in their entirety by, the forms of such documents attached
as Exhibits 10.1-10.8 and 4.1-4.3, respectively, to this Current Report on Form 8-K (this “Current Report”), which are incorporated
herein by reference.
Item
3.02 Unregistered Sales of Equity Securities.
The
information in Item 1.01 regarding the issuance of the Series J Preferred, Series K Preferred, Series L Preferred, Series M Preferred
and Warrants is hereby incorporated herein by reference.
The
shares of Series J Preferred, Series K Preferred, Series L Preferred, Series M Preferred and Warrants issued by the Company (the “Securities”)
have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or any state securities laws,
and were issued to the respective recipients in transactions exempt from registration under the Securities Act in reliance upon the exemption
from registration provided by Section 4(a)(2) under the Securities Act and/or Regulation D promulgated thereunder. Accordingly, the Securities
constitute, and the shares of Company common stock underlying the Preferred Shares and Warrants, when issued upon conversion of the Preferred
Shares and exercise of the Warrants, respectively, will constitute, “restricted securities” within the meaning of Rule 144
under the Act.
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
Series
J Nonvoting Convertible Preferred Stock
On
January 3, 2025, the Company filed a Certificate of Designation of Series J Convertible Preferred Stock (the “Series J Certificate
of Designation”) with the Secretary of State of the State of Nevada, designating 297,788 shares of the Company’s preferred
stock as Series J Convertible Preferred Stock, par value $0.001 per share.
The
terms and conditions set forth in the Series J Certificate of Designation are summarized below:
Ranking.
The Series J Preferred rank pari passu to the Company’s common stock.
Dividends.
Holders of Series J Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.
Voting.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series J Preferred are not entitled
to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series J Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series J Preferred or alter or amend the Series J Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series J Preferred, or (c) enter into any agreement with respect to the foregoing.
Conversion.
On the third business day after the date that the Company’s stockholders approve the conversion of Series J Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series J Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the “Series J Conversion Ratio”),
subject to beneficial ownership limitations.
Liquidation.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series J Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series J Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company’s common stock.
The
foregoing summary of the Series J Certificate of Designation does not purport to be complete and is subject to, and qualified in its
entirety by, the copy of the Series J Certificate of Designation attached as Exhibits 3.1 to this Current Report, which is incorporated
herein by reference.
Series
K Nonvoting Convertible Preferred Stock
On
January 3, 2025, the Company filed a Certificate of Designation of Series K Convertible Preferred Stock (the “Series K Certificate
of Designation”) with the Secretary of State of the State of Nevada, designating 60,595 shares of the Company’s preferred
stock as Series K Convertible Preferred Stock, par value $0.001 per share.
The
terms and conditions set forth in the Series K Certificate of Designation are summarized below:
Ranking.
The Series K Preferred rank pari passu to the Company’s common stock.
Dividends.
Holders of Series K Preferred will be entitled to dividends, on an as-converted basis, equal to dividends actually paid, if any,
on shares of Company common stock.
Voting.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series K Preferred are not entitled
to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series K Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series K Preferred or alter or amend the Series K Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series K Preferred, or (c) enter into any agreement with respect to the foregoing.
Conversion.
On the third business day after the date that the Company’s stockholders approve the conversion of Series K Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series K Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the “Series K Conversion Ratio”),
subject to beneficial ownership limitations.
Liquidation.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series K Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series K Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company’s common stock.
The
foregoing summary of the Series K Certificate of Designation does not purport to be complete and is subject to, and qualified in its
entirety by, the copy of the Series K Certificate of Designation attached as Exhibits 3.2 to this Current Report, which is incorporated
herein by reference.
Series
L Nonvoting Convertible Preferred Stock
On
January 3, 2025, the Company filed a Certificate of Designation of Series L Convertible Preferred Stock (the “Series L Certificate
of Designation”) with the Secretary of State of the State of Nevada, designating 579,469 shares of the Company’s preferred
stock as Series L Convertible Preferred Stock, par value $0.001 per share.
The
terms and conditions set forth in the Series L Certificate of Designation are summarized below:
Ranking.
The Series L Preferred rank pari passu to the Company’s common stock.
Dividends.
Holders of Series L Preferred will be entitled to dividends, if, as and when declared by the Board out of funds at the time legally
available therefor, dividends in the amount of 12% per annum per share of Preferred Stock (subject to appropriate adjustment in the event
of any stock dividend, stock split, combination or other similar recapitalization with respect to the Preferred Stock), and no more.
Dividends on the Preferred Stock shall be fully cumulative, shall accrue without interest and without compounding from the date of first
issuance, and shall, if declared by the Board, be payable quarterly in arrears on March 1, June 1, September 1 and December of each year.
All dividends on the Preferred Stock shall be payable (i) in shares of Common Stock of the Company at the Nasdaq Closing Price; provided,
however, that such prices shall not be less than $3.02 per share, or (ii) cash, at the election of a majority of the independent directors.
Any dividend which shall not be paid on required dividend date on which it shall become due shall be deemed to be “past due”
until such dividend shall be paid or until the share of Preferred Stock with respect to which such dividend became due shall no longer
be outstanding, whichever is the earlier to occur. In the event that any dividend becomes “past due” the per annum rate shall
increase to 14%.
Voting.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series L Preferred are not entitled
to voting rights However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series L Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series L Preferred or alter or amend the Series L Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series L Preferred, or (c) enter into any agreement with respect to the foregoing.
Conversion.
On the third business day after the date that the Company’s stockholders approve the conversion of Series L Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series L Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the “Series L Conversion Ratio”),
subject to beneficial ownership limitations.
Liquidation.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series L Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series L Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company’s common stock.
The
foregoing summary of the Series L Certificate of Designation does not purport to be complete and is subject to, and qualified in its
entirety by, the copy of the Series L Certificate of Designation attached as Exhibits 3.3 to this Current Report, which is incorporated
herein by reference.
Series
M Nonvoting Convertible Preferred Stock
On
January 3, 2025, the Company filed a Certificate of Designation of Series M Convertible Preferred Stock (the “Series M Certificate
of Designation”) with the Secretary of State of the State of Nevada, designating 165,562
shares of the Company’s preferred stock as Series M Convertible
Preferred Stock, par value $0.001 per share.
The
terms and conditions set forth in the Series M Certificate of Designation are summarized below:
Ranking.
The Series M Preferred rank pari passu to the Company’s common stock.
Dividends.
Holders of Series M Preferred will be entitled to dividends, if, as and when declared by the Board out of funds at the time legally
available therefor, dividends in the amount of 12% per annum per share of Preferred Stock (subject to appropriate adjustment in the event
of any stock dividend, stock split, combination or other similar recapitalization with respect to the Preferred Stock), and no more.
Dividends on the Preferred Stock shall be fully cumulative, shall accrue without interest and without compounding from the date of first
issuance, and shall, if declared by the Board, be payable quarterly in arrears on March 1, June 1, September 1 and December of each year.
All dividends on the Preferred Stock shall be payable (i) in shares of Common Stock of the Company at the Nasdaq Closing Price; provided,
however, that such prices shall not be less than $3.02 per share, or (ii) cash, at the election of a majority of the independent directors.
Any dividend which shall not be paid on required dividend date on which it shall become due shall be deemed to be “past due”
until such dividend shall be paid or until the share of Preferred Stock with respect to which such dividend became due shall no longer
be outstanding, whichever is the earlier to occur. In the event that any dividend becomes “past due” the per annum rate shall
increase to 14%.
Voting.
Except as provided by the Charter, or as otherwise required by the Nevada Revised Statutes, holders of Series M Preferred are not entitled
to voting rights. However, the Company may not, without the consent of holders of a majority of the outstanding shares of Series M Preferred,
(i) alter or change adversely the powers, preferences or rights given to the Series M Preferred or alter or amend the Series M Certificate
of Designation, (ii) amend its Charter or other charter documents in any manner that adversely effects any rights of the holders of the
Series M Preferred, or (c) enter into any agreement with respect to the foregoing.
Conversion.
On the third business day after the date that the Company’s stockholders approve the conversion of Series M Preferred into shares
of Common Stock in accordance with the listing rules of Nasdaq, each outstanding share of Series M Preferred shall automatically be converted
into one share of Company common stock (subject to adjustment under certain limited circumstances) (the “Series M Conversion Ratio”),
subject to beneficial ownership limitations.
Liquidation.
In the event of any liquidation, dissolution or winding up of the Company, either voluntary or involuntary, holders of Series M Preferred
will be entitled to participate, on an as-converted-to-common stock basis calculated based on the Series M Conversion Ratio, with holders
of Company common stock in any distribution of assets of the Company to holders of the Company’s common stock.
The
foregoing summary of the Series M Certificate of Designation does not purport to be complete and is subject to, and qualified in its
entirety by, the copy of the Series M Certificate of Designation attached as Exhibits 3.4 to this Current Report, which is incorporated
herein by reference.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
Exhibit
Number |
|
Description |
3.1 |
|
Certificate of Designation of Series J Nonvoting Convertible Preferred Stock. |
3.2 |
|
Certificate of Designation of Series K Nonvoting Convertible Preferred Stock. |
3.3 |
|
Certificate of Designation of Series L Nonvoting Convertible Preferred Stock. |
3.4 |
|
Certificate of Designation of Series M Nonvoting Convertible Preferred Stock. |
4.1 |
|
Form of Cash Warrant. |
4.2 |
|
Form of Cashless Warrant. |
4.3 |
|
Form of Half Cashless Warrant. |
10.1 |
|
Form of Series J Preferred Stock Securities Purchase Agreement, dated as of December 31, 2024. |
10.2 |
|
Form of Series K Preferred Stock Securities Purchase Agreement, dated as of December 31, 2024. |
10.3 |
|
Form of Series M Preferred Stock Securities Purchase Agreement, dated as of December 31, 2024. |
10.4 |
|
Form of Related Party Debt Conversion Agreement, dated as of December 31, 2024. |
10.5 |
|
Form of Debt Conversion Agreement, dated as of December 31, 2024. |
10.6 |
|
Unsecured Promissory Note, dated as of December 31, 2024. |
10.7 |
|
Unsecured Promissory Note, dated as of December 31, 2024. |
10.8 |
|
Registration Rights Agreement, dated as of December 31, 2024. |
104 |
|
Cover
Page Interactive Data File (embedded within the inline XBRL Document) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
NEXTTRIP, INC. |
|
|
|
|
Date: |
January
3, 2025 |
By: |
/s/
William Kerby |
|
|
|
Name:
William Kerby
Title: Chief Executive Officer |
Exhibit
3.1
CERTIFICATE
OF DESIGNATION
OF
NEXTTRIP,
INC.
Pursuant
to Section 78.1955 of the
Nevada
Revised Statutes
SERIES
J NONVOTING CONVERTIBLE PREFERRED STOCK
The
undersigned, William Kerby, Chief Executive Officer, does hereby certify that:
1.
He is the President and Chief Executive Officer of NextTrip, Inc., a Nevada corporation (the “Corporation”).
2.
The Corporation is authorized to issue 10,000,000 shares of preferred stock, of which (a) 1,621,500 shares have been designated as Series
A Convertible Preferred Stock, none of which are presently issued and outstanding; (b) 1,000 shares have been designated as Series B
Convertible Preferred Stock, none of which are presently issued and outstanding; (c) 1,500 shares have been designated as Series C Convertible
Preferred Stock, none of which are presently issued and outstanding; (d) 7,796 shares have been designated as Series D Convertible Preferred
Stock, none of which are presently issued and outstanding; (e) 500 shares have been designated as Series E Convertible Preferred Stock,
316 of which are presently issued and outstanding; (f) 5,843,997 shares have been designated as Series F Convertible Preferred Stock,
none of which are presently issued and outstanding; (g) 100,000 shares have been designated as Series G Convertible Preferred Stock,
100,000 of which are presently issued and outstanding; (h) 150,000 shares have been designated as Series H Convertible Preferred Stock,
150,000 of which are presently issued and outstanding and (i) 331,124 shares have been designated as Series I Convertible Preferred Stock,
318,706 of which are presently issued and outstanding.
3.
The following resolutions were duly adopted by the board of directors of the Corporation (the “Board of Directors”):
WHEREAS,
the amended and restated articles of incorporation of the Corporation, as amended (the “Articles of Incorporation”),
provide for a class of its authorized stock known as preferred stock, consisting of 10,000,000 shares, $0.001 par value per share, issuable
from time to time in one or more series;
WHEREAS,
the Board of Directors is authorized to fix the dividend rights, dividend rate, voting rights, conversion rights, rights and terms of
redemption and liquidation preferences of any wholly unissued series of preferred stock and the number of shares constituting any series
and the designation thereof, of any of them; and
WHEREAS,
it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions and
other matters relating to a series of the preferred stock, which shall consist up to two hundred ninety-seven thousand seven hundred
and eighty-eight (297,788) shares of Series J Convertible Preferred Stock, as follows:
NOW,
THEREFORE, BE IT RESOLVED, that the Board of Directors does hereby provide for the issuance of a series of preferred stock for cash or
exchange of other securities, rights or property and does hereby fix and determine the rights, preferences, restrictions and other matters
relating to such series of preferred stock as follows:
1.
Definitions.
“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.
“Business
Day” means any day other than a Saturday, Sunday or a legal holiday on which commercial banking institutions in New York, New
York are authorized to close for business; provided that banks shall not be deemed to be authorized or obligated to be closed due to
a “shelter in place” or similar closure of physical branch locations at the direction of any governmental authority if such
banks’ electronic funds transfer systems (including for wire transfers) are open for use by customers on such day.
“Common
Stock” means the Corporation’s common stock, par value $0.001 per share.
“Common
Stock Equivalents” means any securities of the Corporation or the its subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.
“Conversion
Date” shall have the meaning set forth in Section 7(a).
“Conversion
Ratio” shall have the meaning set forth in Section 7(a).
“Conversion
Shares” means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance
with the terms hereof.
“Converted
Stock” shall have the meaning set forth in Section 7(a)
“Holder”
means, as of a given point in time, a Person who holds Preferred Stock.
“Liquidation
Event” shall have the meaning set forth in Section 6(a).
“Person”
means an individual, corporation, exempted company, partnership (including a general partnership, limited partnership, exempted limited
partnership or limited liability partnership), limited liability company, association, trust or other entity or organization, including
a government, domestic or foreign, or political subdivision thereof, or an agency or instrumentality thereof.
“Preferred
Stock” shall have the meaning set forth in Section 2.
“Purchase
Agreement” means the Securities Purchase Agreement, dated as of December 31, 2024, among the Corporation and each Purchaser,
as amended, modified or supplemented from time to time in accordance with its terms.
“Purchasers”
means each of those purchasers that purchases securities of the Corporation pursuant to the Purchase Agreement, as identified on the
signature pages to the Purchase Agreement.
“Requisite
Holders” means holders of record of a majority of the outstanding shares of Preferred Stock (excluding, for the avoidance of
doubt, any shares of Preferred Stock that are held by the Corporation or its controlled Affiliates (including in treasury), whether repurchased,
redeemed or otherwise acquired, which shall not be entitled to a vote).
“SEC”
means the United States Securities and Exchange Commission.
“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
“Share
Delivery Date” shall have the meaning set forth in Section 7(c).
“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the Pink Open Market, OTCQB or the OTCQX (or any successors to any of the foregoing).
“Transaction
Documents” means this Certificate of Designation, the Purchase Agreement, the Warrants, all exhibits and schedules thereto
and hereto and any other documents or agreements executed in connection with the transactions contemplated by the Purchase Agreement.
2.
Designation, Amount and Par Value. This series of preferred stock shall be designated and known as “Series J Convertible
Preferred Stock” (the “Preferred Stock”). The number of shares constituting the Preferred Stock shall be two
hundred ninety-seven thousand seven hundred and eighty-eight (297,788) shares. Each share of Preferred Stock shall have a par value of
$0.001 per share.
3.
Ranking. Except as otherwise provided herein, the Preferred Stock shall, with respect to rights on liquidation, winding up and
dissolution, rank pari passu to the common stock, par value $0.001 per share (the “Common Stock”), of the Corporation.
4.
Dividends. Holders of Preferred Stock (each a “Holder” and collectively, the “Holders”)
shall be entitled to receive, and the Corporation shall pay, dividends on shares of Preferred Stock equal (on an as-if-converted-to-Common-Stock
basis calculated based on the Conversion Ratio, disregarding for such purpose any conversion limitations or liquidation preferences hereunder)
to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of
the Common Stock. Other than as set forth in the previous sentence, no other dividends shall be paid on shares of Preferred Stock, and
the Corporation shall pay no dividends (other than dividends in the form of Common Stock) on shares of the Common Stock unless it simultaneously
complies with the previous sentence.
5.
Voting. Except as otherwise provided herein or as otherwise required by the Nevada Revised Statutes, the Preferred Stock shall
have no voting rights. However, as long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative
vote of the holders of a majority of the then outstanding shares of the Preferred Stock alter or change adversely the powers, preferences
or rights given to the Preferred Stock or alter or amend this Certificate of Designation, amend or repeal any provision of, or add any
provision to, the Certificate of Incorporation or Amended and Restated Bylaws of the Corporation, or file any articles of amendment,
certificate of designations, preferences, limitations and relative rights of any series of Preferred Stock, if such action would adversely
alter or change the preferences, rights, privileges or powers of, or restrictions provided for the benefit of the Preferred Stock, regardless
of whether any of the foregoing actions shall be by means of amendment to the Certificate of Incorporation or by merger, consolidation,
recapitalization, reclassification, conversion or otherwise. Holders of shares of Common Stock acquired upon the conversion of shares
of Preferred Stock shall be entitled to the same voting rights as each other holder of Common Stock, except that such holders may not
vote such shares upon the proposal for Stockholder Approval in accordance with Rule 5635 of the listing rules of The Nasdaq Stock Market
LLC.
6.
Liquidation Rights.
(a)
Liquidation. In the event of any liquidation, dissolution or winding up of the Corporation, either voluntary or involuntary (each
a “Liquidation Event”), the Holders of Preferred Stock shall be entitled to participate, on an as-converted-to-Common
Stock basis calculated based on the Conversion Ratio (disregarding for such purpose any conversion limitations or liquidation preferences
hereunder), with holders of the Common Stock in any distribution of assets of the Corporation to the holders of the Common Stock.
(b)
Valuation of Non-Cash Consideration. If any assets of the Corporation distributed to stockholders in connection with any liquidation,
dissolution, or winding up of the Corporation are other than cash, then the value of such assets shall be their fair market value as
determined in good faith by the Board of Directors. In the event of a merger or other acquisition of the Corporation by another entity,
the distribution date shall be deemed to be the date such transaction closes.
7.
Conversion.
(a)
Automatic Conversion. Effective as of 5:00 p.m. Eastern time on the third Business Day after the date that the Corporation’s
stockholders approve the conversion of the Preferred Stock into shares of Common Stock (the “Conversion Date”) in
accordance with the listing rules of the Nasdaq Stock Market, as set forth in Section 4.9 of the Purchase Agreement (the “Stockholder
Approval”), each share of Preferred Stock then outstanding shall automatically convert into a number of shares of Common Stock
equal to the Conversion Ratio (as defined below), subject to the Beneficial Ownership Limitation (the “Automatic Conversion”).
In determining the application of the Beneficial Ownership Limitations solely with respect to the Automatic Conversion, the Corporation
shall calculate beneficial ownership for each Holder assuming beneficial ownership by such Holder of: (x) the number of shares of Common
Stock issuable to such Holder in such Automatic Conversion, plus (y) any additional shares of Common Stock for which a Holder has provided
the Corporation with prior written notice of beneficial ownership within 30 days prior to the date of Stockholder Approval (a “Beneficial
Ownership Statement”) and assuming the conversion of all shares of Preferred Stock held by all other Holders less the aggregate
number of shares of Preferred Stock held by all other Holders that will not convert into shares of Common Stock on account of the application
of any Beneficial Ownership Limitations applicable to any such other Holders. If a Holder fails to provide the Corporation with a Beneficial
Ownership Statement within 30 days prior to the date of Stockholder Approval, then the Corporation shall presume the Holder’s beneficial
ownership of Common Stock (excluding the Conversion Shares) to be zero. The shares of Preferred Stock that are converted in the Automatic
Conversion are referred to as the “Converted Stock”. The Conversion Shares shall be issued as follows: each outstanding share
of Preferred Stock shall be automatically converted into one (1) share of Common Stock (subject to adjustment as set forth herein) (the
“Conversion Ratio”). The shares of Preferred Stock that are converted pursuant to this Section 7 are referred to as
the “Converted Stock.”
(b)
Delivery of Conversion Shares Upon Conversion. Not later than five (5) Business Days after the Conversion Date, the Corporation
shall deliver, or cause to be delivered, to the Holders such number of Conversion Shares being acquired upon the conversion of the Preferred
Stock. The Conversion Shares shall be issued as follows:
i.
Converted Stock that is registered in book entry form shall be automatically cancelled upon the Conversion Date and converted into the
corresponding Conversion Shares, which shares shall be issued in book entry form and without any action on the part of the Holders and
shall be delivered to the Holders within two (2) Business Days of the effectiveness of the conversion.
ii.
Converted Stock that is issued in certificated form shall be deemed converted into the corresponding Conversion Shares on the Conversion
Date and the Holder’s rights as a holder of such shares of Converted Stock shall cease and terminate on such date, excepting only
the right to receive the Conversion Shares upon the Holder tendering to the Corporation (or its designated agent) the stock certificate(s)
(duly endorsed) representing such certificated Converted Stock and any remedies provided herein or otherwise available at law or in equity
to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation.
(c)
Delivery of Certificate or Book Entry Form. Upon conversion, not later than two (2) Business Days after the Conversion Date, or
if the Holder requests the issuance of physical certificate(s), two (2) Business Days after receipt by the Corporation of the original
certificate(s) representing such shares of Preferred Stock being converted, duly endorsed by the Holder (the “Share Delivery
Date”), the Corporation shall either: (a) in the event that the Holder has so elected in a written notice to the Corporation,
deliver, or cause to be delivered, to the converting Holder a physical certificate or certificates representing the number of Conversion
Shares being acquired upon the conversion of shares of Preferred Stock or (b) otherwise shall issue and deliver to such Holder or such
Holder’s nominees, documentation of the book entry for the number of Conversion Shares being acquired.
(d)
Beneficial Ownership Limitation. Notwithstanding anything contrary herein, the Corporation shall not effect the conversion of
any of the Preferred Stock held by a Holder, and such Holder shall not have the right to convert any of the Preferred Stock held by such
Holder pursuant to the terms and conditions of this Certificate of Designation and any such conversion shall be null and void and treated
as if never made, to the extent that after giving effect to such conversion, such Holder (together with the Holder’s Affiliates,
and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution
Parties”)) collectively would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes
of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock held by such Holder and all other Attribution Parties plus the number of shares of
Common Stock issuable upon conversion of the Preferred Stock with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) conversion of the remaining, nonconverted Preferred Stock beneficially
owned by such Holder or any of the other Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion
of any other securities of the Corporation (including, without limitation, any other Common Stock Equivalents) subject to a limitation
on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution
Parties. Except as set forth in the preceding sentence, for purposes of this Section 7(d), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the
Holder that the Corporation is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange
Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation
contained in this Section 7(d) applies, the determination of whether the Preferred Stock is convertible (in relation to other securities
owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of the Holder’s Preferred Stock
is convertible shall be in the sole discretion of the Holder, and the submission of a Notice of Conversion shall be deemed to be the
Holder’s determination of whether the Holder’s Preferred Stock is convertible (in relation to other securities owned by the
Holder together with any Affiliates and Attribution Parties) and of which portion of the Holder’s Preferred Stock is convertible,
in each case subject to the Beneficial Ownership Limitation, and the Corporation shall have no obligation to verify or confirm the accuracy
of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with
Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 7(d), in determining
the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected
in (A) the Corporation’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent
public announcement by the Corporation or (C) a more recent written notice by the Corporation or the Transfer Agent setting forth the
number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Corporation shall within one Trading
Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Corporation, including
the Preferred Stock, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares
of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% (or, upon election by a Holder
in compliance with this Section 7(d) prior to the issuance of any Preferred Stock, 9.99%) of the number of shares of the Common Stock
outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of the Holder’s
Preferred Stock. The Holder, upon notice to the Corporation, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section 7(d), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion of the Preferred Stock held
by the Holder and the provisions of this Section 7(d) shall continue to apply. Any increase in the Beneficial Ownership Limitation will
not be effective until the 61st day after such notice is delivered to the Corporation. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 7(d) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of shares of Preferred Stock.
(d)
Reservation of Shares Issuable Upon Conversion. The Corporation shall reserve and keep available out of its authorized and unissued
shares of Common Stock, for the sole purpose of issuance upon conversion of the Preferred Stock as herein provided, free from preemptive
rights or any other actual contingent purchase rights of Persons other than the Holders, not less than such aggregate number of shares
of the Common Stock as shall (subject to the terms and conditions set forth in the Purchase Agreement) be issuable upon the conversion
of the then outstanding shares of Preferred Stock. All shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized,
validly issued, fully paid and nonassessable.
(e)
Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Preferred
Stock. As to any fraction of a share which a Holder would otherwise be entitled to receive upon such conversion, the Corporation shall
round down to the next whole share of Common Stock.
(f)
Transfer Taxes and Expenses. The issuance of Conversion Shares shall be made without charge to any Holder for any documentary
stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares, provided that the Corporation
shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such
Conversion Shares upon conversion in a name other than that of the Holders of such shares of Preferred Stock and the Corporation shall
not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting the issuance thereof shall
have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation that such tax has
been paid. The Corporation shall pay all transfer agent fees required for same-day processing of any Conversion and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of
the Conversion Shares.
(g)
Certain Adjustments.
i.
Stock Splits. If the Corporation, at any time while the Preferred Stock is outstanding: (A) subdivides outstanding shares of Common
Stock into a larger number of shares; or (B) combines (including by way of a reverse stock split) outstanding shares of Common Stock
into a smaller number of shares, then the Conversion Ratio shall be multiplied by a fraction of which the numerator shall be the number
of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately after such event and of which the
denominator shall be the number of shares of Common Stock outstanding immediately before such event (excluding any treasury shares of
the Corporation). Any adjustment made pursuant to this Section 7(g) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision or combination. Upon the occurrence of each adjustment to the Conversion Ratio, the Corporation,
at its expense, shall, as promptly as reasonably possible but in any event not later than five (5) Business Days thereafter, compute
such adjustment in accordance with the terms hereof and furnish to each Holder a certificate setting forth such adjustment and showing
in detail the facts upon which such adjustment is based. The Corporation shall, as promptly as reasonably practicable after the written
request at any time of any Holder (but in any event not later than five (5) Business Days thereafter), furnish or cause to be furnished
to such Holder a certificate setting forth (i) the Conversion Ratio then in effect and (ii) the number of shares of Common Stock which
then would be received by such Holder upon conversion.
ii.
Calculations. All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th
of a share, as the case may be. For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding
as of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued
and outstanding
8.
Redemption Right. The Preferred Stock shall not have any redemption rights.
9.
Miscellaneous.
(a)
Notices. Except as otherwise provided herein, all notices, requests, consents, claims, demands, waivers, and other communications
hereunder shall be in writing and shall be deemed to have been given: (a) when delivered by hand (with written confirmation of receipt);
(b) when received by the addressee if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by
facsimile or e-mail of a PDF document (with confirmation of transmission) if sent during normal business hours of the recipient, and
on the next business day if sent after normal business hours of the recipient; or (d) on the third day after the date mailed, by certified
or registered mail, return receipt requested, postage prepaid. Such communications must be sent (a) to the Corporation, at its principal
executive offices and (b) to any stockholder, at such holder’s address at it appears in the stock records of the Corporation (or
at such other address for a stockholder as shall be specified in a notice given in accordance with this Section 9).
(b)
Failure or Indulgence Not Waiver. No failure or delay on the part of a Holder in the exercise of any power, right or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude
other or further exercise thereof or of any other right, power or privilege. No waiver shall be effective unless it is in writing and
signed by an authorized representative of the waiving party.
(c)
Transfer of Preferred Stock. A Holder may transfer some or all of its shares of Preferred Stock without the consent of the Corporation
so long as such transfer complies with all applicable securities laws.
(d)
Amendment. This Certificate of Designation or any provision hereof may be amended by obtaining the affirmative vote at a meeting
duly called for such purpose, or written consent without a meeting in accordance with the Nevada Revised Statutes, by a majority of the
Holders, voting separate as a single class, and with such other stockholder approval, if any, as may then be required pursuant to the
Nevada Revised Statutes or the Articles of Incorporation.
IN
WITNESS WHEREOF the undersigned has signed this Designation this 31st day of December 2024.
NEXTTRIP,
INC. |
|
|
|
|
By:
|
|
|
Name:
|
William
Kerby, Chief Executive Officer |
|
Exhibit
3.2
CERTIFICATE
OF DESIGNATION
OF
NEXTTRIP,
INC.
Pursuant
to Section 78.1955 of the
Nevada
Revised Statutes
SERIES
K NONVOTING CONVERTIBLE PREFERRED STOCK
The
undersigned, William Kerby, Chief Executive Officer, does hereby certify that:
1.
He is the President and Chief Executive Officer of NextTrip, Inc., a Nevada corporation (the “Corporation”).
2.
The Corporation is authorized to issue 10,000,000 shares of preferred stock, of which (a) 1,621,500 shares have been designated as Series
A Convertible Preferred Stock, none of which are presently issued and outstanding; (b) 1,000 shares have been designated as Series B
Convertible Preferred Stock, none of which are presently issued and outstanding; (c) 1,500 shares have been designated as Series C Convertible
Preferred Stock, none of which are presently issued and outstanding; (d) 7,796 shares have been designated as Series D Convertible Preferred
Stock, none of which are presently issued and outstanding; (e) 500 shares have been designated as Series E Convertible Preferred Stock,
316 of which are presently issued and outstanding; (f) 5,843,997 shares have been designated as Series F Convertible Preferred Stock,
none of which are presently issued and outstanding; (g) 100,000 shares have been designated as Series G Convertible Preferred Stock,
100,000 of which are presently issued and outstanding; (h) 150,000 shares have been designated as Series H Convertible Preferred Stock,
150,000 of which are presently issued and outstanding and (i) 331,124 shares have been designated as Series I Convertible Preferred Stock,
318,706 of which are presently issued and outstanding and (j) 297,788 shares have been designated as Series J Nonvoting Convertible Preferred
Stock, 297,788 of which are presently issued and outstanding.
3.
The following resolutions were duly adopted by the board of directors of the Corporation (the “Board of Directors”):
WHEREAS,
the amended and restated articles of incorporation of the Corporation, as amended (the “Articles of Incorporation”),
provide for a class of its authorized stock known as preferred stock, consisting of 10,000,000 shares, $0.001 par value per share, issuable
from time to time in one or more series;
WHEREAS,
the Board of Directors is authorized to fix the dividend rights, dividend rate, voting rights, conversion rights, rights and terms of
redemption and liquidation preferences of any wholly unissued series of preferred stock and the number of shares constituting any series
and the designation thereof, of any of them; and
WHEREAS,
it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions and
other matters relating to a series of the preferred stock, which shall consist up to sixty thousand five hundred and ninety-five (60,595)
shares of Series K Convertible Preferred Stock, as follows:
NOW,
THEREFORE, BE IT RESOLVED, that the Board of Directors does hereby provide for the issuance of a series of preferred stock for cash or
exchange of other securities, rights or property and does hereby fix and determine the rights, preferences, restrictions and other matters
relating to such series of preferred stock as follows:
1. Definitions.
“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.
“Business
Day” means any day other than a Saturday, Sunday or a legal holiday on which commercial banking institutions in New York, New
York are authorized to close for business; provided that banks shall not be deemed to be authorized or obligated to be closed due to
a “shelter in place” or similar closure of physical branch locations at the direction of any governmental authority if such
banks’ electronic funds transfer systems (including for wire transfers) are open for use by customers on such day.
“Common
Stock” means the Corporation’s common stock, par value $0.001 per share.
“Common
Stock Equivalents” means any securities of the Corporation or the its subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.
“Conversion
Date” shall have the meaning set forth in Section 7(a).
“Conversion
Ratio” shall have the meaning set forth in Section 7(a).
“Conversion
Shares” means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance
with the terms hereof.
“Converted
Stock” shall have the meaning set forth in Section 7(a)
“Holder”
means, as of a given point in time, a Person who holds Preferred Stock.
“Liquidation
Event” shall have the meaning set forth in Section 6(a).
“Person”
means an individual, corporation, exempted company, partnership (including a general partnership, limited partnership, exempted limited
partnership or limited liability partnership), limited liability company, association, trust or other entity or organization, including
a government, domestic or foreign, or political subdivision thereof, or an agency or instrumentality thereof.
“Preferred
Stock” shall have the meaning set forth in Section 2.
“Purchase
Agreement” means the Securities Purchase Agreement, dated as of December 31, 2024, among the Corporation and each Purchaser,
as amended, modified or supplemented from time to time in accordance with its terms.
“Purchasers”
means each of those purchasers that purchases securities of the Corporation pursuant to the Purchase Agreement, as identified on the
signature pages to the Purchase Agreement.
“Requisite
Holders” means holders of record of a majority of the outstanding shares of Preferred Stock (excluding, for the avoidance of
doubt, any shares of Preferred Stock that are held by the Corporation or its controlled Affiliates (including in treasury), whether repurchased,
redeemed or otherwise acquired, which shall not be entitled to a vote).
“SEC”
means the United States Securities and Exchange Commission.
“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
“Share
Delivery Date” shall have the meaning set forth in Section 7(c).
“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the Pink Open Market, OTCQB or the OTCQX (or any successors to any of the foregoing).
“Transaction
Documents” means this Certificate of Designation, the Purchase Agreement, the Warrants, all exhibits and schedules thereto
and hereto and any other documents or agreements executed in connection with the transactions contemplated by the Purchase Agreement.
2.
Designation, Amount and Par Value. This series of preferred stock shall be designated and known as “Series K Convertible
Preferred Stock” (the “Preferred Stock”). The number of shares constituting the Preferred Stock shall be sixty
thousand five hundred and ninety-five (60,595) shares. Each share of Preferred Stock shall have a par value of $0.001 per share.
3.
Ranking. Except as otherwise provided herein, the Preferred Stock shall, with respect to rights on liquidation, winding up and
dissolution, rank pari passu to the common stock, par value $0.001 per share (the “Common Stock”), of the Corporation.
4.
Dividends. Holders of Preferred Stock (each a “Holder” and collectively, the “Holders”)
shall be entitled to receive, and the Corporation shall pay, dividends on shares of Preferred Stock equal (on an as-if-converted-to-Common-Stock
basis calculated based on the Conversion Ratio, disregarding for such purpose any conversion limitations or liquidation preferences hereunder)
to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of
the Common Stock. Other than as set forth in the previous sentence, no other dividends shall be paid on shares of Preferred Stock, and
the Corporation shall pay no dividends (other than dividends in the form of Common Stock) on shares of the Common Stock unless it simultaneously
complies with the previous sentence.
5.
Voting. Except as otherwise provided herein or as otherwise required by the Nevada Revised Statutes, the Preferred Stock shall
have no voting rights. However, as long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative
vote of the holders of a majority of the then outstanding shares of the Preferred Stock alter or change adversely the powers, preferences
or rights given to the Preferred Stock or alter or amend this Certificate of Designation, amend or repeal any provision of, or add any
provision to, the Certificate of Incorporation or Amended and Restated Bylaws of the Corporation, or file any articles of amendment,
certificate of designations, preferences, limitations and relative rights of any series of Preferred Stock, if such action would adversely
alter or change the preferences, rights, privileges or powers of, or restrictions provided for the benefit of the Preferred Stock, regardless
of whether any of the foregoing actions shall be by means of amendment to the Certificate of Incorporation or by merger, consolidation,
recapitalization, reclassification, conversion or otherwise. Holders of shares of Common Stock acquired upon the conversion of shares
of Preferred Stock shall be entitled to the same voting rights as each other holder of Common Stock, except that such holders may not
vote such shares upon the proposal for Stockholder Approval in accordance with Rule 5635 of the listing rules of The Nasdaq Stock Market
LLC.
6.
Liquidation Rights.
(a) Liquidation.
In the event of any liquidation, dissolution or winding up of the Corporation, either voluntary or involuntary (each a “Liquidation
Event”), the Holders of Preferred Stock shall be entitled to participate, on an as-converted-to-Common Stock basis calculated
based on the Conversion Ratio (disregarding for such purpose any conversion limitations or liquidation preferences hereunder), with holders
of the Common Stock in any distribution of assets of the Corporation to the holders of the Common Stock.
(b) Valuation
of Non-Cash Consideration. If any assets of the Corporation distributed to stockholders in connection with any liquidation, dissolution,
or winding up of the Corporation are other than cash, then the value of such assets shall be their fair market value as determined in
good faith by the Board of Directors. In the event of a merger or other acquisition of the Corporation by another entity, the distribution
date shall be deemed to be the date such transaction closes.
7.
Conversion.
(a) Automatic
Conversion. Effective as of 5:00 p.m. Eastern time on the third Business Day after the date that the Corporation’s stockholders
approve the conversion of the Preferred Stock into shares of Common Stock (the “Conversion Date”) in accordance with
the listing rules of the Nasdaq Stock Market, as set forth in Section 4.7 of the Purchase Agreement (the “Stockholder Approval”),
each share of Preferred Stock then outstanding shall automatically convert into a number of shares of Common Stock equal to the Conversion
Ratio (as defined below), subject to the Beneficial Ownership Limitation (the “Automatic Conversion”). In determining
the application of the Beneficial Ownership Limitations solely with respect to the Automatic Conversion, the Corporation shall calculate
beneficial ownership for each Holder assuming beneficial ownership by such Holder of: (x) the number of shares of Common Stock issuable
to such Holder in such Automatic Conversion, plus (y) any additional shares of Common Stock for which a Holder has provided the Corporation
with prior written notice of beneficial ownership within 30 days prior to the date of Stockholder Approval (a “Beneficial Ownership
Statement”) and assuming the conversion of all shares of Preferred Stock held by all other Holders less the aggregate number
of shares of Preferred Stock held by all other Holders that will not convert into shares of Common Stock on account of the application
of any Beneficial Ownership Limitations applicable to any such other Holders. If a Holder fails to provide the Corporation with a Beneficial
Ownership Statement within 30 days prior to the date of Stockholder Approval, then the Corporation shall presume the Holder’s beneficial
ownership of Common Stock (excluding the Conversion Shares) to be zero. The shares of Preferred Stock that are converted in the Automatic
Conversion are referred to as the “Converted Stock”. The Conversion Shares shall be issued as follows: each outstanding share
of Preferred Stock shall be automatically converted into one (1) share of Common Stock (subject to adjustment as set forth herein) (the
“Conversion Ratio”). The shares of Preferred Stock that are converted pursuant to this Section 7 are referred to as
the “Converted Stock.”
(b)
Delivery of Conversion Shares Upon Conversion. Not later than five (5) Business Days after the Conversion Date, the Corporation
shall deliver, or cause to be delivered, to the Holders such number of Conversion Shares being acquired upon the conversion of the Preferred
Stock. The Conversion Shares shall be issued as follows:
i. Converted
Stock that is registered in book entry form shall be automatically cancelled upon the Conversion Date and converted into the corresponding
Conversion Shares, which shares shall be issued in book entry form and without any action on the part of the Holders and shall be delivered
to the Holders within two (2) Business Days of the effectiveness of the conversion.
ii. Converted
Stock that is issued in certificated form shall be deemed converted into the corresponding Conversion Shares on the Conversion Date and
the Holder’s rights as a holder of such shares of Converted Stock shall cease and terminate on such date, excepting only the right
to receive the Conversion Shares upon the Holder tendering to the Corporation (or its designated agent) the stock certificate(s) (duly
endorsed) representing such certificated Converted Stock and any remedies provided herein or otherwise available at law or in equity
to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation.
(c) Delivery
of Certificate or Book Entry Form. Upon conversion, not later than two (2) Business Days after the Conversion Date, or if the Holder
requests the issuance of physical certificate(s), two (2) Business Days after receipt by the Corporation of the original certificate(s)
representing such shares of Preferred Stock being converted, duly endorsed by the Holder (the “Share Delivery Date”),
the Corporation shall either: (a) in the event that the Holder has so elected in a written notice to the Corporation, deliver, or cause
to be delivered, to the converting Holder a physical certificate or certificates representing the number of Conversion Shares being acquired
upon the conversion of shares of Preferred Stock or (b) otherwise shall issue and deliver to such Holder or such Holder’s nominees,
documentation of the book entry for the number of Conversion Shares being acquired.
(d) Beneficial
Ownership Limitation. Notwithstanding anything contrary herein, the Corporation shall not effect the conversion of any of the Preferred
Stock held by a Holder, and such Holder shall not have the right to convert any of the Preferred Stock held by such Holder pursuant to
the terms and conditions of this Certificate of Designation and any such conversion shall be null and void and treated as if never made,
to the extent that after giving effect to such conversion, such Holder (together with the Holder’s Affiliates, and any other Persons
acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”))
collectively would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing
sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include
the number of shares of Common Stock held by such Holder and all other Attribution Parties plus the number of shares of Common Stock
issuable upon conversion of the Preferred Stock with respect to which such determination is being made, but shall exclude the number
of shares of Common Stock which would be issuable upon (i) conversion of the remaining, nonconverted Preferred Stock beneficially owned
by such Holder or any of the other Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of
any other securities of the Corporation (including, without limitation, any other Common Stock Equivalents) subject to a limitation on
conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution
Parties. Except as set forth in the preceding sentence, for purposes of this Section 7(d), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the
Holder that the Corporation is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange
Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation
contained in this Section 7(d) applies, the determination of whether the Preferred Stock is convertible (in relation to other securities
owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of the Holder’s Preferred Stock
is convertible shall be in the sole discretion of the Holder, and the submission of a Notice of Conversion shall be deemed to be the
Holder’s determination of whether the Holder’s Preferred Stock is convertible (in relation to other securities owned by the
Holder together with any Affiliates and Attribution Parties) and of which portion of the Holder’s Preferred Stock is convertible,
in each case subject to the Beneficial Ownership Limitation, and the Corporation shall have no obligation to verify or confirm the accuracy
of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with
Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 7(d), in determining
the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected
in (A) the Corporation’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent
public announcement by the Corporation or (C) a more recent written notice by the Corporation or the Transfer Agent setting forth the
number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Corporation shall within one Trading
Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Corporation, including
the Preferred Stock, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares
of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% (or, upon election by a Holder
in compliance with this Section 7(d) prior to the issuance of any Preferred Stock, 9.99%) of the number of shares of the Common Stock
outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of the Holder’s
Preferred Stock. The Holder, upon notice to the Corporation, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section 7(d), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion of the Preferred Stock held
by the Holder and the provisions of this Section 7(d) shall continue to apply. Any increase in the Beneficial Ownership Limitation will
not be effective until the 61st day after such notice is delivered to the Corporation. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 7(d) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of shares of Preferred Stock.
(d)
Reservation of Shares Issuable Upon Conversion. The Corporation shall reserve and keep available out of its authorized and unissued
shares of Common Stock, for the sole purpose of issuance upon conversion of the Preferred Stock as herein provided, free from preemptive
rights or any other actual contingent purchase rights of Persons other than the Holders, not less than such aggregate number of shares
of the Common Stock as shall (subject to the terms and conditions set forth in the Purchase Agreement) be issuable upon the conversion
of the then outstanding shares of Preferred Stock. All shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized,
validly issued, fully paid and nonassessable.
(e) Fractional Shares. No fractional shares or scrip representing fractional shares shall
be issued upon the conversion of the Preferred Stock. As to any fraction of a share which a Holder would otherwise be entitled to receive
upon such conversion, the Corporation shall round down to the next whole share of Common Stock.
(f)
Transfer Taxes and Expenses. The issuance of Conversion Shares shall be made without charge to any Holder for any documentary
stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares, provided that the Corporation
shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such
Conversion Shares upon conversion in a name other than that of the Holders of such shares of Preferred Stock and the Corporation shall
not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting the issuance thereof shall
have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation that such tax has
been paid. The Corporation shall pay all transfer agent fees required for same-day processing of any Conversion and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of
the Conversion Shares.
(g) Certain Adjustments.
i. Stock Splits. If the Corporation, at any time while the Preferred Stock is outstanding:
(A) subdivides outstanding shares of Common Stock into a larger number of shares; or (B) combines (including by way of a reverse stock
split) outstanding shares of Common Stock into a smaller number of shares, then the Conversion Ratio shall be multiplied by a fraction
of which the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately
after such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately before such event
(excluding any treasury shares of the Corporation). Any adjustment made pursuant to this Section 7(g) shall become effective immediately
after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision or combination. Upon the occurrence of each adjustment to the Conversion
Ratio, the Corporation, at its expense, shall, as promptly as reasonably possible but in any event not later than five (5) Business Days
thereafter, compute such adjustment in accordance with the terms hereof and furnish to each Holder a certificate setting forth such adjustment
and showing in detail the facts upon which such adjustment is based. The Corporation shall, as promptly as reasonably practicable after
the written request at any time of any Holder (but in any event not later than five (5) Business Days thereafter), furnish or cause to
be furnished to such Holder a certificate setting forth (i) the Conversion Ratio then in effect and (ii) the number of shares of Common
Stock which then would be received by such Holder upon conversion.
ii.
Calculations. All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th
of a share, as the case may be. For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding
as of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued
and outstanding
8.
Redemption Right. The Preferred Stock shall not have any redemption rights.
9.
Miscellaneous.
(a) Notices.
Except as otherwise provided herein, all notices, requests, consents, claims, demands, waivers, and other communications hereunder shall
be in writing and shall be deemed to have been given: (a) when delivered by hand (with written confirmation of receipt); (b) when received
by the addressee if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by facsimile or e-mail
of a PDF document (with confirmation of transmission) if sent during normal business hours of the recipient, and on the next business
day if sent after normal business hours of the recipient; or (d) on the third day after the date mailed, by certified or registered mail,
return receipt requested, postage prepaid. Such communications must be sent (a) to the Corporation, at its principal executive offices
and (b) to any stockholder, at such holder’s address at it appears in the stock records of the Corporation (or at such other address
for a stockholder as shall be specified in a notice given in accordance with this Section 9).
(b)
Failure or Indulgence Not Waiver. No failure or delay on the part of a Holder in the exercise of any power, right or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude
other or further exercise thereof or of any other right, power or privilege. No waiver shall be effective unless it is in writing and
signed by an authorized representative of the waiving party.
(c)
Transfer of Preferred Stock. A Holder may transfer some or all of its shares of Preferred Stock without the consent of the Corporation
so long as such transfer complies with all applicable securities laws.
(d)
Amendment. This Certificate of Designation or any provision hereof may be amended by obtaining the affirmative vote at a meeting
duly called for such purpose, or written consent without a meeting in accordance with the Nevada Revised Statutes, by a majority of the
Holders, voting separate as a single class, and with such other stockholder approval, if any, as may then be required pursuant to the
Nevada Revised Statutes or the Articles of Incorporation.
IN
WITNESS WHEREOF the undersigned has signed this Designation this 31st day of December 2024.
NEXTTRIP,
INC. |
|
|
|
By:
|
|
|
Name:
|
William
Kerby, Chief Executive Officer |
|
Exhibit
3.3
CERTIFICATE
OF DESIGNATION
OF
NEXTTRIP,
INC.
Pursuant
to Section 78.1955 of the
Nevada
Revised Statutes
SERIES
L NONVOTING CONVERTIBLE PREFERRED STOCK
The
undersigned, William Kerby, Chief Executive Officer, does hereby certify that:
1.
He is the President and Chief Executive Officer of NextTrip, Inc., a Nevada corporation (the “Corporation”).
2.
The Corporation is authorized to issue 10,000,000 shares of preferred stock, of which (a) 1,621,500 shares have been designated as Series
A Convertible Preferred Stock, none of which are presently issued and outstanding; (b) 1,000 shares have been designated as Series B
Convertible Preferred Stock, none of which are presently issued and outstanding; (c) 1,500 shares have been designated as Series C Convertible
Preferred Stock, none of which are presently issued and outstanding; (d) 7,796 shares have been designated as Series D Convertible Preferred
Stock, none of which are presently issued and outstanding; (e) 500 shares have been designated as Series E Convertible Preferred Stock,
316 of which are presently issued and outstanding; (f) 5,843,997 shares have been designated as Series F Convertible Preferred Stock,
none of which are presently issued and outstanding; (g) 100,000 shares have been designated as Series G Convertible Preferred Stock,
100,000 of which are presently issued and outstanding; (h) 150,000 shares have been designated as Series H Convertible Preferred Stock,
150,000 of which are presently issued and outstanding, (i) 331,124 shares have been designated as Series I Convertible Preferred Stock,
318,706 of which are presently issued and outstanding, (j) 297,788 shares have been designated as Series J Convertible Preferred Stock,
297,788 of which are presently issued and outstanding and (k) 49,668 shares have been designated as Series K Convertible Preferred Stock,
49,668 of which are presently issued and outstanding.
3.
The following resolutions were duly adopted by the board of directors of the Corporation (the “Board of Directors”):
WHEREAS,
the amended and restated articles of incorporation of the Corporation, as amended (the “Articles of Incorporation”),
provide for a class of its authorized stock known as preferred stock, consisting of 10,000,000 shares, $0.001 par value per share, issuable
from time to time in one or more series;
WHEREAS,
the Board of Directors is authorized to fix the dividend rights, dividend rate, voting rights, conversion rights, rights and terms of
redemption and liquidation preferences of any wholly unissued series of preferred stock and the number of shares constituting any series
and the designation thereof, of any of them; and
WHEREAS,
it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions and
other matters relating to a series of the preferred stock, which shall consist up to five hundred seventy-nine thousand four hundred
and sixty-nine (579,469) shares of Series L Convertible Preferred Stock, as follows:
NOW,
THEREFORE, BE IT RESOLVED, that the Board of Directors does hereby provide for the issuance of a series of preferred stock for cash or
exchange of other securities, rights or property and does hereby fix and determine the rights, preferences, restrictions and other matters
relating to such series of preferred stock as follows:
1. Definitions.
“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.
“Business
Day” means any day other than a Saturday, Sunday or a legal holiday on which commercial banking institutions in New York, New
York are authorized to close for business; provided that banks shall not be deemed to be authorized or obligated to be closed due to
a “shelter in place” or similar closure of physical branch locations at the direction of any governmental authority if such
banks’ electronic funds transfer systems (including for wire transfers) are open for use by customers on such day.
“Common
Stock” means the Corporation’s common stock, par value $0.001 per share.
“Common
Stock Equivalents” means any securities of the Corporation or the its subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.
“Conversion
Date” shall have the meaning set forth in Section 7(a).
“Conversion
Ratio” shall have the meaning set forth in Section 7(a).
“Conversion
Shares” means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance
with the terms hereof.
“Converted
Stock” shall have the meaning set forth in Section 7(a)
“Holder”
means, as of a given point in time, a Person who holds Preferred Stock.
“Liquidation
Event” shall have the meaning set forth in Section 6(a).
“Person”
means an individual, corporation, exempted company, partnership (including a general partnership, limited partnership, exempted limited
partnership or limited liability partnership), limited liability company, association, trust or other entity or organization, including
a government, domestic or foreign, or political subdivision thereof, or an agency or instrumentality thereof.
“Preferred
Stock” shall have the meaning set forth in Section 2.
“Purchase
Agreement” means the Securities Purchase Agreement, dated as of December 31, 2024, among the Corporation and each Purchaser,
as amended, modified or supplemented from time to time in accordance with its terms.
“Purchasers”
means each of those purchasers that purchases securities of the Corporation pursuant to the Purchase Agreement, as identified on the
signature pages to the Purchase Agreement.
“Requisite
Holders” means holders of record of a majority of the outstanding shares of Preferred Stock (excluding, for the avoidance of
doubt, any shares of Preferred Stock that are held by the Corporation or its controlled Affiliates (including in treasury), whether repurchased,
redeemed or otherwise acquired, which shall not be entitled to a vote).
“SEC”
means the United States Securities and Exchange Commission.
“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
“Share
Delivery Date” shall have the meaning set forth in Section 7(c).
“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the Pink Open Market, OTCQB or the OTCQX (or any successors to any of the foregoing).
“Transaction
Documents” means this Certificate of Designation, the Purchase Agreement, all exhibits and schedules thereto and hereto and
any other documents or agreements executed in connection with the transactions contemplated by the Purchase Agreement.
2.
Designation, Amount and Par Value. This series of preferred stock shall be designated and known as “Series L Convertible
Preferred Stock” (the “Preferred Stock”). The number of shares constituting the Preferred Stock shall be five
hundred seventy-nine thousand four hundred and sixty-nine (579,469) shares. Each share of Preferred Stock shall have a par value of $0.001
per share.
3.
Ranking. Except as otherwise provided herein, the Preferred Stock shall, with respect to rights on liquidation, winding up and
dissolution, rank pari passu to the common stock, par value $0.001 per share (the “Common Stock”), of the Corporation.
4.
Dividends. The Holders of Preferred Stock (each a “Holder” and collectively, the “Holders”)
shall be entitled to receive, if, as and when declared by the Board out of funds at the time legally available therefor, dividends in
the amount of 12% per annum per share of Preferred Stock (subject to appropriate adjustment in the event of any stock dividend, stock
split, combination or other similar recapitalization with respect to the Preferred Stock), and no more. Dividends on the Preferred Stock
shall be fully cumulative, shall accrue without interest and without compounding from the date of first issuance, and shall, if declared
by the Board, be payable quarterly in arrears on March 1, June 1, September 1 and December 1 (each, a “Dividend Date”)
of each year (except that if any such date is a Saturday, Sunday or a Legal Holiday, then such dividend shall be payable on the next
succeeding day that is not a Saturday, Sunday or a Legal Holiday) to Holders as they appear on the stock transfer books of the Corporation
on the close of business on the fifth Business Day prior to such Dividend Date. All dividends on the Preferred Stock shall be payable
(i) in shares of Common Stock of the Company at the Nasdaq Closing Price; provided, however, that such prices shall not be less than
$3.02 per share, or (ii) cash, at the election of a majority of the independent directors. For purposes hereof, the term “Legal
Holiday” shall mean any day on which banking institutions are authorized to close in New York, New York and the term “Business
Day” shall mean any day except Saturday, Sunday or a Legal Holiday. Dividends on account of arrears for any past dividend period
may be declared and paid at any time, without reference to any regular dividend payment date. The amount of dividends payable per share
of Preferred Stock with respect to the amounts determined pursuant to this paragraph for each quarterly dividend period shall be computed
by dividing the annual dividend amount by four. The amount of dividends payable for the initial dividend period and any period shorter
than a full quarterly dividend period shall be computed on the basis of the number of days actually elapsed during such period based
on a 360-day year, provided that in no event shall the dividend amount for any period shorter than a full quarterly dividend period be
greater than the full quarterly dividend amount.
On
each Dividend Date, all dividends which shall have accrued on each share of Preferred Stock outstanding on such Dividend Date shall accumulate
and be deemed to become “due” whether or not there shall be funds legally available for the payment thereof. Any dividend
which shall not be paid on the Dividend Date on which it shall become due shall be deemed to be “past due” until such dividend
shall be paid or until the share of Preferred Stock with respect to which such dividend became due shall no longer be outstanding, whichever
is the earlier to occur. In the event that any dividend becomes “past due” the per annum rate shall increase to 14%. Other
than the foregoing, no other interest, sum of money in lieu of interest, or other property or securities shall be payable in respect
of any dividend payment or payments which are past due. Dividends paid on shares of Preferred Stock in an amount less than the total
amount of such dividends at the time accumulated and payable on such shares shall be allocated pro rata on a share-by-share basis among
all such shares at the time outstanding.
No
dividends shall be paid or declared and set apart for payment on the Common Stock or on any other class or series of the Corporation’s
capital stock ranking, as to dividends, junior to the Preferred Stock or on any class or series of the Corporation’s capital stock
ranking, as to dividends, on a parity with the Preferred Stock (the “Parity Dividend Stock”) for any period unless
full cumulative dividends have been, or contemporaneously are, paid or declared and set apart for such payment on the Preferred Stock
for all dividend payment periods terminating on or prior to the date of payment of such full cumulative dividends. No dividends shall
be paid or declared and set apart for payment on the Preferred Stock for any period unless cumulative dividends have been, or contemporaneously
are, paid or declared and set apart for payment on the Parity Dividend Stock for all dividend periods terminating on or prior to the
date of payment of such full cumulative dividends. When dividends are not paid in full upon the Preferred Stock and the Parity Dividend
Stock, all dividends paid or declared and set aside for payment upon shares of Preferred Stock and the Parity Dividend Stock shall be
paid or declared and set aside for payment pro rata so that the amount of dividends paid or declared and set aside for payment per share
on the Preferred Stock and the Parity Dividend Stock shall in all cases bear to each other the same ratio that accrued and unpaid dividends
per share on the shares of Preferred Stock and the Parity Dividend Stock bear to each other.
5.
Voting. Except as otherwise provided herein or as otherwise required by the Nevada Revised Statutes, the Preferred Stock shall
have no voting rights. However, as long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative
vote of the holders of a majority of the then outstanding shares of the Preferred Stock alter or change adversely the powers, preferences
or rights given to the Preferred Stock or alter or amend this Certificate of Designation, amend or repeal any provision of, or add any
provision to, the Certificate of Incorporation or Amended and Restated Bylaws of the Corporation, or file any articles of amendment,
certificate of designations, preferences, limitations and relative rights of any series of Preferred Stock, if such action would adversely
alter or change the preferences, rights, privileges or powers of, or restrictions provided for the benefit of the Preferred Stock, regardless
of whether any of the foregoing actions shall be by means of amendment to the Certificate of Incorporation or by merger, consolidation,
recapitalization, reclassification, conversion or otherwise. Holders of shares of Common Stock acquired upon the conversion of shares
of Preferred Stock shall be entitled to the same voting rights as each other holder of Common Stock, except that such holders may not
vote such shares upon the proposal for Stockholder Approval in accordance with Rule 5635 of the listing rules of The Nasdaq Stock Market
LLC.
6.
Liquidation Rights.
(a)
Liquidation. In the event of any liquidation, dissolution or winding up of the Corporation, either voluntary or involuntary (each
a “Liquidation Event”), the Holders of Preferred Stock shall be entitled to participate, on an as-converted-to-Common
Stock basis calculated based on the Conversion Ratio (disregarding for such purpose any conversion limitations or liquidation preferences
hereunder), with holders of the Common Stock in any distribution of assets of the Corporation to the holders of the Common Stock.
(b)
Valuation of Non-Cash Consideration. If any assets of the Corporation distributed to stockholders in connection with any liquidation,
dissolution, or winding up of the Corporation are other than cash, then the value of such assets shall be their fair market value as
determined in good faith by the Board of Directors. In the event of a merger or other acquisition of the Corporation by another entity,
the distribution date shall be deemed to be the date such transaction closes.
7.
Conversion.
(a)
Automatic Conversion. Effective as of 5:00 p.m. Eastern time on the third Business Day after the date that the Corporation’s
stockholders approve the conversion of the Preferred Stock into shares of Common Stock (the “Conversion Date”) in
accordance with the listing rules of the Nasdaq Stock Market, as set forth in Section 4.9 of the Purchase Agreement (the “Stockholder
Approval”), each share of Preferred Stock then outstanding shall automatically convert into a number of shares of Common Stock
equal to the Conversion Ratio (as defined below), subject to the Beneficial Ownership Limitation (the “Automatic Conversion”).
In determining the application of the Beneficial Ownership Limitations solely with respect to the Automatic Conversion, the Corporation
shall calculate beneficial ownership for each Holder assuming beneficial ownership by such Holder of: (x) the number of shares of Common
Stock issuable to such Holder in such Automatic Conversion, plus (y) any additional shares of Common Stock for which a Holder has provided
the Corporation with prior written notice of beneficial ownership within 30 days prior to the date of Stockholder Approval (a “Beneficial
Ownership Statement”) and assuming the conversion of all shares of Preferred Stock held by all other Holders less the aggregate
number of shares of Preferred Stock held by all other Holders that will not convert into shares of Common Stock on account of the application
of any Beneficial Ownership Limitations applicable to any such other Holders. If a Holder fails to provide the Corporation with a Beneficial
Ownership Statement within 30 days prior to the date of Stockholder Approval, then the Corporation shall presume the Holder’s beneficial
ownership of Common Stock (excluding the Conversion Shares) to be zero. The shares of Preferred Stock that are converted in the Automatic
Conversion are referred to as the “Converted Stock”. The Conversion Shares shall be issued as follows: each outstanding share
of Preferred Stock shall be automatically converted into one (1) share of Common Stock (subject to adjustment as set forth herein) (the
“Conversion Ratio”). The shares of Preferred Stock that are converted pursuant to this Section 7 are referred to as
the “Converted Stock.”
(b)
Delivery of Conversion Shares Upon Conversion. Not later than five (5) Business Days after the Conversion Date, the Corporation
shall deliver, or cause to be delivered, to the Holders such number of Conversion Shares being acquired upon the conversion of the Preferred
Stock. The Conversion Shares shall be issued as follows:
i.
Converted Stock that is registered in book entry form shall be automatically cancelled upon the Conversion Date and converted into the
corresponding Conversion Shares, which shares shall be issued in book entry form and without any action on the part of the Holders and
shall be delivered to the Holders within two (2) Business Days of the effectiveness of the conversion.
ii.
Converted Stock that is issued in certificated form shall be deemed converted into the corresponding Conversion Shares on the Conversion
Date and the Holder’s rights as a holder of such shares of Converted Stock shall cease and terminate on such date, excepting only
the right to receive the Conversion Shares upon the Holder tendering to the Corporation (or its designated agent) the stock certificate(s)
(duly endorsed) representing such certificated Converted Stock and any remedies provided herein or otherwise available at law or in equity
to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of Designation.
(c)
Delivery of Certificate or Book Entry Form. Upon conversion, not later than two (2) Business Days after the Conversion Date, or
if the Holder requests the issuance of physical certificate(s), two (2) Business Days after receipt by the Corporation of the original
certificate(s) representing such shares of Preferred Stock being converted, duly endorsed by the Holder (the “Share Delivery
Date”), the Corporation shall either: (a) in the event that the Holder has so elected in a written notice to the Corporation,
deliver, or cause to be delivered, to the converting Holder a physical certificate or certificates representing the number of Conversion
Shares being acquired upon the conversion of shares of Preferred Stock or (b) otherwise shall issue and deliver to such Holder or such
Holder’s nominees, documentation of the book entry for the number of Conversion Shares being acquired.
(d)
Beneficial Ownership Limitation. Notwithstanding anything contrary herein, the Corporation shall not effect the conversion of
any of the Preferred Stock held by a Holder, and such Holder shall not have the right to convert any of the Preferred Stock held by such
Holder pursuant to the terms and conditions of this Certificate of Designation and any such conversion shall be null and void and treated
as if never made, to the extent that after giving effect to such conversion, such Holder (together with the Holder’s Affiliates,
and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution
Parties”)) collectively would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes
of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties
shall include the number of shares of Common Stock held by such Holder and all other Attribution Parties plus the number of shares of
Common Stock issuable upon conversion of the Preferred Stock with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) conversion of the remaining, nonconverted Preferred Stock beneficially
owned by such Holder or any of the other Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion
of any other securities of the Corporation (including, without limitation, any other Common Stock Equivalents) subject to a limitation
on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution
Parties. Except as set forth in the preceding sentence, for purposes of this Section 7(d), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the
Holder that the Corporation is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange
Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation
contained in this Section 7(d) applies, the determination of whether the Preferred Stock is convertible (in relation to other securities
owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of the Holder’s Preferred Stock
is convertible shall be in the sole discretion of the Holder, and the submission of a Notice of Conversion shall be deemed to be the
Holder’s determination of whether the Holder’s Preferred Stock is convertible (in relation to other securities owned by the
Holder together with any Affiliates and Attribution Parties) and of which portion of the Holder’s Preferred Stock is convertible,
in each case subject to the Beneficial Ownership Limitation, and the Corporation shall have no obligation to verify or confirm the accuracy
of such determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with
Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 7(d), in determining
the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected
in (A) the Corporation’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent
public announcement by the Corporation or (C) a more recent written notice by the Corporation or the Transfer Agent setting forth the
number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Corporation shall within one Trading
Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding
shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Corporation, including
the Preferred Stock, by the Holder or its Affiliates or Attribution Parties since the date as of which such number of outstanding shares
of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% (or, upon election by a Holder
in compliance with this Section 7(d) prior to the issuance of any Preferred Stock, 9.99%) of the number of shares of the Common Stock
outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon conversion of the Holder’s
Preferred Stock. The Holder, upon notice to the Corporation, may increase or decrease the Beneficial Ownership Limitation provisions
of this Section 7(d), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common
Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon conversion of the Preferred Stock held
by the Holder and the provisions of this Section 7(d) shall continue to apply. Any increase in the Beneficial Ownership Limitation will
not be effective until the 61st day after such notice is delivered to the Corporation. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 7(d) to correct this paragraph (or any
portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make
changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of shares of Preferred Stock.
(d)
Reservation of Shares Issuable Upon Conversion. The Corporation shall reserve and keep available out of its authorized and unissued
shares of Common Stock, for the sole purpose of issuance upon conversion of the Preferred Stock as herein provided, free from preemptive
rights or any other actual contingent purchase rights of Persons other than the Holders, not less than such aggregate number of shares
of the Common Stock as shall (subject to the terms and conditions set forth in the Purchase Agreement) be issuable upon the conversion
of the then outstanding shares of Preferred Stock. All shares of Common Stock that shall be so issuable shall, upon issue, be duly authorized,
validly issued, fully paid and nonassessable.
(e)
Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the conversion of the Preferred
Stock. As to any fraction of a share which a Holder would otherwise be entitled to receive upon such conversion, the Corporation shall
round down to the next whole share of Common Stock.
(f)
Transfer Taxes and Expenses. The issuance of Conversion Shares shall be made without charge to any Holder for any documentary
stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares, provided that the Corporation
shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance and delivery of any such
Conversion Shares upon conversion in a name other than that of the Holders of such shares of Preferred Stock and the Corporation shall
not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting the issuance thereof shall
have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation that such tax has
been paid. The Corporation shall pay all transfer agent fees required for same-day processing of any Conversion and all fees to the Depository
Trust Company (or another established clearing corporation performing similar functions) required for same-day electronic delivery of
the Conversion Shares.
(g)
Certain Adjustments.
i.
Stock Splits. If the Corporation, at any time while the Preferred Stock is outstanding: (A) subdivides outstanding shares of Common
Stock into a larger number of shares; or (B) combines (including by way of a reverse stock split) outstanding shares of Common Stock
into a smaller number of shares, then the Conversion Ratio shall be multiplied by a fraction of which the numerator shall be the number
of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately after such event and of which the
denominator shall be the number of shares of Common Stock outstanding immediately before such event (excluding any treasury shares of
the Corporation). Any adjustment made pursuant to this Section 7(g) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision or combination. Upon the occurrence of each adjustment to the Conversion Ratio, the Corporation,
at its expense, shall, as promptly as reasonably possible but in any event not later than five (5) Business Days thereafter, compute
such adjustment in accordance with the terms hereof and furnish to each Holder a certificate setting forth such adjustment and showing
in detail the facts upon which such adjustment is based. The Corporation shall, as promptly as reasonably practicable after the written
request at any time of any Holder (but in any event not later than five (5) Business Days thereafter), furnish or cause to be furnished
to such Holder a certificate setting forth (i) the Conversion Ratio then in effect and (ii) the number of shares of Common Stock which
then would be received by such Holder upon conversion.
ii.
Calculations. All calculations under this Section 7 shall be made to the nearest cent or the nearest 1/100th
of a share, as the case may be. For purposes of this Section 7, the number of shares of Common Stock deemed to be issued and outstanding
as of a given date shall be the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued
and outstanding
8.
Redemption Right. The Preferred Stock shall not have any redemption rights.
9.
Miscellaneous.
(a)
Notices. Except as otherwise provided herein, all notices, requests, consents, claims, demands, waivers, and other communications
hereunder shall be in writing and shall be deemed to have been given: (a) when delivered by hand (with written confirmation of receipt);
(b) when received by the addressee if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by
facsimile or e-mail of a PDF document (with confirmation of transmission) if sent during normal business hours of the recipient, and
on the next business day if sent after normal business hours of the recipient; or (d) on the third day after the date mailed, by certified
or registered mail, return receipt requested, postage prepaid. Such communications must be sent (a) to the Corporation, at its principal
executive offices and (b) to any stockholder, at such holder’s address at it appears in the stock records of the Corporation (or
at such other address for a stockholder as shall be specified in a notice given in accordance with this Section 9).
(b)
Failure or Indulgence Not Waiver. No failure or delay on the part of a Holder in the exercise of any power, right or privilege
hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude
other or further exercise thereof or of any other right, power or privilege. No waiver shall be effective unless it is in writing and
signed by an authorized representative of the waiving party.
(c)
Transfer of Preferred Stock. A Holder may transfer some or all of its shares of Preferred Stock without the consent of the Corporation
so long as such transfer complies with all applicable securities laws.
(d)
Amendment. This Certificate of Designation or any provision hereof may be amended by obtaining the affirmative vote at a meeting
duly called for such purpose, or written consent without a meeting in accordance with the Nevada Revised Statutes, by a majority of the
Holders, voting separate as a single class, and with such other stockholder approval, if any, as may then be required pursuant to the
Nevada Revised Statutes or the Articles of Incorporation.
IN
WITNESS WHEREOF the undersigned has signed this Designation this 31st day of December 2024.
NEXTTRIP,
INC. |
|
|
|
By:
|
|
|
Name:
|
William
Kerby, Chief Executive Officer |
|
Exhibit
3.4
CERTIFICATE
OF DESIGNATION
OF
NEXTTRIP,
INC.
Pursuant
to Section 78.1955 of the
Nevada
Revised Statutes
SERIES
M NONVOTING CONVERTIBLE PREFERRED STOCK
The
undersigned, William Kerby, Chief Executive Officer, does hereby certify that:
1.
He is the President and Chief Executive Officer of NextTrip, Inc., a Nevada corporation (the “Corporation”).
2.
The Corporation is authorized to issue 10,000,000 shares of preferred stock, of which (a) 1,621,500 shares have been designated as Series
A Convertible Preferred Stock, none of which are presently issued and outstanding; (b) 1,000 shares have been designated as Series B
Convertible Preferred Stock, none of which are presently issued and outstanding; (c) 1,500 shares have been designated as Series C Convertible
Preferred Stock, none of which are presently issued and outstanding; (d) 7,796 shares have been designated as Series D Convertible Preferred
Stock, none of which are presently issued and outstanding; (e) 500 shares have been designated as Series E Convertible Preferred Stock,
316 of which are presently issued and outstanding; (f) 5,843,997 shares have been designated as Series F Convertible Preferred Stock,
none of which are presently issued and outstanding; (g) 100,000 shares have been designated as Series G Convertible Preferred Stock,
100,000 of which are presently issued and outstanding; (h) 150,000 shares have been designated as Series H Convertible Preferred Stock,
150,000 of which are presently issued and outstanding, (i) 331,124 shares have been designated as Series I Convertible Preferred Stock,
318,706 of which are presently issued and outstanding, (j) 297,788 shares have been designated as Series J Convertible Preferred Stock,
297,788 of which are presently issued and outstanding, (k) 60,595 shares have been designated as Series K Convertible Preferred Stock,
60,595 of which are presently issued and outstanding and (l) 579,469 shares have been designated as Series L Convertible Preferred Stock,
579,469 of which are presently issued and outstanding.
3.
The following resolutions were duly adopted by the board of directors of the Corporation (the “Board of Directors”):
WHEREAS,
the amended and restated articles of incorporation of the Corporation, as amended (the “Articles of Incorporation”),
provide for a class of its authorized stock known as preferred stock, consisting of 10,000,000 shares, $0.001 par value per share, issuable
from time to time in one or more series;
WHEREAS,
the Board of Directors is authorized to fix the dividend rights, dividend rate, voting rights, conversion rights, rights and terms of
redemption and liquidation preferences of any wholly unissued series of preferred stock and the number of shares constituting any series
and the designation thereof, of any of them; and
WHEREAS,
it is the desire of the Board of Directors, pursuant to its authority as aforesaid, to fix the rights, preferences, restrictions and
other matters relating to a series of the preferred stock, which shall consist up to one hundred sixty-five thousand five
hundred and sixty-two (165,562) shares of Series M Convertible Preferred Stock, as follows:
NOW,
THEREFORE, BE IT RESOLVED, that the Board of Directors does hereby provide for the issuance of a series of preferred stock for cash or
exchange of other securities, rights or property and does hereby fix and determine the rights, preferences, restrictions and other matters
relating to such series of preferred stock as follows:
1.
Definitions.
“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person, as such terms are used in and construed under Rule 405 of the Securities Act.
“Business
Day” means any day other than a Saturday, Sunday or a legal holiday on which commercial banking institutions in New York, New
York are authorized to close for business; provided that banks shall not be deemed to be authorized or obligated to be closed due to
a “shelter in place” or similar closure of physical branch locations at the direction of any governmental authority if such
banks’ electronic funds transfer systems (including for wire transfers) are open for use by customers on such day.
“Common
Stock” means the Corporation’s common stock, par value $0.001 per share.
“Common
Stock Equivalents” means any securities of the Corporation or the its subsidiaries which would entitle the holder thereof to
acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument
that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common
Stock.
“Conversion
Date” shall have the meaning set forth in Section 7(a).
“Conversion
Ratio” shall have the meaning set forth in Section 7(a).
“Conversion
Shares” means, collectively, the shares of Common Stock issuable upon conversion of the shares of Preferred Stock in accordance
with the terms hereof.
“Converted
Stock” shall have the meaning set forth in Section 7(a)
“Holder”
means, as of a given point in time, a Person who holds Preferred Stock.
“Liquidation
Event” shall have the meaning set forth in Section 6(a).
“Person”
means an individual, corporation, exempted company, partnership (including a general partnership, limited partnership, exempted limited
partnership or limited liability partnership), limited liability company, association, trust or other entity or organization, including
a government, domestic or foreign, or political subdivision thereof, or an agency or instrumentality thereof.
“Preferred
Stock” shall have the meaning set forth in Section 2.
“Purchase
Agreement” means the Securities Purchase Agreement, dated as of December 31, 2024, among the Corporation and each Purchaser,
as amended, modified or supplemented from time to time in accordance with its terms.
“Purchasers”
means each of those purchasers that purchases securities of the Corporation pursuant to the Purchase Agreement, as identified on the
signature pages to the Purchase Agreement.
“Requisite
Holders” means holders of record of a majority of the outstanding shares of Preferred Stock (excluding, for the avoidance of
doubt, any shares of Preferred Stock that are held by the Corporation or its controlled Affiliates (including in treasury), whether repurchased,
redeemed or otherwise acquired, which shall not be entitled to a vote).
“SEC”
means the United States Securities and Exchange Commission.
“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
“Share
Delivery Date” shall have the meaning set forth in Section 7(c).
“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the Pink Open Market, OTCQB or the OTCQX (or any successors to any of the foregoing).
“Transaction
Documents” means this Certificate of Designation, the Purchase Agreement, all exhibits and schedules thereto and hereto and
any other documents or agreements executed in connection with the transactions contemplated by the Purchase Agreement.
2.
Designation, Amount and Par Value. This series of preferred stock shall be designated and known as “Series M Convertible
Preferred Stock” (the “Preferred Stock”). The number of shares constituting the Preferred Stock shall be one
hundred sixty-five thousand five hundred and sixty-two (165,562) shares. Each share of Preferred Stock
shall have a par value of $0.001 per share.
3.
Ranking. Except as otherwise provided herein, the Preferred Stock shall, with respect to rights on liquidation, winding up and
dissolution, rank pari passu to the common stock, par value $0.001 per share (the “Common Stock”), of the Corporation.
4.
Dividends. The Holders of Preferred Stock (each a “Holder” and collectively, the “Holders”)
shall be entitled to receive, if, as and when declared by the Board out of funds at the time legally available therefor, dividends in
the amount of 12% per annum per share of Preferred Stock (subject to appropriate adjustment in the event of any stock dividend, stock
split, combination or other similar recapitalization with respect to the Preferred Stock), and no more. Dividends on the Preferred Stock
shall be fully cumulative, shall accrue without interest and without compounding from the date of first issuance, and shall, if declared
by the Board, be payable quarterly in arrears on March 1, June 1, September 1 and December 1 (each, a “Dividend Date”)
of each year (except that if any such date is a Saturday, Sunday or a Legal Holiday, then such dividend shall be payable on the next
succeeding day that is not a Saturday, Sunday or a Legal Holiday) to Holders as they appear on the stock transfer books of the Corporation
on the close of business on the fifth Business Day prior to such Dividend Date. All dividends on the Preferred Stock shall be payable
(i) in shares of Common Stock of the Company at the Nasdaq Closing Price; provided, however, that such prices shall not be less than
$3.02 per share, or (ii) cash, at the election of a majority of the independent directors. For purposes hereof, the term “Legal
Holiday” shall mean any day on which banking institutions are authorized to close in New York, New York and the term “Business
Day” shall mean any day except Saturday, Sunday or a Legal Holiday. Dividends on account of arrears for any past dividend period
may be declared and paid at any time, without reference to any regular dividend payment date. The amount of dividends payable per share
of Preferred Stock with respect to the amounts determined pursuant to this paragraph for each quarterly dividend period shall be computed
by dividing the annual dividend amount by four. The amount of dividends payable for the initial dividend period and any period shorter
than a full quarterly dividend period shall be computed on the basis of the number of days actually elapsed during such period based
on a 360-day year, provided that in no event shall the dividend amount for any period shorter than a full quarterly dividend period be
greater than the full quarterly dividend amount.
On
each Dividend Date, all dividends which shall have accrued on each share of Preferred Stock outstanding on such Dividend Date shall accumulate
and be deemed to become “due” whether or not there shall be funds legally available for the payment thereof. Any dividend
which shall not be paid on the Dividend Date on which it shall become due shall be deemed to be “past due” until such dividend
shall be paid or until the share of Preferred Stock with respect to which such dividend became due shall no longer be outstanding, whichever
is the earlier to occur. In the event that any dividend becomes “past due” the per annum rate shall increase to 14%. Other
than the foregoing, no other interest, sum of money in lieu of interest, or other property or securities shall be payable in respect
of any dividend payment or payments which are past due. Dividends paid on shares of Preferred Stock in an amount less than the total
amount of such dividends at the time accumulated and payable on such shares shall be allocated pro rata on a share-by-share basis among
all such shares at the time outstanding.
No
dividends shall be paid or declared and set apart for payment on the Common Stock or on any other class or series of the Corporation’s
capital stock ranking, as to dividends, junior to the Preferred Stock or on any class or series of the Corporation’s capital stock
ranking, as to dividends, on a parity with the Preferred Stock (the “Parity Dividend Stock”) for any period unless
full cumulative dividends have been, or contemporaneously are, paid or declared and set apart for such payment on the Preferred Stock
for all dividend payment periods terminating on or prior to the date of payment of such full cumulative dividends. No dividends shall
be paid or declared and set apart for payment on the Preferred Stock for any period unless cumulative dividends have been, or contemporaneously
are, paid or declared and set apart for payment on the Parity Dividend Stock for all dividend periods terminating on or prior to the
date of payment of such full cumulative dividends. When dividends are not paid in full upon the Preferred Stock and the Parity Dividend
Stock, all dividends paid or declared and set aside for payment upon shares of Preferred Stock and the Parity Dividend Stock shall be
paid or declared and set aside for payment pro rata so that the amount of dividends paid or declared and set aside for payment per share
on the Preferred Stock and the Parity Dividend Stock shall in all cases bear to each other the same ratio that accrued and unpaid dividends
per share on the shares of Preferred Stock and the Parity Dividend Stock bear to each other.
5.
Voting. Except as otherwise provided herein or as otherwise required by the Nevada Revised Statutes, the Preferred Stock shall
have no voting rights. However, as long as any shares of Preferred Stock are outstanding, the Corporation shall not, without the affirmative
vote of the holders of a majority of the then outstanding shares of the Preferred Stock alter or change adversely the powers, preferences
or rights given to the Preferred Stock or alter or amend this Certificate of Designation, amend or repeal any provision of, or add any
provision to, the Certificate of Incorporation or Amended and Restated Bylaws of the Corporation, or file any articles of amendment,
certificate of designations, preferences, limitations and relative rights of any series of Preferred Stock, if such action would adversely
alter or change the preferences, rights, privileges or powers of, or restrictions provided for the benefit of the Preferred Stock, regardless
of whether any of the foregoing actions shall be by means of amendment to the Certificate of Incorporation or by merger, consolidation,
recapitalization, reclassification, conversion or otherwise. Holders of shares of Common Stock acquired upon the conversion of shares
of Preferred Stock shall be entitled to the same voting rights as each other holder of Common Stock, except that such holders may not
vote such shares upon the proposal for Stockholder Approval in accordance with Rule 5635 of the listing rules of The Nasdaq Stock Market
LLC.
6.
Liquidation Rights.
(a) Liquidation.
In the event of any liquidation, dissolution or winding up of the Corporation, either voluntary or involuntary (each a
“Liquidation Event”), the Holders of Preferred Stock shall be entitled to participate, on an
as-converted-to-Common Stock basis calculated based on the Conversion Ratio (disregarding for such purpose any conversion
limitations or liquidation preferences hereunder), with holders of the Common Stock in any distribution of assets of the Corporation
to the holders of the Common Stock.
(b) Valuation
of Non-Cash Consideration. If any assets of the Corporation distributed to stockholders in connection with any liquidation,
dissolution, or winding up of the Corporation are other than cash, then the value of such assets shall be their fair market value as
determined in good faith by the Board of Directors. In the event of a merger or other acquisition of the Corporation by another
entity, the distribution date shall be deemed to be the date such transaction closes.
7.
Conversion.
(a) Automatic
Conversion. Effective as of 5:00 p.m. Eastern time on the third Business Day after the date that the Corporation’s
stockholders approve the conversion of the Preferred Stock into shares of Common Stock (the “Conversion Date”) in
accordance with the listing rules of the Nasdaq Stock Market, as set forth in Section 4.9 of the Purchase Agreement (the
“Stockholder Approval”), each share of Preferred Stock then outstanding shall automatically convert into a number
of shares of Common Stock equal to the Conversion Ratio (as defined below), subject to the Beneficial Ownership Limitation (the
“Automatic Conversion”). In determining the application of the Beneficial Ownership Limitations solely with
respect to the Automatic Conversion, the Corporation shall calculate beneficial ownership for each Holder assuming beneficial
ownership by such Holder of: (x) the number of shares of Common Stock issuable to such Holder in such Automatic Conversion, plus (y)
any additional shares of Common Stock for which a Holder has provided the Corporation with prior written notice of beneficial
ownership within 30 days prior to the date of Stockholder Approval (a “Beneficial Ownership Statement”) and
assuming the conversion of all shares of Preferred Stock held by all other Holders less the aggregate number of shares of Preferred
Stock held by all other Holders that will not convert into shares of Common Stock on account of the application of any Beneficial
Ownership Limitations applicable to any such other Holders. If a Holder fails to provide the Corporation with a Beneficial Ownership
Statement within 30 days prior to the date of Stockholder Approval, then the Corporation shall presume the Holder’s beneficial
ownership of Common Stock (excluding the Conversion Shares) to be zero. The shares of Preferred Stock that are converted in the
Automatic Conversion are referred to as the “Converted Stock”. The Conversion Shares shall be issued as follows: each
outstanding share of Preferred Stock shall be automatically converted into one (1) share of Common Stock (subject to adjustment as
set forth herein) (the “Conversion Ratio”). The shares of Preferred Stock that are converted pursuant to this
Section 7 are referred to as the “Converted Stock.”
(b) Delivery
of Conversion Shares Upon Conversion. Not later than five (5) Business Days after the Conversion Date, the Corporation shall
deliver, or cause to be delivered, to the Holders such number of Conversion Shares being acquired upon the conversion of the
Preferred Stock. The Conversion Shares shall be issued as follows:
i.
Converted Stock that is registered in book entry form shall be automatically cancelled upon the Conversion Date and converted into
the corresponding Conversion Shares, which shares shall be issued in book entry form and without any action on the part of the
Holders and shall be delivered to the Holders within two (2) Business Days of the effectiveness of the conversion.
ii.
Converted Stock that is issued in certificated form shall be deemed converted into the corresponding Conversion Shares on the
Conversion Date and the Holder’s rights as a holder of such shares of Converted Stock shall cease and terminate on such date,
excepting only the right to receive the Conversion Shares upon the Holder tendering to the Corporation (or its designated agent) the
stock certificate(s) (duly endorsed) representing such certificated Converted Stock and any remedies provided herein or otherwise
available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this Certificate of
Designation.
(c) Delivery
of Certificate or Book Entry Form. Upon conversion, not later than two (2) Business Days after the Conversion Date, or if the
Holder requests the issuance of physical certificate(s), two (2) Business Days after receipt by the Corporation of the original
certificate(s) representing such shares of Preferred Stock being converted, duly endorsed by the Holder (the “Share
Delivery Date”), the Corporation shall either: (a) in the event that the Holder has so elected in a written notice to the
Corporation, deliver, or cause to be delivered, to the converting Holder a physical certificate or certificates representing the
number of Conversion Shares being acquired upon the conversion of shares of Preferred Stock or (b) otherwise shall issue and deliver
to such Holder or such Holder’s nominees, documentation of the book entry for the number of Conversion Shares being
acquired.
(d) Beneficial
Ownership Limitation. Notwithstanding anything contrary herein, the Corporation shall not effect the conversion of any of the
Preferred Stock held by a Holder, and such Holder shall not have the right to convert any of the Preferred Stock held by such Holder
pursuant to the terms and conditions of this Certificate of Designation and any such conversion shall be null and void and treated
as if never made, to the extent that after giving effect to such conversion, such Holder (together with the Holder’s
Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons,
“Attribution Parties”)) collectively would beneficially own in excess of the Beneficial Ownership Limitation (as
defined below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and
its Affiliates and Attribution Parties shall include the number of shares of Common Stock held by such Holder and all other
Attribution Parties plus the number of shares of Common Stock issuable upon conversion of the Preferred Stock with respect to which
such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable upon (i) conversion
of the remaining, nonconverted Preferred Stock beneficially owned by such Holder or any of the other Attribution Parties and (ii)
exercise or conversion of the unexercised or nonconverted portion of any other securities of the Corporation (including, without
limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise analogous to the limitation
contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties. Except as set forth in the
preceding sentence, for purposes of this Section 7(d), beneficial ownership shall be calculated in accordance with Section 13(d) of
the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Corporation is
not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is
solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in
this Section 7(d) applies, the determination of whether the Preferred Stock is convertible (in relation to other securities owned by
the Holder together with any Affiliates and Attribution Parties) and of which portion of the Holder’s Preferred Stock is
convertible shall be in the sole discretion of the Holder, and the submission of a Notice of Conversion shall be deemed to be the
Holder’s determination of whether the Holder’s Preferred Stock is convertible (in relation to other securities owned by
the Holder together with any Affiliates and Attribution Parties) and of which portion of the Holder’s Preferred Stock is
convertible, in each case subject to the Beneficial Ownership Limitation, and the Corporation shall have no obligation to verify or
confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall be
determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 7(d), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of
outstanding shares of Common Stock as reflected in (A) the Corporation’s most recent periodic or annual report filed with the
Commission, as the case may be, (B) a more recent public announcement by the Corporation or (C) a more recent written notice by the
Corporation or the Transfer Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request
of a Holder, the Corporation shall within one Trading Day confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the
conversion or exercise of securities of the Corporation, including the Preferred Stock, by the Holder or its Affiliates or
Attribution Parties since the date as of which such number of outstanding shares of Common Stock was reported. The
“Beneficial Ownership Limitation” shall be 4.99% (or, upon election by a Holder in compliance with this Section
7(d) prior to the issuance of any Preferred Stock, 9.99%) of the number of shares of the Common Stock outstanding immediately after
giving effect to the issuance of shares of Common Stock issuable upon conversion of the Holder’s Preferred Stock. The Holder,
upon notice to the Corporation, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 7(d),
provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding
immediately after giving effect to the issuance of shares of Common Stock upon conversion of the Preferred Stock held by the Holder
and the provisions of this Section 7(d) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be
effective until the 61st day after such notice is delivered to the Corporation. The provisions of this paragraph shall be construed
and implemented in a manner otherwise than in strict conformity with the terms of this Section 7(d) to correct this paragraph (or
any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to
make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this
paragraph shall apply to a successor holder of shares of Preferred Stock.
(d)
Reservation of Shares Issuable Upon Conversion. The Corporation shall reserve and keep
available out of its authorized and unissued shares of Common Stock, for the sole purpose of issuance upon conversion of the Preferred
Stock as herein provided, free from preemptive rights or any other actual contingent purchase rights of Persons other than the Holders,
not less than such aggregate number of shares of the Common Stock as shall (subject to the terms and conditions set forth in the Purchase
Agreement) be issuable upon the conversion of the then outstanding shares of Preferred Stock. All shares of Common Stock that shall be
so issuable shall, upon issue, be duly authorized, validly issued, fully paid and nonassessable.
(e)
Fractional Shares. No fractional shares or scrip representing fractional shares shall
be issued upon the conversion of the Preferred Stock. As to any fraction of a share which a Holder would otherwise be entitled to receive
upon such conversion, the Corporation shall round down to the next whole share of Common Stock.
(f)
Transfer Taxes and Expenses. The issuance of Conversion Shares shall be made without charge
to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such Conversion Shares,
provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved in the issuance
and delivery of any such Conversion Shares upon conversion in a name other than that of the Holders of such shares of Preferred Stock
and the Corporation shall not be required to issue or deliver such Conversion Shares unless or until the Person or Persons requesting
the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established to the satisfaction of the Corporation
that such tax has been paid. The Corporation shall pay all transfer agent fees required for same-day processing of any Conversion and
all fees to the Depository Trust Company (or another established clearing corporation performing similar functions) required for same-day
electronic delivery of the Conversion Shares.
(g)
Certain Adjustments.
i.
Stock Splits. If the Corporation, at any time while the Preferred Stock is outstanding: (A)
subdivides outstanding shares of Common Stock into a larger number of shares; or (B) combines (including by way of a reverse stock split)
outstanding shares of Common Stock into a smaller number of shares, then the Conversion Ratio shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding any treasury shares of the Corporation) outstanding immediately
after such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately before such event
(excluding any treasury shares of the Corporation). Any adjustment made pursuant to this Section 7(g) shall become effective immediately
after the record date for the determination of stockholders entitled to receive such dividend or distribution and shall become effective
immediately after the effective date in the case of a subdivision or combination. Upon the occurrence of each adjustment to the Conversion
Ratio, the Corporation, at its expense, shall, as promptly as reasonably possible but in any event not later than five (5) Business Days
thereafter, compute such adjustment in accordance with the terms hereof and furnish to each Holder a certificate setting forth such adjustment
and showing in detail the facts upon which such adjustment is based. The Corporation shall, as promptly as reasonably practicable after
the written request at any time of any Holder (but in any event not later than five (5) Business Days thereafter), furnish or cause to
be furnished to such Holder a certificate setting forth (i) the Conversion Ratio then in effect and (ii) the number of shares of Common
Stock which then would be received by such Holder upon conversion.
ii.
Calculations. All calculations under this Section 7 shall be made to the nearest cent
or the nearest 1/100th of a share, as the case may be. For purposes of this Section 7, the number of shares of Common
Stock deemed to be issued and outstanding as of a given date shall be the sum of the number of shares of Common Stock (excluding any
treasury shares of the Corporation) issued and outstanding
8.
Redemption Right. The Preferred Stock shall not have any redemption rights.
9.
Miscellaneous.
(a) Notices.
Except as otherwise provided herein, all notices, requests, consents, claims, demands, waivers, and other communications hereunder
shall be in writing and shall be deemed to have been given: (a) when delivered by hand (with written confirmation of receipt); (b)
when received by the addressee if sent by a nationally recognized overnight courier (receipt requested); (c) on the date sent by
facsimile or e-mail of a PDF document (with confirmation of transmission) if sent during normal business hours of the recipient, and
on the next business day if sent after normal business hours of the recipient; or (d) on the third day after the date mailed, by
certified or registered mail, return receipt requested, postage prepaid. Such communications must be sent (a) to the Corporation, at
its principal executive offices and (b) to any stockholder, at such holder’s address at it appears in the stock records of the
Corporation (or at such other address for a stockholder as shall be specified in a notice given in accordance with this Section
9).
(b) Failure
or Indulgence Not Waiver. No failure or delay on the part of a Holder in the exercise of any power, right or privilege hereunder
shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or
further exercise thereof or of any other right, power or privilege. No waiver shall be effective unless it is in writing and signed
by an authorized representative of the waiving party.
(c) Transfer
of Preferred Stock. A Holder may transfer some or all of its shares of Preferred Stock without the consent of the Corporation so
long as such transfer complies with all applicable securities laws.
(d)
Amendment. This Certificate of Designation or any provision hereof may be amended by obtaining
the affirmative vote at a meeting duly called for such purpose, or written consent without a meeting in accordance with the Nevada Revised
Statutes, by a majority of the Holders, voting separate as a single class, and with such other stockholder approval, if any, as may then
be required pursuant to the Nevada Revised Statutes or the Articles of Incorporation.
IN
WITNESS WHEREOF the undersigned has signed this Designation this 31st day of December 2024.
NEXTTRIP,
INC. |
|
|
|
|
By:
|
|
|
Name:
|
William
Kerby, Chief Executive Officer |
|
Exhibit
4.1
NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.
COMMON
STOCK PURCHASE WARRANT
NEXTTRIP,
INC.
Warrant
Shares: 250,000 |
Issue
Date: December 31, 2024 |
THIS
COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the
“Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time or times on or after the date that is six (6) months from the Issue Date (the “Initial Exercise Date”)
and on or prior to 5:00 p.m. (New York City time) on June 30, 2028, the three (3) year anniversary of the Initial Exercise Date (the
“Termination Date”), but not thereafter, to subscribe for and purchase from NextTrip, Inc., a Nevada corporation (the
“Company”), up to 250,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of
Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in
Section 2(b).
Section
1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the “Purchase Agreement”), dated December 31, 2024, among the Company and the
purchasers signatory thereto.
Section
2. Exercise.
a)
Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(c)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank.
No ink-original Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Notice of Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically
surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has
been exercised in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably
practicable of the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting
in purchases of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding
number of Warrant Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and
the Company shall maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver
any objection to any Notice of Exercise within one (1) Trading Day of receipt of such notice. The Holder and any assignee, by acceptance
of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the
Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount
stated on the face hereof.
b)
Exercise Price. The exercise price per share of Common Stock under this Warrant shall be $4.00, subject to adjustment hereunder
(the “Exercise Price”).
c)
Mechanics of Exercise.
i.
Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
limitations pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the Company’s share register
in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise
to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the
delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price to the Company
and (iii) the number of Trading Days comprising the Standard Settlement Period after the delivery to the Company of the Notice of Exercise
(such date, the “Warrant Share Delivery Date”). Upon delivery of the Notice of Exercise, the Holder shall be deemed
for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised,
irrespective of the date of delivery of the Warrant Shares, provided that payment of the aggregate Exercise Price is received by the
Warrant Share Delivery Date. The Company agrees to maintain a transfer agent that is a participant in the FAST program so long as this
Warrant remains outstanding and exercisable. As used herein, “Standard Settlement Period” means the standard settlement
period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock as in effect
on the date of delivery of the Notice of Exercise.
ii.
Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.
iii.
Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(c)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.
iv.
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.
v.
Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided,
however, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.
vi.
Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.
d)
Holder’s Exercise Limitations.
i.
Beneficial Ownership Limitation. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right
to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock held by such Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon
exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock
which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or
any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other
securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or
exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 2(d), beneficial ownership shall be calculated in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that
the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder
is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in
this Section 2(d) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder
together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion
of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2(d), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer
Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall
within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case,
the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% (or, upon
election by a Holder in compliance with this Section 2(d) prior to the issuance of any Warrants, 9.99%) of the number of shares of the
Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.
The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(d),
provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of
this Section 2(d) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st
day after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner
otherwise than in strict conformity with the terms of this Section 2(d) to correct this paragraph (or any portion hereof) which may be
defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary
or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder
of this Warrant.
Section
3. Certain Adjustments.
a)
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.
b)
Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale
of such Purchase Rights.
c)
Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof) immediately before the date of which a
record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock
are to be determined for the participation in such Distribution.
d)
Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding
Common Stock or more than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one
or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v)
the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another
Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock or more
than 50% of the voting power of the common equity of the Company (each a “Fundamental Transaction”), then, upon any
subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable
upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to
any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation
or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor
entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in
writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions
of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
(without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on
the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the
purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and
which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall be added to the term “Company” under this Warrant (so that from and after the occurrence or consummation of
such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the “Company”
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of Warrant Shares
and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.
e)
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.
f)
Notice to Holder.
i.
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.
ii.
Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.
Section
4. Transfer of Warrant.
a)
Transferability. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof
and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation,
any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company
or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by
the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such
surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee
or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to
the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.
b)
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant
and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.
c)
Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
“Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.
d)
Transfer Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.
e)
Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.
Section
5. Miscellaneous.
a)
No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(c)(i), except as expressly
set forth in Section 3. In no event shall the Company be required to net cash settle an exercise of this Warrant.
b)
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.
c)
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.
d)
Authorized Shares. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized
and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers
who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The
Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein
without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be
listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this
Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith,
be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in
respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).
e)
Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.
f)
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will
have restrictions upon resale imposed by state and federal securities laws.
g)
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies, notwithstanding the fact that
the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.
h)
Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.
i)
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.
j)
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.
k)
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.
l)
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on
the one hand, and the Holder of this Warrant, on the other hand.
m)
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.
n)
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.
********************
(Signature
Page Follows)
IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.
|
|
NEXTTRIP,
INC. |
|
|
|
|
By: |
|
|
Name: |
William
Kerby |
|
Title: |
Chief
Executive Officer |
NOTICE
OF EXERCISE
To: NEXTTRIP,
inc.
(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.
(2)
Payment shall take the form of lawful money of the United States.
(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:
_______________________________
The
Warrant Shares shall be delivered to the following DWAC Account Number:
_______________________________
_______________________________
_______________________________
(4)
Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.
[SIGNATURE
OF HOLDER]
Name
of Investing Entity: ___________________________________________________________________________
Signature
of Authorized Signatory of Investing Entity: _____________________________________________________
Name
of Authorized Signatory: _______________________________________________________________________
Title
of Authorized Signatory: ________________________________________________________________________
Date:
___________________________________________________________________________________________
EXHIBIT
B
ASSIGNMENT
FORM
(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)
FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to
Name: |
|
|
|
|
(Please
Print) |
|
|
|
Address: |
|
|
|
|
(Please
Print) |
|
|
|
Phone
Number: |
|
|
|
|
|
Email
Address: |
|
|
|
|
|
Dated:
_______________ __, ______ |
|
|
Holder’s
Signature:_____________________________ |
|
|
Holder’s
Address: _____________________________ |
|
|
Exhibit
4.2
NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION
OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED
(THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.
COMMON
STOCK PURCHASE WARRANT
NEXTTRIP,
INC.
Warrant Shares: 250,000 |
Issue Date: December 31, 2024 |
THIS
COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [___________] or its assigns (the
“Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set
forth, at any time or times on or after the date that is six (6) months from the Issue Date (the “Initial Exercise Date”)
and on or prior to 5:00 p.m. (New York City time) on June 30, 2028, the three (3) year anniversary of the Initial Exercise Date (the
“Termination Date”), but not thereafter, to subscribe for and purchase from NextTrip, Inc., a Nevada corporation (the
“Company”), up to 250,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of
Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in
Section 2(b).
Section
1. Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain
Securities Purchase Agreement (the “Purchase Agreement”), dated December 31, 2024, among the Company and the
purchasers signatory thereto.
Section
2. Exercise.
a)
Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any time
or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly executed PDF
copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto (the “Notice of Exercise”).
Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined
in Section 2(c)(i) herein) following the date of exercise as aforesaid, the Holder shall deliver the aggregate Exercise Price for the
Warrant Shares specified in the applicable Notice of Exercise by wire transfer or cashier’s check drawn on a United States bank
unless the cashless exercise procedure specified in Section 2(c) below is specified in the applicable Notice of Exercise. No ink-original
Notice of Exercise shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Notice of
Exercise be required. Notwithstanding anything herein to the contrary, the Holder shall not be required to physically surrender this
Warrant to the Company until the Holder has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised
in full, in which case, the Holder shall surrender this Warrant to the Company for cancellation as soon as reasonably practicable of
the date on which the final Notice of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases
of a portion of the total number of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant
Shares purchasable hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall
maintain records showing the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection
to any Notice of Exercise within one (1) Trading Day of receipt of such notice. The Holder and any assignee, by acceptance of this
Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated
on the face hereof.
b)
Exercise Price. The exercise price per share of Common Stock under this Warrant shall be $4.00, subject to adjustment hereunder
(the “Exercise Price”).
c)
Cashless Exercise. Alternatively, this Warrant may be exercised, in whole or in part, at such time by means of a “cashless
exercise” in which the Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained by dividing
[(A-B) (X)] by (A), where:
(A)
= as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice of
Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both executed and
delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours” (as defined in
Rule 600(b) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) the VWAP on the Trading Day immediately
preceding the date of the applicable Notice of Exercise of the applicable Notice of Exercise if such Notice of Exercise is executed during
“regular trading hours” on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours
after the close of “regular trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date
of the applicable Notice of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed
and delivered pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;
(B)
= the Exercise Price of this Warrant, as adjusted hereunder; and
(X)
= the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such
exercise were by means of a cash exercise rather than a cashless exercise.
If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9) of the
Securities Act, the Warrant Shares shall take on the registered characteristics of the Warrants being exercised. The Company agrees not
to take any position contrary to this Section 2(c).
d)
Mechanics of Exercise.
i.
Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted by
the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with The Depository
Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company is then a participant
in such system and either (A) there is an effective registration statement permitting the issuance of the Warrant Shares to or resale
of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder without volume or manner-of-sale
limitations pursuant to Rule 144, and otherwise by physical delivery of a certificate, registered in the Company’s share register
in the name of the Holder or its designee, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise
to the address specified by the Holder in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days after the
delivery to the Company of the Notice of Exercise, (ii) one (1) Trading Day after delivery of the aggregate Exercise Price (other than
in the case of a cashless exercise) to the Company and (iii) the number of Trading Days comprising the Standard Settlement Period after
the delivery to the Company of the Notice of Exercise (such date, the “Warrant Share Delivery Date”). Upon delivery
of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares
with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant Shares, provided that payment
of the aggregate Exercise Price is received by the Warrant Share Delivery Date. The Company agrees to maintain a transfer agent that
is a participant in the FAST program so long as this Warrant remains outstanding and exercisable. As used herein, “Standard
Settlement Period” means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary
Trading Market with respect to the Common Stock as in effect on the date of delivery of the Notice of Exercise.
ii.
Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request of
a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which new Warrant shall in
all other respects be identical with this Warrant.
iii.
Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant to Section
2(c)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.
iv.
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the Company
shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied
by the Exercise Price or round up to the next whole share.
v.
Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer tax
or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid by the Company,
and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed by the Holder; provided,
however, that, in the event that Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant when
surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly executed by the Holder and the Company may
require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise and all fees to the Depository Trust Company
(or another established clearing corporation performing similar functions) required for same-day electronic delivery of the Warrant Shares.
vi.
Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.
e)
Holder’s Exercise Limitations.
i.
Beneficial Ownership Limitation. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the right
to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other
Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons, “Attribution Parties”)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its Affiliates and Attribution Parties shall include the number
of shares of Common Stock held by such Holder and all other Attribution Parties plus the number of shares of Common Stock issuable upon
exercise of this Warrant with respect to which such determination is being made, but shall exclude the number of shares of Common Stock
which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or
any of its Affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other
securities of the Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or
exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 2(d), beneficial ownership shall be calculated in accordance
with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that
the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder
is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in
this Section 2(d) applies, the determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder
together with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable shall be in the sole discretion
of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of whether this Warrant
is exercisable (in relation to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which
portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company shall have no obligation
to verify or confirm the accuracy of such determination. In addition, a determination as to any group status as contemplated above shall
be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes
of this Section 2(d), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding
shares of Common Stock as reflected in (A) the Company’s most recent periodic or annual report filed with the Commission, as the
case may be, (B) a more recent public announcement by the Company or (C) a more recent written notice by the Company or the Transfer
Agent setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall
within one Trading Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case,
the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities
of the Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be 4.99% (or, upon
election by a Holder in compliance with this Section 2(d) prior to the issuance of any Warrants, 9.99%) of the number of shares of the
Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.
The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership Limitation provisions of this Section 2(d),
provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of the Common Stock outstanding immediately
after giving effect to the issuance of shares of Common Stock upon exercise of this Warrant held by the Holder and the provisions of
this Section 2(d) shall continue to apply. Any increase in the Beneficial Ownership Limitation will not be effective until the 61st day
after such notice is delivered to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise
than in strict conformity with the terms of this Section 2(d) to correct this paragraph (or any portion hereof) which may be defective
or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable
to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.
Section
3. Certain Adjustments.
a)
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or otherwise
makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities payable in shares
of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company upon exercise of this
Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines (including by way of reverse
stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by reclassification of shares of the
Common Stock any shares of capital stock of the Company, then in each case the Exercise Price shall be multiplied by a fraction of which
the numerator shall be the number of shares of Common Stock (excluding treasury shares, if any) outstanding immediately before such event
and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event, and the number of
shares issuable upon exercise of this Warrant shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant
shall remain unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately after the record date for
the determination of stockholders entitled to receive such dividend or distribution and shall become effective immediately after the
effective date in the case of a subdivision, combination or re-classification.
b)
Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company grants,
issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata to the record
holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will be entitled to acquire,
upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had
held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations on exercise
hereof) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such
record is taken, the date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale
of such Purchase Rights.
c)
Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend or
other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of capital
or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend,
spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”),
at any time after the issuance of this Warrant, then, in each such case, the Holder shall be entitled to participate in such Distribution
to the same extent that the Holder would have participated therein if the Holder had held the number of shares of Common Stock acquirable
upon complete exercise of this Warrant (without regard to any limitations on exercise hereof) immediately before the date of which a
record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common Stock
are to be determined for the participation in such Distribution.
d)
Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or
more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company (or any Subsidiary),
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender
or exchange their shares for other securities, cash or property and has been accepted by the holders of more than 50% of the outstanding
Common Stock or more than 50% of the voting power of the common equity of the Company, (iv) the Company, directly or indirectly, in one
or more related transactions effects any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share
exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v)
the Company, directly or indirectly, in one or more related transactions consummates a stock or share purchase agreement or other business
combination (including, without limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another
Person or group of Persons whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock or more
than 50% of the voting power of the common equity of the Company (each a “Fundamental Transaction”), then, upon any
subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would have been issuable
upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the Holder (without regard to
any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock of the successor or acquiring corporation
or of the Company, if it is the surviving corporation, and any additional consideration (the “Alternate Consideration”)
receivable as a result of such Fundamental Transaction by a holder of the number of shares of Common Stock for which this Warrant is
exercisable immediately prior to such Fundamental Transaction (without regard to any limitation in Section 2(e) on the exercise of this
Warrant). For purposes of any such exercise, the determination of the Exercise Price shall be appropriately adjusted to apply to such
Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental
Transaction, and the Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable manner reflecting the
relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any choice as to the
securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. The Company shall cause any successor
entity in a Fundamental Transaction in which the Company is not the survivor (the “Successor Entity”) to assume in
writing all of the obligations of the Company under this Warrant and the other Transaction Documents in accordance with the provisions
of this Section 3(d) pursuant to written agreements in form and substance reasonably satisfactory to the Holder and approved by the Holder
(without unreasonable delay) prior to such Fundamental Transaction and shall, at the option of the Holder, deliver to the Holder in exchange
for this Warrant a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
this Warrant which is exercisable for a corresponding number of shares of capital stock of such Successor Entity (or its parent entity)
equivalent to the shares of Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on
the exercise of this Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder
to such shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being for the
purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction), and
which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction, the Successor
Entity shall be added to the term “Company” under this Warrant (so that from and after the occurrence or consummation of
such Fundamental Transaction, each and every provision of this Warrant and the other Transaction Documents referring to the “Company”
shall refer instead to each of the Company and the Successor Entity or Successor Entities, jointly and severally), and the Successor
Entity or Successor Entities, jointly and severally with the Company, may exercise every right and power of the Company prior thereto
and the Successor Entity or Successor Entities shall assume all of the obligations of the Company prior thereto under this Warrant and
the other Transaction Documents with the same effect as if the Company and such Successor Entity or Successor Entities, jointly and severally,
had been named as the Company herein. For the avoidance of doubt, the Holder shall be entitled to the benefits of the provisions of this
Section 3(d) regardless of (i) whether the Company has sufficient authorized shares of Common Stock for the issuance of
Warrant Shares and/or (ii) whether a Fundamental Transaction occurs prior to the Initial Exercise Date.
e)
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share, as the
case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as of a given date
shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.
f)
Notice to Holder.
i.
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the Company
shall promptly deliver to the Holder by email a notice setting forth the Exercise Price after such adjustment and any resulting adjustment
to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.
ii.
Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on
the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common Stock, (C) the
Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of
capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall be required in connection with
any reclassification of the Common Stock, any consolidation or merger to which the Company (or any of its Subsidiaries) is a party, any
sale or transfer of all or substantially all of its assets, or any compulsory share exchange whereby the Common Stock is converted into
other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding
up of the affairs of the Company, then, in each case, the Company shall cause to be delivered by email to the Holder at its last email
address as it shall appear upon the Warrant Register of the Company, at least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action required to
be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the Commission pursuant to a
Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such
notice to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.
Section
4. Transfer of Warrant.
a)
Transferability. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d) hereof
and to the provisions of Section 4.1 of the Purchase Agreement, this Warrant and all rights hereunder (including, without limitation,
any registration rights) are transferable, in whole or in part, upon surrender of this Warrant at the principal office of the Company
or its designated agent, together with a written assignment of this Warrant substantially in the form attached hereto duly executed by
the Holder or its agent or attorney and funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such
surrender and, if required, such payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee
or assignees, as applicable, and in the denomination or denominations specified in such instrument of assignment, and shall issue to
the assignor a new Warrant evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding
anything herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading Days
of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if properly assigned
in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a new Warrant issued.
b)
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office of
the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued, signed by
the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved in such division
or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided
or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated the Issue Date of this Warrant
and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant thereto.
c)
Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose (the
“Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and treat the
registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution to the Holder,
and for all other purposes, absent actual notice to the contrary.
d)
Transfer Restrictions. If, at the time of the surrender of this Warrant in connection with any transfer of this Warrant, the transfer
of this Warrant shall not be either (i) registered pursuant to an effective registration statement under the Securities Act and under
applicable state securities or blue sky laws or (ii) eligible for resale without volume or manner-of-sale restrictions or current public
information requirements pursuant to Rule 144, the Company may require, as a condition of allowing such transfer, that the Holder or
transferee of this Warrant, as the case may be, comply with the provisions of Section 5.7 of the Purchase Agreement.
e)
Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a view to
or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable state securities
law, except pursuant to sales registered or exempted under the Securities Act.
Section
5. Miscellaneous.
a)
No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting rights,
dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(c)(i), except as expressly
set forth in Section 3. Without limiting any rights of a Holder to receive Warrant Shares on a “cashless exercise” pursuant
to Section 2(c), in no event shall the Company be required to net cash settle an exercise of this Warrant.
b)
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant Shares,
and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case of the Warrant,
shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate, if mutilated, the
Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of such Warrant
or stock certificate.
c)
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business
Day.
d)
Authorized Shares. The Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized
and unissued Common Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase
rights under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers
who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant. The
Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein
without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common Stock may be
listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights represented by this
Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant Shares in accordance herewith,
be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens and charges created by the Company in
respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously with such issue).
e)
Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be determined
in accordance with the provisions of the Purchase Agreement.
f)
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered, will
have restrictions upon resale imposed by state and federal securities laws.
g)
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder shall
operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies, notwithstanding the fact that
the right to exercise this Warrant terminates on the Termination Date. Without limiting any other provision of this Warrant or the Purchase
Agreement, if the Company willfully and knowingly fails to comply with any provision of this Warrant, which results in any material damages
to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including, but
not limited to, reasonable attorneys’ fees, including those of appellate proceedings, incurred by the Holder in collecting any
amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.
h)
Notices. Any notice, request or other document required or permitted to be given or delivered to the Holder by the Company shall
be delivered in accordance with the notice provisions of the Purchase Agreement.
i)
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability of
the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted by the Company
or by creditors of the Company.
j)
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages, will
be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not be adequate
compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees to waive and not to
assert the defense in any action for specific performance that a remedy at law would be adequate.
k)
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby shall
inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted assigns
of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant and shall
be enforceable by the Holder or holder of Warrant Shares.
l)
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company, on
the one hand, and the Holder of this Warrant, on the other hand.
m)
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid
under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall
be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining
provisions of this Warrant.
n)
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed
a part of this Warrant.
********************
(Signature
Page Follows)
IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first above
indicated.
|
NEXTTRIP,
INC.
|
|
|
|
By: |
|
|
Name: |
William Kerby |
|
Title: |
Chief Executive Officer |
NOTICE
OF EXERCISE
To:
NEXTTRIP, inc.
(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant (only
if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.
(2)
Payment shall take the form of (check applicable box):
☐
in lawful money of the United States; or
☐
if permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise procedure
set forth in subsection 2(c).
(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:
_______________________________
The
Warrant Shares shall be delivered to the following DWAC Account Number:
_______________________________
_______________________________
_______________________________
(4)
Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.
[SIGNATURE
OF HOLDER]
Name
of Investing Entity: ________________________________________________________
Signature
of Authorized Signatory of Investing Entity: __________________________________
Name
of Authorized Signatory: ____________________________________________________
Title
of Authorized Signatory: _____________________________________________________
Date:
_________________________________________________________________________
EXHIBIT
B
ASSIGNMENT
FORM
(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to exercise the Warrant to purchase
shares.)
FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to
Name: |
|
|
|
|
(Please
Print) |
|
|
|
Address: |
|
|
|
|
(Please
Print) |
|
|
|
Phone
Number: |
|
|
|
|
|
Email
Address: |
|
|
|
|
|
Dated:
_______________ __, ______ |
|
|
Holder’s
Signature:_____________________________ |
|
|
Holder’s
Address: _____________________________ |
|
|
Exhibit
4.3
THIS
SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AND MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF (a) AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 OR (b) AN OPINION REASONABLY SATISFACTORY TO NEXTTRIP, INC., FROM COUNSEL FOR
NEXTTRIP, INC., OR FROM COUNSEL FOR THE PROPOSED TRANSFEROR REASONABLY SATISFACTORY TO NEXTTRIP, INC., TO THE EFFECT THAT THE TRANSFER
MAY BE EFFECTED WITHOUT SUCH REGISTRATION.
Original
Issue Date: December 31, 2024
NEXTTRIP,
INC.
WARRANT
TO PURCHASE COMMON STOCK
This
certifies that, for good and valuable consideration, the receipt of which is hereby acknowledged, or its assigns
(“Holder”) is entitled to purchase, subject to the terms and conditions of this Warrant, from NextTrip,
Inc., a Nevada corporation (the “Company”), the Initial Warrant Number of Shares of the Company’s
Common Stock (subject to adjustment as provided hereunder, the “Shares”). The purchase price of one Share under
this Warrant shall be equal to the Exercise Price (as defined below). Holder shall be entitled to purchase the Shares in accordance
with Section 2 at any time subsequent to the Original Issue Date of this Warrant as set forth above (the “Original
Issue Date”) and prior to the Expiration Date (as defined below). The Exercise Price and Shares are subject to adjustment
from time to time pursuant to the terms hereof. This Warrant is issued pursuant to a Promissory Note. Capitalized terms used, but
not defined, herein have the respective meanings ascribed to them in the Note.
In
this Warrant, the term “Initial Warrant Number of Shares” is Two Hundred Twenty Thousand (220,000).
1.
Exercise Period; Exercise of Warrant.
1.1
Exercise Period. This Warrant shall terminate at 5:00 p.m. Eastern Time on the Third (3rd ) anniversary of the Original
Issue Date (the “Expiration Date”).
1.2
Exercise. At the option of the Holder, this Warrant shall be exercisable, in whole or in any part, to purchase a number of shares
of the Common Stock of the Company, par value $0.001 per share (“Common Stock”), up to the Initial Warrant Number
of Shares, at the Exercise Price. The Initial Warrant Number of Shares is subject to adjustment as provided below in this Warrant.
1.3
Exercise Price. The initial exercise price for the purchase of each Share under this Warrant (the “Initial Exercise Price”)
shall equal Four and No/100 Dollars ($4.00) (“Exercise Price”).
2.
Exercise Procedure and Payment.
2.1
Cash Exercise. At any time after the Original Issue Date, this Warrant may be exercised by delivery of a Notice of Exercise in
the form attached hereto, duly completed and executed by Holder, to the Company at the principal corporate offices of the Company and,
in the case of a full exercise of this Warrant, surrender of this Warrant, together with payment in the amount obtained by multiplying
the Exercise Price then in effect by the number of Shares thereby purchased, as designated in the Notice of Exercise. Payment may be
in cash or by check payable to the order of the Company.
2.2
Net Issuance. If, at the time of any exercise of this Warrant, there is no effective registration statement registering, or no
current prospectus available for, the issuance or resale of the Shares by the Holder, then, in lieu of payment of the Exercise Price
described in Section 2.1, and only in respect of up to one half (1/2) of the Initial Warrant Number of Shares of Common Stock
set out under this Warrant, Holder may elect to receive, without the payment by Holder of any additional consideration, Shares equal
to the value of the exercised portion of this Warrant by delivery of a Net Issuance Election in the form attached hereto, duly
executed, at the principal executive offices of the Company. Thereupon, the Company shall issue to Holder such number of fully paid and
nonassessable Shares as is computed using the following formula:
|
X
= |
the
number of Shares to be issued to Holder pursuant to this Section 2. |
|
|
|
|
Y
= |
the
number of Shares being exercised under this Warrant in respect of which the net issuance election is made pursuant to this Section
2. |
|
|
|
|
A
= |
the
“fair market value” of one Share, as determined in accordance with the provisions of this Section 2. |
|
|
|
|
B
= |
the
Exercise Price in effect under this Warrant at the time the Net Issuance Election is made pursuant to this Section 2. |
For
purposes of this Section 2, the term “fair market value” shall mean the per share fair market value of the
Shares as determined in good faith by the Board of Directors of the Company.
2.3
Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not have the
right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect to such issuance
after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s affiliates, and any other
persons acting as a group together with the Holder or any of the Holder’s affiliates (such persons, “Attribution Parties”)),
would beneficially own in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the
number of shares of Common Stock beneficially owned by the Holder and its affiliates and Attribution Parties shall include the number
of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, but shall exclude
the number of shares of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised portion of this Warrant
beneficially owned by the Holder or any of its affiliates or Attribution Parties and (ii) exercise or conversion of the unexercised or
nonconverted portion of any other securities of the Company (including, without limitation, any other Common Stock equivalent) subject
to a limitation on conversion or exercise analogous to the limitation contained herein beneficially owned by the Holder or any of its
affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 2.3, beneficial ownership
shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being
acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d)
of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2.3 applies, the determination of whether this Warrant is exercisable (in relation to other
securities owned by the Holder together with any affiliates and Attribution Parties) and of which portion of this Warrant is exercisable
shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be the Holder’s determination
of whether this Warrant is exercisable (in relation to other securities owned by the Holder together with any affiliates and Attribution
Parties) and of which portion of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation, and the Company
shall have no obligation to verify or confirm the accuracy of such determination. In addition, a determination as to any group status
as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
thereunder. For purposes of this Section 2.3, in determining the number of outstanding shares of Common Stock, a Holder may rely on the
number of outstanding shares of Common Stock as reflected in a more recent public announcement by the Company or a more recent written
notice by the Company or its transfer agent (if any) setting forth the number of shares of Common Stock outstanding. Upon the written
or oral request of a Holder, the Company shall within one (1) Trading Day confirm orally and in writing to the Holder the number of shares
of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect
to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its affiliates or Attribution Parties
since the date as of which such number of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation”
shall be 4.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common
Stock issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2.3, provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number
of the shares of Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon exercise of
this Warrant held by the Holder and the provisions of this Section 2.3 shall continue to apply. Any increase in the Beneficial Ownership
Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions of this paragraph shall
be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 2.3 to correct this paragraph
(or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or
to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph
shall apply to a successor holder of this Warrant.
3.
Reservation of Shares. The Company hereby agrees that at all times there shall be reserved for issuance and delivery upon exercise
of this Warrant at least two hundred percent (200%) of such number of Shares from time to time issuable upon exercise of this Warrant.
All such shares shall be duly authorized, and when issued upon such exercise, shall be validly issued, fully paid and non-assessable,
free and clear of all liens, security interests, charges and other encumbrances or restrictions on sale and free and clear of all preemptive
rights.
4.
Delivery of Stock Certificates. Within a reasonable time after exercise, in whole or in part, of this Warrant, the Company shall
issue in the name of and deliver to Holder a certificate or certificates for the number of fully paid and nonassessable Shares which
Holder shall have requested in the Notice of Exercise and/or Net Issuance Election, as applicable.
5.
No Fractional Shares. No fractional Shares or scrip representing fractional shares will be issued upon exercise of this Warrant.
If upon any exercise of this Warrant a fraction of a Share results, the Company will round up such fraction and issue to the Holder an
additional whole Share in lieu of such fractional Share.
6.
Charges, Taxes and Expenses. The Company shall pay all issue or transfer taxes or other incidental charges, if any, in connection
with the issuance or transfer of the Shares purchased pursuant to the exercise hereof from the Company.
7.
Loss, Theft, Destruction or Mutilation of Warrant. Upon receipt by the Company of evidence reasonably satisfactory to it of the
loss, theft, destruction or mutilation of this Warrant, and in case of loss, theft or destruction, of indemnity or security reasonably
satisfactory to the Company, and upon reimbursement to the Company of all reasonable expenses incidental thereto, and upon surrender
and cancellation of this Warrant, if mutilated, the Company will make and deliver a new Warrant of like tenor and dated as of such cancellation,
in lieu of this Warrant.
8.
Saturdays, Sundays, Holidays, Etc. If the last or appointed day for the taking of any action or the expiration of any right required
or granted herein shall be a Saturday or a Sunday or shall be a legal holiday, then such action may be taken or such right may be exercised
on the next succeeding weekday which is not a legal holiday.
9.
Adjustment of Exercise Price and Number of Shares. The Exercise Price and the number of and kind of securities purchasable upon
exercise of this Warrant shall be subject to adjustment from time to time as follows:
9.1
Subdivisions, Combinations, Dividends and Other Issuances. If the Company shall at any time after the Original Issue Date hereof
but prior to the Expiration Date subdivide its outstanding shares of Common Stock by stock split, split-up or otherwise, combine its
outstanding Common Stock, or pay a dividend in Shares or a distribution in Shares, the number of Shares as to which this Warrant is exercisable
as of the date of such subdivision, dividend or distribution shall forthwith be proportionately increased in the case of a subdivision,
dividend or distribution, or proportionately decreased in the case of a combination. Appropriate adjustments shall also be made to the
Exercise Price, but the aggregate purchase price payable for the total number of Shares thereafter purchasable under this Warrant as
of such date shall remain the same.
9.2
Other Distributions. If the Company shall at any time after the Original Issue Date hereof but prior to the Expiration Date distribute
to holders of its Shares any cash, Common Stock Equivalents, shares of its capital stock, evidences of indebtedness, purchase or other
rights or any of other assets (“Distribution Assets”), then the Company may, at its option, either (i) appropriately
adjust the number of Shares purchasable upon exercise of this Warrant and decrease the Exercise Price based upon the value Distribution
Assets with respect to each Share, each as determined in good faith by the Company’s Board of Directors or (ii) provide by resolution
of the Company’s Board of Directors that on exercise of this Warrant, Holder hereof shall thereafter be entitled to receive, in
addition to the Shares otherwise receivable on exercise hereof, the Distribution Assets distributed by the Company with respect to such
number of Shares.
9.3
Effect of Consolidation, Merger or Sale. In case of any reclassification, capital reorganization, or change of securities of the
class issuable upon exercise of this Warrant (other than a change in par value, or from par value to no par value, or from no par value
to par value, or as a result of any subdivision, combination, stock dividend or other distribution provided for in Sections 9.1,
and 9.2 above), or in case of any consolidation or merger of the Company with or into any corporation (other than a consolidation
or merger with another corporation in which the Company is the acquiring and the surviving corporation and which does not result in any
reclassification or change of outstanding securities issuable upon exercise of this Warrant), or in case of any sale of all or substantially
all of the assets of the Company, the Company, or such successor or purchasing corporation, as the case may be, shall duly execute and
deliver to the holder of this Warrant a new Warrant (in form and substance satisfactory to the holder of this Warrant), or the Company
shall make appropriate provision without the issuance of a new Warrant, so that the holder of this Warrant shall have the right to receive,
at a total purchase price not to exceed that payable upon the exercise of the unexercised portion of this Warrant, and in lieu of the
Shares theretofore issuable upon exercise of this Warrant, the kind and amount of shares of stock, other securities, money and property
receivable upon such reclassification, capital reorganization, change, merger or sale by a holder of the number of Shares then purchasable
under this Warrant. In any such case, appropriate provisions shall be made with respect to the rights and interest of Holder so that
the provisions hereof shall thereafter be applicable to any shares of stock or other securities and property deliverable upon exercise
hereof, or to any new Warrant delivered pursuant to this Section 9.3, and appropriate adjustments shall be made to the Exercise
Price per share payable hereunder, provided, that the aggregate Exercise Price shall remain the same. The provisions of this Section
9.3 shall similarly apply to successive reclassifications, capital reorganizations, changes, mergers and transfers.
10.
Notice of Adjustments; Notices. Whenever the Exercise Price or number or kind(s) of securities purchasable hereunder shall be
adjusted pursuant to Section 9 hereof, the Company shall execute and deliver to Holder a certificate setting forth, in reasonable
detail, the event requiring the adjustment, the amount of the adjustment, the method by which such adjustment was calculated and the
Exercise Price and number of and kind(s) of securities purchasable hereunder after giving effect to such adjustment, and shall cause
a copy of such certificate to be mailed (by first class mail, postage prepaid) to Holder.
11.
Rights As Shareholder; Notice to Holders. Nothing contained in this Warrant shall be construed as conferring upon Holder or his
or its transferees the right to vote or to receive dividends (except as provided in Section 9 hereof) or to consent or to receive
notice as a shareholder in respect of any meeting of shareholders for the election of directors of the Company or of any other matter,
or any rights whatsoever as shareholders of the Company. The Company shall give notice to Holder by registered mail if at any time prior
to the Expiration Date or exercise in full of the Warrants, any of the following events shall occur:
(i)
a dissolution, liquidation or winding up of the Company shall be proposed;
(ii)
a capital reorganization or reclassification of the Common Stock or Qualified Financing (other than a change in par value, or from par
value to no par value, or from no par value to par value, or as a result of any subdivision, combination, stock dividend or other distribution)
or any consolidation or merger of the Company with or into another corporation (other than a consolidation or merger with another corporation
in which the Company is the acquiring and the surviving corporation and which does not result in any reclassification or change of the
securities issuable upon exercise of this Warrant), or in the case of any sale of all or substantially all of the assets of the Company;
(iii)
a taking by the Company of a record of the holders of any class of securities for the purpose of determining the holders thereof who
are entitled to receive any dividend (other than a cash dividend) for other distribution, any right to subscribe for, purchase or otherwise
acquire any shares of stock of any class or any other securities or property, or to receive any other rights; and
(iv)
any other event described in Section 9 hereof.
Such
giving of notice shall be simultaneous with the giving of notice to holders of Common Stock. Such notice shall specify the record date
or the date of closing the stock transfer books, as the case may be. Failure to provide such notice shall not affect the validity of
any action taken in connection with any action contemplated in this Section 11.
12.
Restricted Securities. The Holder understands that this Warrant and the Shares purchasable hereunder constitute “restricted
securities” under the federal securities laws inasmuch as they are, or will be, acquired from the Company in transactions not
involving a public offering and accordingly may not, under such laws and applicable regulations, be resold or transferred without registration
under the Securities Act of 1933, as amended (the “Act”), or an applicable exemption from such registration. The Holder
further acknowledges that a securities legend to the foregoing effect shall be placed on any Shares issued to Holder upon exercise of
this Warrant.
13.
Transferability. This Warrant shall be transferable only on the books of the Company, upon delivery thereof duly endorsed by Holder
or by its duly authorized attorney or representative, accompanied by proper evidence of succession, assignment or authority to transfer.
Upon any registration of transfer, the Company shall execute and deliver new Warrants to the person entitled thereto.
14.
Miscellaneous.
14.1
Net Cash Settlement. Notwithstanding anything herein to the contrary, in no event will the Holder hereof be entitled to receive
a net-cash settlement as liquidated damages in lieu of physical settlement in shares of Common Stock, regardless of whether the Common
Stock underlying this Warrant is registered pursuant to an effective registration statement; provided, however, that the foregoing will
not preclude the Holder from seeking other remedies at law or equity for breaches by the Company of its registration obligations hereunder
and from enforcing or collecting on any resulting legal or equitable judgment(s).
14.2
Binding Effect. This Warrant and the various rights and obligations arising hereunder shall be binding upon and inure to the benefit
of the parties hereto and their respective successors and assigns.
14.3
Entire Agreement. This Warrant and the Promissory Note constitute the entire agreement between the parties with respect to the
subject matter hereof and supersede all prior and contemporaneous agreements, whether oral or written, between the parties hereto with
respect to the subject matter hereof.
14.4
Amendment and Waiver. Any term of this Warrant may be amended and the observance of any term hereof may be waived (either generally
or in a particular instance and either retroactively or prospectively), with the written consent of the Company and the Holder.
14.5
Governing Law. This Agreement shall be governed by and construed under the laws of the State of Nevada without reference to the
conflicts of law principles thereof.
14.6
Headings. The headings in this Agreement are for convenience only and shall not alter or otherwise affect the meaning hereof.
14.7
Severability. If one or more provisions of this Warrant are held to be unenforceable under applicable law, such provision shall
be excluded from this Warrant and the balance of the Warrant shall be interpreted as if such provision were so excluded and the balance
shall be enforceable in accordance with its terms.
14.8
Counterparts. This Warrant may be executed in two or more counterparts, each of which shall be deemed an original for all purposes.
14.9
Notices. Unless otherwise provided, any notice required or permitted under this Warrant shall be given in the same manner as provided
in the Promissory Note.
[Signature
Page Follows]
IN
WITNESS WHEREOF, the parties hereto have executed and delivered this Warrant as of the date appearing on the first page of this Warrant.
|
THE
COMPANY: |
|
|
|
NEXTTRIP,
INC. |
|
|
|
|
|
|
|
By: |
Bill
Kerby |
|
Its: |
Chief
Executive Officer |
NOTICE
OF EXERCISE
1.
The undersigned hereby elects to purchase _____________ Shares of NextTrip, Inc., a Nevada corporation, Common Stock, pursuant to the
terms of the attached Warrant, and tenders herewith payment of the Exercise Price thereof pursuant to the terms of the Warrant.
2.
Please issue certificates representing the Shares purchased hereunder in the names and in the denominations indicated below.
NET
ISSUANCE ELECTION NOTICE
The
undersigned hereby elects under Section 2.2 of the attached Warrant to purchase ___________ Shares of Common Stock. The Certificate(s)
for the shares issuable upon such net issuance election shall be issued in the name of the undersigned or as otherwise indicated below.
Signature:
_____________________________________
Name
for Registration:
_____________________________________
Mailing
Address:
_____________________________________
_____________________________________
Exhibit
10.1
SECURITIES
PURCHASE AGREEMENT
This
Securities Purchase Agreement (this “Agreement”) is dated as of December 31, 2024, between NextTrip, Inc.,
a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including
its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section
5 of the Securities Act contained in Section 4(a)(2) thereof and/or Regulation D promulgated thereunder, the Company desires to issue
and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company
as more fully described in this Agreement.
NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:
ARTICLE
I.
DEFINITIONS
1.1
Definitions. In addition to the terms defined elsewhere in this Agreement, (a) capitalized terms that are not otherwise defined
herein have the meanings given to such terms in the Certificate of Designation (as defined herein), and (b) the following terms have
the meanings set forth in this Section 1.1:
“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.
“Articles
of Incorporation” means the amended and restated articles of incorporation, as amended, of the Company on file with the Secretary
of State of Nevada.
“Board
of Directors” means the board of directors of the Company.
“Business
Day” means any day other than a Saturday, Sunday or a legal holiday on which commercial banking institutions in New York, New
York are authorized to close for business; provided that banks shall not be deemed to be authorized or obligated to be closed due to
a “shelter in place” or similar closure of physical branch locations at the direction of any governmental authority if such
banks’ electronic funds transfer systems (including for wire transfers) are open for use by customers on such day.
“Certificate
of Designation” means the Certificate of Designation to be filed prior to the Closing by the Company with the Secretary of
State of the State of Nevada, in the form attached as Exhibit A hereto.
“Closing”
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.
“Closing
Date” means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers’ obligations to pay the Subscription Amount and (ii) the Company’s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2nd)
Trading Day following the date hereof.
“Commission”
means the United States Securities and Exchange Commission.
“Common
Stock” means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.
“Common
Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.
“Company
Counsel” means Snell & Wilmer LLP, with offices located at 12230 El Camino Real, Suite 300, San Diego, California 92130.
“Conversion
Ratio” shall have the meaning ascribed to such term in the Certificate of Designation.
“Conversion
Shares” means, collectively, the shares of Common Stock issuable upon conversion of the Preferred Shares in accordance with
the terms hereof.
“Disclosure
Schedules” means the Disclosure Schedules of the Company delivered concurrently herewith.
“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
“Exchange
Cap” means that the Company shall not issue or sell any shares of Common Stock pursuant to the issuance of Conversion Shares
to the extent that after giving effect thereto, the aggregate number of shares of Common Stock that would be issued would exceed 19.99%
of the shares of Common Stock outstanding on the date of this Agreement (which number of shares shall be reduced, on a share-for-share
basis, by the number of shares of Common Stock issued or issuable pursuant to any transaction or series of transactions that may be aggregated
with the transactions contemplated by this Agreement under applicable rules of the Nasdaq Capital Market or any other Trading Market
on which the Common Stock may be listed or quoted) unless and until the Company elects to solicit stockholder approval of the issuance
of Common Stock as contemplated by this Agreement and the stockholders of the Company have in fact approved such issuance in accordance
with the applicable rules and regulations of the Nasdaq Capital Market or any other Trading Market on which the Common Stock may be then
listed or quoted.
“GAAP”
shall have the meaning ascribed to such term in Section 3.1(h).
“Legend
Removal Date” shall have the meaning ascribed to such term in Section 4.1(c).
“Liens”
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.
“Material
Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).
“Per
Share Purchase Price” equals $3.02, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement.
“Person”
means an individual, corporation, exempted company, partnership (including a general partnership, limited partnership, exempted limited
partnership or limited liability partnership), limited liability company, association, trust or other entity or organization, including
a government, domestic or foreign, or political subdivision thereof, or an agency or instrumentality thereof.
“Preferred
Shares” means the up to 297,788 shares of the Company’s Series J Nonvoting Convertible Preferred Stock issued or issuable
to the Purchasers pursuant to this Agreement, having the rights, preferences and privileges set forth in the Certificate of Designation.
“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.
“Required
Approvals” shall have the meaning ascribed to such term in Section 3.1(e).
“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.
“SEC
Reports” shall have the meaning ascribed to such term in Section 3.1(h).
“Securities”
means the Preferred Shares and the Conversion Shares.
“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
“Short
Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).
“Subscription
Amount” means, as to each Purchaser, the aggregate amount to be paid for Preferred Shares purchased hereunder as specified
below such Purchaser’s name on the signature page of this Agreement and next to the heading “Subscription Amount,”
in United States dollars and in immediately available funds.
“Subsidiary”
means any subsidiary of the Company as set forth on Schedule 3.1(a), and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.
“Trading
Day” means a day on which the principal Trading Market is open for trading.
“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the Pink Open Market, OTCQB or the OTCQX (or any successors to any of the foregoing).
“Transaction
Documents” means this Agreement, the Certificate of Designation, all exhibits and schedules thereto and hereto and any other
documents or agreements executed in connection with the transactions contemplated hereunder.
“Transfer
Agent” means Issuer Direct Corporation, the current transfer agent of the Company, with a mailing address of 1981 Murray Holladay
Road, Suite 100 Salt Lake City, Utah 84117, and any successor transfer agent of the Company.
ARTICLE
II.
PURCHASE
AND SALE
2.1
Closing. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the
execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly,
agree to purchase, up to an aggregate of $899,319.76 of Preferred Shares. Each Purchaser shall deliver to the Company, via wire transfer
immediately available funds (or such other consideration as agreed to by the Company) equal to such Purchaser’s Subscription Amount
as set forth on the signature page hereto executed by such Purchaser, and the Company shall deliver to the Company each Purchaser’s
respective Preferred Shares, as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items
set forth in Section 2.2(b) deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and
2.3, the Closing shall take place remotely by electronic transfer of the Closing documentation.
2.2
Deliveries.
(a)
On or prior to the Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser the
following:
(i)
this Agreement duly executed by the Company;
(ii)
subject to Section 2.1, the Company shall have provided each Purchaser with the Company’s wire instructions;
(iii)
a certificate evidencing that number of Preferred Shares equal to such Purchaser’s Subscription Amount divided by the Per Share
Purchase Price, which Preferred Shares shall be registered in the name of such Purchaser; and
(iv)
evidence of the filing and acceptance of the Certificate of Designation from the Secretary of State of Nevada.
(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:
(i)
this Agreement duly executed by such Purchaser; and
(ii)
such Purchaser’s Subscription Amount by wire transfer to the account specified in writing by the Company (or such other consideration
as agreed to by the Company).
2.3
Closing Conditions.
(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:
(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects)
on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein, in
which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality,
in all respects) as of such date);
(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed; and
(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.
(b)
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:
(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein, in which case they shall be accurate in all material respects (or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects) as of such date);
(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;
(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;
(iv)
there shall have been no Material Adverse Effect with respect to the Company; and
(v)
from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company’s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.
ARTICLE
III.
REPRESENTATIONS
AND WARRANTIES
3.1
Representations and Warranties of the Company. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall
be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the
corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:
(a)
Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly
or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued
and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive
and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries
or any of them in the Transaction Documents shall be disregarded.
(b)
Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material
Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification.
(c)
Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors or the Company’s stockholders in connection herewith or therewith
other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been
(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.
(d)
No Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.
(e)
Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the notice
and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing of the Conversion
Shares for trading thereon in the time and manner required thereby, (ii) the filing of Form D with the Commission, (iii) such filings
as are required to be made under applicable state securities laws, and (iv) as it relates to the conversion of Preferred Shares to Common
Stock, stockholder approval for the removal of the Exchange Cap (collectively, the “Required Approvals”).
(f)
Issuance of the Securities. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.
The Preferred Shares and the Conversion Shares, when issued in accordance with the terms of the Transaction Documents, will be validly
issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company shall reserve from its duly authorized
capital stock a number of shares of Common Stock necessary for issuance as the Preferred Shares.
(g)
Capitalization. The capitalization of the Company is set forth in the SEC Reports. Except as set forth in the SEC Reports, no
Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities and as set forth in the SEC
Reports, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating
to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe
for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents
or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue
shares of Common Stock or other securities to any Person (other than the Purchasers). Except as set forth in the SEC Reports, there are
no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange
or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. Except as set forth in
the SEC Reports, there are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar
provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may
become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or “phantom
stock” plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are
duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws,
and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities.
Except for the Required Approvals, no further approval or authorization of any stockholder, the Board of Directors or others is required
for the issuance and sale of the Securities. Except as set forth in the SEC Reports, there are no stockholders agreements, voting agreements
or other similar agreements with respect to the Company’s capital stock to which the Company is a party or, to the knowledge of
the Company, between or among any of the Company’s stockholders.
(h)
SEC Reports; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the
“SEC Reports”). As of their respective dates, the SEC Reports complied in all material respects with the requirements
of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of
a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the
SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with
respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally
accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as may be
otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain
all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, immaterial, year-end audit adjustments.
(i)
Certain Fees. No brokerage or finder’s fees or commissions are or will be payable by the Company or any Subsidiary to any
broker, financial advisor or consultant, finder, other placement agent, investment banker, bank or other Person with respect to the transactions
contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims
made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions
contemplated by the Transaction Documents.
(j)
Listing and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received
notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance
with the listing or maintenance requirements of such Trading Market. Except as set forth in the SEC Reports, the Company is, and has
no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements.
The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation
and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in
connection with such electronic transfer.
(k)
No Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of the
Securities, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company
are listed or designated.
(l)
Acknowledgment Regarding Purchasers’ Purchase of Securities. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers’ purchase of the Securities. The Company further represents to each Purchaser that the Company’s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.
(m)
Regulation M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company.
(n)
Private Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, no
registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated
hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.
(o)
No General Solicitation. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and
certain other “accredited investors” within the meaning of Rule 501 under the Securities Act.
(p)
No Disqualification Events. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the
Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of
the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company’s outstanding voting equity
securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act)
connected with the Company in any capacity at the time of sale (each, an “Issuer Covered Person” and, together, “Issuer
Covered Persons”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii)
under the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification
Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the
Purchasers a copy of any disclosures provided thereunder.
(q)
Other Covered Persons. The Company is not aware of any person (other than any Issuer Covered Person) that has been or will be
paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.
(r)
Notice of Disqualification Events. The Company will notify the Purchasers in writing, prior to the Closing Date of (i) any Disqualification
Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably be expected to become
a Disqualification Event relating to any Issuer Covered Person.
3.2
Representations and Warranties of the Purchasers. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case
they shall be accurate as of such date):
(a)
Organization; Authority. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except:
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.
(b)
Understandings or Arrangements. Such Purchaser is acquiring the Securities as principal for its own account and has no direct
or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities. Such
Purchaser is acquiring the Securities hereunder in the ordinary course of its business. Such Purchaser understands that the Securities
are “restricted securities” and have not been registered under the Securities Act or any applicable state securities law
and is acquiring such Securities as principal for his, her or its own account and not with a view to or for distributing or reselling
such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention
of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or
indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation
of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser’s right
to sell such Securities pursuant to a registration statement or otherwise in compliance with applicable federal and state securities
laws).
(c)
Purchaser Status. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each
date on which it converts any Preferred Shares, it will be an “accredited investor” as defined in Rule 501(a)(1), (a)(2),
(a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act.
(d)
Experience of Such Purchaser. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.
(e)
Access to Information. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the
Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment.
(f)
Certain Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, such Purchaser has
not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser’s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser’s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.
(g)
General Solicitation. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other
communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or
presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.
(h)
Restrictions Regarding Purchaser’s Trading Activity. Anything in this Agreement or elsewhere herein to the contrary notwithstanding,
it is understood and acknowledged by the Purchaser that: (i) the Purchasers have been asked by the Company and the Purchasers agreed,
to desist from purchasing or selling short, securities of the Company, or “derivative” securities based on securities issued
by the Company; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short
Sales or “derivative” transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company’s publicly-traded securities; and (iii) any Purchaser, and counter-parties in “derivative”
transactions to which any such Purchaser is a party, directly or indirectly, presently may not have a “short” position in
the Common Stock. The Purchasers further acknowledge that (y) the Purchasers may not engage in hedging activities at various times during
the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Conversion Shares
deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing
stockholders’ equity interests in the Company at and after the time that the hedging activities are being conducted. The Purchasers
acknowledge that such aforementioned hedging activities constitute a breach of the Transaction Documents.
The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser’s
right to rely on the Company’s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.
ARTICLE
IV.
OTHER
AGREEMENTS OF THE PARTIES
4.1
Removal of Legends.
(a)
The Preferred Shares and Conversion Shares may only be disposed of in compliance with state and federal securities laws. In connection
with any transfer of Preferred Shares or Conversion Shares other than pursuant to an effective registration statement or Rule 144, to
the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require
the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company,
the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require
registration under the Securities Act.
(b)
The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Preferred Shares or Conversion
Shares in the following form:
NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE OR EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION
OR EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN
WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER
LOAN SECURED BY SUCH SECURITIES.
(c)
Certificates evidencing the Conversion Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof):
(i) while a registration statement covering the resale of such security is effective under the Securities Act, if any, or (ii) if such
legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued
by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser
promptly if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively.
If all or any portion of a Preferred Share is converted into shares of Common Stock at a time when there is an effective registration
statement to cover the resale of the Conversion Shares, or if such Conversion Shares may be sold under Rule 144 or if such legend is
not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued
by the staff of the Commission) then such Conversion Shares shall be issued free of all legends. The Company agrees that following such
time as such legend is no longer required under this Section 4.1(c), the Company will, no later than the earlier of (i) two (2) Trading
Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser
to the Company or the Transfer Agent of a certificate representing Conversion Shares issued with a restrictive legend (such date, the
“Legend Removal Date”), deliver or cause to be delivered to such Purchaser a certificate representing such shares
that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions to the
Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Conversion Shares subject to legend removal hereunder
shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser’s prime broker with the Depository
Trust Company System as directed by such Purchaser. As used herein, “Standard Settlement Period” means the standard
settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock
as in effect on the date of delivery of a certificate representing shares issued with a restrictive legend.
4.2
Furnishing of Information. Until the time that no Purchaser owns Securities, the Company covenants to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.
4.3
Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would
require the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of
the Securities for purposes of the Exchange Cap as well as rules and regulations of any Trading Market such that it would require stockholder
approval prior to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent
transaction.
4.4
Conversion and Exercise Procedures. Each of the form of Notice of Conversion included in the Certificate of Designation set forth
the totality of the procedures required of the Purchasers in order to convert the Preferred Shares.
4.5
Use of Proceeds. Except as set forth on Schedule 4.5 attached hereto, the Company shall use the net proceeds from the sale
of the Securities hereunder for working capital purposes and shall not use such proceeds for the redemption of any Common Stock or Common
Stock Equivalents.
4.6
Reservation of Common Stock. The Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance
pursuant to the Transaction Documents in such amount as may then be required to fulfill its obligations in full under the Transaction
Documents.
4.7
Listing of Common Stock. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock
on the Trading Market on which it is currently listed. The Company shall, if applicable: (i) in the time and manner required by the principal
Trading Market submit an additional shares listing application covering the Conversion Shares, and (ii) take all steps necessary to cause
such shares of Common Stock to be approved for listing or quotation on such Trading Market as soon as possible thereafter. The Company
agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established
clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established
clearing corporation in connection with such electronic transfer.
4.8
Form D; Blue Sky Filings. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or “Blue Sky” laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.
4.9
Restrictions on Conversions and Exercises. Each Purchaser agrees and acknowledges that the Preferred Shares may not be converted
into Conversion Shares unless and until such time as the Company has lifted the Exchange Cap. Buyer further agrees and acknowledges that
Buyer shall bear the economic risk of loss associated with holding the Preferred Shares pending the satisfaction of the conditions set
forth in this Section 4.9.
ARTICLE
V.
MISCELLANEOUS
5.1
Termination. This Agreement may be terminated by any Purchaser, as to such Purchaser’s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5th) Trading Day following the date hereof; provided, however,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).
5.2
Fees and Expenses. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any conversion or
exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities
to the Purchasers.
5.3
Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.
5.4
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New
York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if
sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required
to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.
5.5
Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Preferred Shares
based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver,
by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver
disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser
(or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement of
this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner
impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the
rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior
written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon
each Purchaser and holder of Securities and the Company.
5.6
Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.
5.7
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the “Purchasers.”
5.8
No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise
set forth in this Section 5.8.
5.9
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles
of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of
the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective
affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and
federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and
federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction
Documents), and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to
the jurisdiction of any such court, that such Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby
irrevocably waives personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof
via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices
to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall
commence a Proceeding to enforce any provisions of the Transaction Documents, then, the prevailing party in such Proceeding shall be
reimbursed by the non-prevailing party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such Proceeding.
5.10
Survival. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.
5.11
Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such “.pdf” signature page were an original thereof.
5.12
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.
5.13
Replacement of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.
5.14
Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that
a remedy at law would be adequate.
5.15
Payment Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.
5.16 Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.
5.17
Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.
(Signature
Pages Follow)
IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.
NextTrip,
INC. |
|
Address
for Notice: |
|
|
|
By: |
|
|
3900
Paseo Del Sol, |
Name: |
William
Kerby |
|
Santa
Fe, New Mexico 87507 |
Title: |
Chief
Executive Officer |
|
|
|
|
|
E-Mail:
bill.kerby@nexttrip.com |
|
|
|
|
With
a copy to (which shall not constitute notice): |
|
|
Snell
& Wilmer LLP
Attn:
Christopher L. Tinen, Esq.
12230
El Camino Real, Suite 300
San
Diego, California 92130
E-Mail:
ctinen@swlaw.com |
|
|
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK
SIGNATURE
PAGE FOR PURCHASER FOLLOWS]
[PURCHASER
SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT]
IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.
Name
of Purchaser: ________________________________________________________
Signature
of Authorized Signatory of Purchaser: _________________________________
Name
of Authorized Signatory: _______________________________________________
Title
of Authorized Signatory: ________________________________________________
Email
Address of Authorized Signatory: _________________________________________
Address
for Notice to Purchaser:
Address
for Delivery of Securities to Purchaser (if not same as address for notice):
Subscription
Amount: $_________________
Preferred
Shares: _________________ Beneficial Ownership Blocker ☐ 4.99% or ☐ 9.99%
EIN
Number: ____________________
☐
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)
the Closing shall occur on the second (2nd) Trading Day following the date of this Agreement and (iii) any condition to Closing
contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed
of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead
be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate
or the like or purchase price (as applicable) to such other party on the Closing Date.
EXHIBIT
A
Form
of Certificate of Designation
Exhibit
10.2
SECURITIES
PURCHASE AGREEMENT
This
Securities Purchase Agreement (this “Agreement”) is dated as of December 31, 2024, between NextTrip, Inc., a Nevada
corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors
and assigns, a “Purchaser” and collectively the “Purchasers”).
WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section
5 of the Securities Act contained in Section 4(a)(2) thereof and/or Regulation D promulgated thereunder, the Company desires to issue
and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company
as more fully described in this Agreement.
NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:
ARTICLE
I.
DEFINITIONS
1.1 Definitions. In addition to the terms defined elsewhere in this Agreement, (a) capitalized terms that are not otherwise defined
herein have the meanings given to such terms in the Certificate of Designation or the Warrant (in each case, as defined herein), and
(b) the following terms have the meanings set forth in this Section 1.1:
“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.
“Articles
of Incorporation” means the amended and restated articles of incorporation, as amended, of the Company on file with the Secretary
of State of Nevada.
“Board
of Directors” means the board of directors of the Company.
“Business
Day” means any day other than a Saturday, Sunday or a legal holiday on which commercial banking institutions in New York, New
York are authorized to close for business; provided that banks shall not be deemed to be authorized or obligated to be closed due to
a “shelter in place” or similar closure of physical branch locations at the direction of any governmental authority if such
banks’ electronic funds transfer systems (including for wire transfers) are open for use by customers on such day.
“Certificate
of Designation” means the Certificate of Designation to be filed prior to the Closing by the Company with the Secretary of
State of the State of Nevada, in the form attached as Exhibit A hereto.
“Closing”
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.
“Closing
Date” means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers’ obligations to pay the Subscription Amount and (ii) the Company’s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2nd)
Trading Day following the date hereof.
“Commission”
means the United States Securities and Exchange Commission.
“Common
Stock” means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.
“Common
Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.
“Company
Counsel” means Snell & Wilmer LLP, with offices located at 12230 El Camino Real, Suite 300, San Diego, California 92130.
“Conversion
Ratio” shall have the meaning ascribed to such term in the Certificate of Designation.
“Conversion
Shares” means, collectively, the shares of Common Stock issuable upon conversion of the Preferred Shares in accordance with
the terms hereof.
“Disclosure
Schedules” means the Disclosure Schedules of the Company delivered concurrently herewith.
“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
“Exchange
Cap” means that the Company shall not issue or sell any shares of Common Stock pursuant to the issuance of Conversion Shares
or exercise of Warrant Shares to the extent that after giving effect thereto, the aggregate number of shares of Common Stock that would
be issued would exceed 19.99% of the shares of Common Stock outstanding on the date of this Agreement (which number of shares shall be
reduced, on a share-for-share basis, by the number of shares of Common Stock issued or issuable pursuant to any transaction or series
of transactions that may be aggregated with the transactions contemplated by this Agreement under applicable rules of the Nasdaq Capital
Market or any other Trading Market on which the Common Stock may be listed or quoted, unless and until the Company elects to solicit
stockholder approval of the issuance of Common Stock as contemplated by this Agreement and the stockholders of the Company have in fact
approved such issuance in accordance with the applicable rules and regulations of the Nasdaq Capital Market or any other Trading Market
on which the Common Stock may be then listed or quoted.
“GAAP”
shall have the meaning ascribed to such term in Section 3.1(h).
“Legend
Removal Date” shall have the meaning ascribed to such term in Section 4.1(c).
“Liens”
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.
“Material
Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).
“Per
Share Purchase Price” equals $3.02, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement.
“Person”
means an individual, corporation, exempted company, partnership (including a general partnership, limited partnership, exempted limited
partnership or limited liability partnership), limited liability company, association, trust or other entity or organization, including
a government, domestic or foreign, or political subdivision thereof, or an agency or instrumentality thereof.
“Preferred
Shares” means the up to 60,595 shares of the Company’s Series K Nonvoting Convertible Preferred Stock issued or issuable
to the Purchasers pursuant to this Agreement, having the rights, preferences and privileges set forth in the Certificate of Designation.
“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.
“Promissory
Note(s)” means a non-convertible promissory note in the form attached hereto as Exhibit B.
“Required
Approvals” shall have the meaning ascribed to such term in Section 3.1(e).
“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.
“SEC
Reports” shall have the meaning ascribed to such term in Section 3.1(h).
“Securities”
means the Preferred Shares, the Conversion Shares, the Warrants and the Warrant Shares.
“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
“Short
Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).
“Subscription
Amount” means, as to each Purchaser, the aggregate amount to be paid for Preferred Shares and Warrants purchased hereunder
as specified below such Purchaser’s name on the signature page of this Agreement and next to the heading “Subscription Amount,”
in United States dollars and in immediately available funds.
“Subsidiary”
means any subsidiary of the Company as set forth on Schedule 3.1(a), and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.
“Trading
Day” means a day on which the principal Trading Market is open for trading.
“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the Pink Open Market, OTCQB or the OTCQX (or any successors to any of the foregoing).
“Transaction
Documents” means this Agreement, the Certificate of Designation, the Warrants, all exhibits and schedules thereto and hereto
and any other documents or agreements executed in connection with the transactions contemplated hereunder.
“Transfer
Agent” means Issuer Direct Corporation, the current transfer agent of the Company, with a mailing address of 1981 Murray Holladay
Road, Suite 100 Salt Lake City, Utah 84117, and any successor transfer agent of the Company.
“Warrants”
means collectively, the Warrants delivered to the Purchasers at the Closing in accordance with Section 2.2(a) hereof, which Warrants
shall be exercisable on or after the date that is six (6) months following the date of issuance, and have a term of exercise equal to
three (3) years from the Initial Exercise Date.
“Warrant
Shares” means the shares of Common Stock issuable upon exercise of the Warrants.
ARTICLE
II.
PURCHASE AND SALE
2.1 Closing.
On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and delivery
of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase,
up to an aggregate of $1,220,000 in the form of a Promissory Note, as well as up to $183,000 of Preferred Shares as consideration for
15% prepaid interest on the Promissory Note(s) and Warrants. Each Purchaser shall deliver to the Company, via wire transfer immediately
available funds equal to such Purchaser’s Subscription Amount as set forth on the signature page hereto executed by such Purchaser,
and the Company shall deliver to the Company each Purchaser’s respective Preferred Shares and Warrant, as determined pursuant to
Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth in Section 2.2(b) deliverable at the Closing.
Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall take place remotely by electronic
transfer of the Closing documentation.
2.2 Deliveries.
(a) On
or prior to the Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser the following:
(i) this
Agreement duly executed by the Company;
(ii) the
Promissory Note duly executed by the Company;
(iii) subject
to Section 2.1, the Company shall have provided each Purchaser with the Company’s wire instructions;
(iv) a
certificate evidencing that number of Preferred Shares equal to such Purchaser’s Subscription Amount divided by the Per Share Purchase
Price, which Preferred Shares shall be registered in the name of such Purchaser;
(v) evidence
of the filing and acceptance of the Certificate of Designation from the Secretary of State of Nevada; and
(vi) a
Warrant registered in the name of such Purchaser to purchase up to a number of shares of Common Stock equal to 100% of the sum of such
Purchaser’s Promissory Note, with an exercise price equal to $4.00 per share, subject to adjustment therein.
(b) On
or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:
(i) this
Agreement duly executed by such Purchaser; and
(ii) such
Purchaser’s Subscription Amount by wire transfer to the account specified in writing by the Company.
2.3 Closing
Conditions.
(a) The
obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:
(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects) on
the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein, in which
case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality, in
all respects) as of such date);
(ii) all
obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed;
and
(iii) the
delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.
(b) The
respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:
(i) the
accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect,
in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless as of
a specific date therein, in which case they shall be accurate in all material respects (or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects) as of such date);
(ii) all
obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;
(iii) the
delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;
(iv) there
shall have been no Material Adverse Effect with respect to the Company; and
(v) from
the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company’s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.
ARTICLE
III.
REPRESENTATIONS AND WARRANTIES
3.1 Representations
and Warranties of the Company. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall be deemed a part
hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the corresponding section
of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:
(a) Subsidiaries.
All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly or indirectly,
all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued and outstanding
shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights
to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries or any of them
in the Transaction Documents shall be disregarded.
(b) Organization
and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing
and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority
to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary
is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or other organizational
or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification
necessary, except where the failure to be so qualified or in good standing, as the case may be, could not have or reasonably be expected
to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material
adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the Company and the
Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in any material respect
on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material Adverse Effect”)
and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail
such power and authority or qualification.
(c) Authorization;
Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated
by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The
execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the
transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further
action is required by the Company, the Board of Directors or the Company’s stockholders in connection herewith or therewith other
than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been (or
upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.
(d) No
Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to which
it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.
(e) Filings,
Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to,
or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in
connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the notice and/or
application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing of the Conversion Shares
and Warrant Shares for trading thereon in the time and manner required thereby, (ii) the filing of Form D with the Commission, (iii)
such filings as are required to be made under applicable state securities laws, and (iv) as it relates to the conversion of Preferred
Shares to Common Stock, stockholder approval for the removal of the Exchange Cap (collectively, the “Required Approvals”).
(f) Issuance
of the Securities. The Securities are duly authorized and, when issued and paid for in accordance with the applicable Transaction
Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Preferred
Shares, the Conversion Shares and the Warrant Shares, when issued in accordance with the terms of the Transaction Documents, will be
validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company shall reserve from its
duly authorized capital stock a number of shares of Common Stock necessary for issuance as the Preferred Shares and the Warrant Shares.
(g) Capitalization.
The capitalization of the Company is set forth in the SEC Reports. Except as set forth in the SEC Reports, no Person has any right of
first refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the
Transaction Documents. Except as a result of the purchase and sale of the Securities and as set forth in the SEC Reports, there are no
outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities,
rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire,
any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements by which
the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents or capital
stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue shares of Common
Stock or other securities to any Person (other than the Purchasers). Except as set forth in the SEC Reports, there are no outstanding
securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange or reset
price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. Except as set forth in the SEC
Reports, there are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar provisions,
and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may become bound
to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or “phantom stock”
plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are duly authorized,
validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of
such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. Except
for the Required Approvals, no further approval or authorization of any stockholder, the Board of Directors or others is required for
the issuance and sale of the Securities. Except as set forth in the SEC Reports, there are no stockholders agreements, voting agreements
or other similar agreements with respect to the Company’s capital stock to which the Company is a party or, to the knowledge of
the Company, between or among any of the Company’s stockholders.
(h) SEC
Reports; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required to be
filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the
“SEC Reports”). As of their respective dates, the SEC Reports complied in all material respects with the requirements
of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of
a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the
SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with
respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally
accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as may be
otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain
all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, immaterial, year-end audit adjustments.
(i) Certain
Fees. No brokerage or finder’s fees or commissions are or will be payable by the Company or any Subsidiary to any broker, financial
advisor or consultant, finder, other placement agent, investment banker, bank or other Person with respect to the transactions contemplated
by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by
or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated
by the Transaction Documents.
(j) Listing
and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading
Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing
or maintenance requirements of such Trading Market. Except as set forth in the SEC Reports, the Company is, and has no reason to believe
that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. The Common
Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation
and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in
connection with such electronic transfer.
(k) No
Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, neither
the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or
sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of the
Securities, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company
are listed or designated.
(l) Acknowledgment Regarding Purchasers’ Purchase of Securities. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers’ purchase of the Securities. The Company further represents to each Purchaser that the Company’s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.
(m) Regulation
M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action
designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale
or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any of the
Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities of
the Company.
(n) Private
Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, no registration
under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated hereby.
The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.
(o) No
General Solicitation. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and
certain other “accredited investors” within the meaning of Rule 501 under the Securities Act.
(p) No
Disqualification Events. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the Securities
Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of the Company
participating in the offering hereunder, any beneficial owner of 20% or more of the Company’s outstanding voting equity securities,
calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act) connected with
the Company in any capacity at the time of sale (each, an “Issuer Covered Person” and, together, “Issuer
Covered Persons”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii)
under the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification
Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the
Purchasers a copy of any disclosures provided thereunder.
(q) Other
Covered Persons. The Company is not aware of any person (other than any Issuer Covered Person) that has been or will be paid (directly
or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.
(r) Notice
of Disqualification Events. The Company will notify the Purchasers in writing, prior to the Closing Date of (i) any Disqualification
Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably be expected to become
a Disqualification Event relating to any Issuer Covered Person.
3.2 Representations
and Warranties of the Purchasers. Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the
date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate
as of such date):
(a) Organization;
Authority. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing
under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise
to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such
Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership,
limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a
party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute
the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited
by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.
(b) Understandings
or Arrangements. Such Purchaser is acquiring the Securities as principal for its own account and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Securities. Such Purchaser is acquiring
the Securities hereunder in the ordinary course of its business. Such Purchaser understands that the Securities are “restricted
securities” and have not been registered under the Securities Act or any applicable state securities law and is acquiring such
Securities as principal for his, her or its own account and not with a view to or for distributing or reselling such Securities or any
part thereof in violation of the Securities Act or any applicable state securities law, has no present intention of distributing any
of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement
or understandings with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities
Act or any applicable state securities law (this representation and warranty not limiting such Purchaser’s right to sell such Securities
pursuant to a registration statement or otherwise in compliance with applicable federal and state securities laws).
(c) Purchaser
Status. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which
it converts any Preferred Shares or exercises any Warrants, it will be an “accredited investor” as defined in Rule 501(a)(1),
(a)(2), (a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act.
(d) Experience
of Such Purchaser. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience
in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities,
and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
Securities and, at the present time, is able to afford a complete loss of such investment.
(e) Access
to Information. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits
and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed necessary
of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results
of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity
to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment.
(f) Certain
Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, such Purchaser has not, nor has
any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any purchases or
sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first
received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms
of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing, in the
case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s
assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other
portions of such Purchaser’s assets, the representation set forth above shall only apply with respect to the portion of assets
managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to
other Persons party to this Agreement or to such Purchaser’s representatives, including, without limitation, its officers, directors,
partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of all disclosures
made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing,
for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions, with respect
to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.
(g)
General Solicitation. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other
communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or
presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.
(h)
Restrictions Regarding Purchaser’s Trading Activity. Anything in this Agreement
or elsewhere herein to the contrary notwithstanding, it is understood and acknowledged by the Purchaser that: (i) the Purchasers have
been asked by the Company and the Purchasers agreed, to desist from purchasing or selling short, securities of the Company, or “derivative”
securities based on securities issued by the Company; (ii) past or future open market or other transactions by any Purchaser, specifically
including, without limitation, Short Sales or “derivative” transactions, before or after the closing of this or future private
placement transactions, may negatively impact the market price of the Company’s publicly-traded securities; and (iii) any Purchaser,
and counter-parties in “derivative” transactions to which any such Purchaser is a party, directly or indirectly, presently
may not have a “short” position in the Common Stock. The Purchasers further acknowledge that (y) the Purchasers may
not engage in hedging activities at various times during the period that the Securities are outstanding, including, without limitation,
during the periods that the value of the Conversion Shares or the Warrant Shares deliverable with respect to Securities are being determined,
and (z) such hedging activities (if any) could reduce the value of the existing stockholders’ equity interests in the Company at
and after the time that the hedging activities are being conducted. The Purchasers acknowledge that such aforementioned hedging activities
constitute a breach of the Transaction Documents.
The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser’s
right to rely on the Company’s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.
ARTICLE
IV.
OTHER AGREEMENTS OF THE PARTIES
4.1 Removal
of Legends.
(a) The
Preferred Shares, Conversion Shares, Warrants and Warrant Shares may only be disposed of in compliance with state and federal securities
laws. In connection with any transfer of Preferred Shares, Conversion Shares, Warrants or the Warrant Shares other than pursuant to an
effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated
in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor
and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to
the effect that such transfer does not require registration of such transferred Warrants under the Securities Act.
(b) The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Preferred Shares, Conversion
Shares, Warrants or Warrant Shares in the following form:
NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE OR EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION
OR EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN
WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER
LOAN SECURED BY SUCH SECURITIES.
(c) Certificates
evidencing the Conversion Shares and/or Warrant Shares shall not contain any legend (including the legend set forth in Section 4.1(b)
hereof): (i) while a registration statement covering the resale of such security is effective under the Securities Act, if any, or (ii)
if such legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements
issued by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser
promptly if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively.
If all or any portion of a Preferred Share is converted into shares of Common Stock or a Warrant is exercised at a time when there is
an effective registration statement to cover the resale of the Conversion Shares and/or Warrant Shares, as applicable, or if such Conversion
Shares and/or Warrant Shares may be sold under Rule 144 or if such legend is not otherwise required under applicable requirements of
the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such Conversion
Shares and/or Warrant Shares, as applicable, shall be issued free of all legends. The Company agrees that following such time as such
legend is no longer required under this Section 4.1(c), the Company will, no later than the earlier of (i) two (2) Trading Days and (ii)
the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser to the
Company or the Transfer Agent of a certificate representing Conversion Shares or Warrant Shares, as applicable, issued with a restrictive
legend (such date, the “Legend Removal Date”), deliver or cause to be delivered to such Purchaser a certificate representing
such shares that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions
to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Conversion Shares and/or Warrant Shares
subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser’s
prime broker with the Depository Trust Company System as directed by such Purchaser. As used herein, “Standard Settlement Period”
means the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of a certificate representing shares issued with a restrictive legend.
4.2 Furnishing
of Information. Until the earlier of the time that (i) no Purchaser owns Securities or (ii) the Warrants have expired, the Company
covenants to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to
be filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements
of the Exchange Act.
4.3 Integration.
The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in
Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the
registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities
for purposes of the Exchange Cap as well as rules and regulations of any Trading Market such that it would require stockholder approval
prior to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction.
4.4 Conversion
and Exercise Procedures. Each of the form of Notice of Exercise included in the Warrants and the form of Notice of Conversion included
in the Certificate of Designation set forth the totality of the procedures required of the Purchasers in order to exercise the Warrants
or convert the Preferred Shares.
4.5 Use
of Proceeds. Except as set forth on Schedule 4.5 attached hereto, the Company shall use the net proceeds from the sale of
the Securities hereunder for working capital purposes and shall not use such proceeds for the redemption of any Common Stock or Common
Stock Equivalents.
4.6 Reservation
of Common Stock. The Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance pursuant to the
Transaction Documents in such amount as may then be required to fulfill its obligations in full under the Transaction Documents.
4.7 Listing
of Common Stock. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on the Trading
Market on which it is currently listed. The Company shall, if applicable: (i) in the time and manner required by the principal Trading
Market an additional shares listing application covering the Conversion Shares and Warrant Shares, and (ii) take all steps necessary
to cause such shares of Common Stock to be approved for listing or quotation on such Trading Market as soon as possible thereafter. The
Company agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another
established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other
established clearing corporation in connection with such electronic transfer.
4.8 Form
D; Blue Sky Filings. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and
to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or “Blue Sky” laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.
4.9 Restrictions
on Conversions and Exercises. Each Purchaser agrees and acknowledges that the Preferred Shares may not be converted into Conversion
Shares unless and until such time as the Company has lifted the Exchange Cap. Buyer further agrees and acknowledges that Buyer shall
bear the economic risk of loss associated with holding the Preferred Shares and Warrants pending the satisfaction of the conditions set
forth in this Section 4.9.
ARTICLE
V.
MISCELLANEOUS
5.1 Termination.
This Agreement may be terminated by any Purchaser, as to such Purchaser’s obligations hereunder only and without any effect whatsoever
on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been
consummated on or before the fifth (5th) Trading Day following the date hereof; provided, however, that no such
termination will affect the right of any party to sue for any breach by any other party (or parties).
5.2 Fees
and Expenses. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses
of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including, without
limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any conversion or exercise
notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities to
the Purchasers.
5.3 Entire
Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties
with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect
to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.
5.4 Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall
be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is delivered via email
attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New York City time) on
a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered via email attachment
at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New
York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally
recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address
for such notices and communications shall be as set forth on the signature pages attached hereto.
5.5 Amendments;
Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in
the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Preferred Shares based on the
initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver, by the
party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver disproportionately
and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers)
shall also be required. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed
to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement
hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right.
Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser
relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected
Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon each Purchaser and holder of Securities and
the Company.
5.6 Headings.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.
5.7 Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns.
The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser
(other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns
or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities,
by the provisions of the Transaction Documents that apply to the “Purchasers.”
5.8 No
Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted
assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in
this Section 5.8.
5.9 Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed
by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles of conflicts
of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates,
directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and federal courts
sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents),
and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction
of any such court, that such Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably waives
personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified
mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall
be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall commence a Proceeding
to enforce any provisions of the Transaction Documents, then, the prevailing party in such Proceeding shall be reimbursed by the non-prevailing
party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution
of such Proceeding.
5.10 Survival.
The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.
5.11 Execution.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a “.pdf”
format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature
is executed) with the same force and effect as if such “.pdf” signature page were an original thereof.
5.12 Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable.
5.13 Replacement
of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of
and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company
of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable
third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.
5.14 Remedies.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers
and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may
not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and
hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law
would be adequate.
5.15 Payment
Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a
Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or
any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or
are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.
5.16 Saturdays,
Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right required or granted
herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.
5.17 Construction.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall
not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each and every reference to
share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits,
stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the date of this Agreement.
(Signature
Pages Follow)
IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.
NextTrip, INC. |
Address
for Notice: |
|
|
|
By: |
|
3900
Paseo Del Sol, |
Name:
|
William
Kerby |
Santa
Fe, New Mexico 87507 |
Title:
|
Chief
Executive Officer |
|
|
E-Mail:
bill.kerby@nexttrip.com |
|
|
|
With a copy to (which shall not constitute notice): |
|
Snell & Wilmer LLP |
|
Attn: Christopher L. Tinen, Esq. |
|
12230 El Camino Real, Suite 300 |
|
San Diego, California 92130 |
|
E-Mail: ctinen@swlaw.com |
|
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK
SIGNATURE
PAGE FOR PURCHASER FOLLOWS]
[PURCHASER
SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT]
IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.
Name
of Purchaser: ________________________________________________________
Signature
of Authorized Signatory of Purchaser: _________________________________
Name
of Authorized Signatory: _______________________________________________
Title
of Authorized Signatory: ________________________________________________
Email
Address of Authorized Signatory: _________________________________________
Address
for Notice to Purchaser:
Address
for Delivery of Securities to Purchaser (if not same as address for notice):
Subscription
Amount: $_________________
Preferred
Shares: _________________ Beneficial Ownership Blocker ☐ 4.99% or ☐ 9.99%
Warrant
Shares: ___________ Beneficial Ownership Blocker ☐ 4.99% or ☐ 9.99%
EIN
Number: ____________________
☐
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)
the Closing shall occur on the second (2nd) Trading Day following the date of this Agreement and (iii) any condition to Closing
contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed
of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead
be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate
or the like or purchase price (as applicable) to such other party on the Closing Date.
EXHIBIT
A
Form
of Certificate of Designation
EXHIBIT
A
Form
of Promissory Note
EXHIBIT
C-1
Form
of Warrant
EXHIBIT
C-2
Form
of Warrant
Exhibit
10.3
SECURITIES
PURCHASE AGREEMENT
This
Securities Purchase Agreement (this “Agreement”) is dated as of December 31, 2024, between NextTrip, Inc., a Nevada
corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors
and assigns, a “Purchaser” and collectively the “Purchasers”).
WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section
5 of the Securities Act contained in Section 4(a)(2) thereof and/or Regulation D promulgated thereunder, the Company desires to issue
and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company
as more fully described in this Agreement.
NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration the receipt
and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:
ARTICLE
I.
DEFINITIONS
1.1
Definitions. In addition to the terms defined elsewhere in this Agreement, (a) capitalized terms that are not otherwise defined
herein have the meanings given to such terms in the Certificate of Designation (as defined herein), and (b) the following terms have
the meanings set forth in this Section 1.1:
“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control
with a Person as such terms are used in and construed under Rule 405 under the Securities Act.
“Articles
of Incorporation” means the amended and restated articles of incorporation, as amended, of the Company on file with the Secretary
of State of Nevada.
“Board
of Directors” means the board of directors of the Company.
“Business
Day” means any day other than a Saturday, Sunday or a legal holiday on which commercial banking institutions in New York, New
York are authorized to close for business; provided that banks shall not be deemed to be authorized or obligated to be closed due to
a “shelter in place” or similar closure of physical branch locations at the direction of any governmental authority if such
banks’ electronic funds transfer systems (including for wire transfers) are open for use by customers on such day.
“Certificate
of Designation” means the Certificate of Designation to be filed prior to the Closing by the Company with the Secretary of
State of the State of Nevada, in the form attached as Exhibit A hereto.
“Closing”
means the closing of the purchase and sale of the Securities pursuant to Section 2.1.
“Closing
Date” means the Trading Day on which all of the Transaction Documents have been executed and delivered by the applicable parties
thereto, and all conditions precedent to (i) the Purchasers’ obligations to pay the Subscription Amount and (ii) the Company’s
obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the second (2nd)
Trading Day following the date hereof.
“Commission”
means the United States Securities and Exchange Commission.
“Common
Stock” means the common stock of the Company, par value $0.001 per share, and any other class of securities into which such
securities may hereafter be reclassified or changed.
“Common
Stock Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is
at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.
“Company
Counsel” means Snell & Wilmer LLP, with offices located at 12230 El Camino Real, Suite 300, San Diego, California 92130.
“Conversion
Ratio” shall have the meaning ascribed to such term in the Certificate of Designation.
“Conversion
Shares” means, collectively, the shares of Common Stock issuable upon conversion of the Preferred Shares in accordance with
the terms hereof.
“Disclosure
Schedules” means the Disclosure Schedules of the Company delivered concurrently herewith.
“Exchange
Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
“Exchange
Cap” means that the Company shall not issue or sell any shares of Common Stock pursuant to the issuance of Conversion Shares
to the extent that after giving effect thereto, the aggregate number of shares of Common Stock that would be issued would exceed 19.99%
of the shares of Common Stock outstanding on the date of this Agreement (which number of shares shall be reduced, on a share-for-share
basis, by the number of shares of Common Stock issued or issuable pursuant to any transaction or series of transactions that may be aggregated
with the transactions contemplated by this Agreement under applicable rules of the Nasdaq Capital Market or any other Trading Market
on which the Common Stock may be listed or quoted) unless and until the Company elects to solicit stockholder approval of the issuance
of Common Stock as contemplated by this Agreement and the stockholders of the Company have in fact approved such issuance in accordance
with the applicable rules and regulations of the Nasdaq Capital Market or any other Trading Market on which the Common Stock may be then
listed or quoted.
“GAAP”
shall have the meaning ascribed to such term in Section 3.1(h).
“Legend
Removal Date” shall have the meaning ascribed to such term in Section 4.1(c).
“Liens”
means a lien, charge, pledge, security interest, encumbrance, right of first refusal, preemptive right or other restriction.
“Material
Adverse Effect” shall have the meaning assigned to such term in Section 3.1(b).
“Per
Share Purchase Price” equals $3.02, subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations
and other similar transactions of the Common Stock that occur after the date of this Agreement.
“Person”
means an individual, corporation, exempted company, partnership (including a general partnership, limited partnership, exempted limited
partnership or limited liability partnership), limited liability company, association, trust or other entity or organization, including
a government, domestic or foreign, or political subdivision thereof, or an agency or instrumentality thereof.
“Preferred
Shares” means the up to 165,562 shares of the Company’s Series M Nonvoting Convertible Preferred Stock issued
or issuable to the Purchasers pursuant to this Agreement, having the rights, preferences and privileges set forth in the Certificate
of Designation.
“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding,
such as a deposition), whether commenced or threatened.
“Required
Approvals” shall have the meaning ascribed to such term in Section 3.1(e).
“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect
as such Rule.
“SEC
Reports” shall have the meaning ascribed to such term in Section 3.1(h).
“Securities”
means the Preferred Shares and the Conversion Shares.
“Securities
Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.
“Short
Sales” means all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be
deemed to include locating and/or borrowing shares of Common Stock).
“Subscription
Amount” means, as to each Purchaser, the aggregate amount to be paid for Preferred Shares purchased hereunder as specified
below such Purchaser’s name on the signature page of this Agreement and next to the heading “Subscription Amount,”
in United States dollars and in immediately available funds.
“Subsidiary”
means any subsidiary of the Company as set forth on Schedule 3.1(a), and shall, where applicable, also include any direct or indirect
subsidiary of the Company formed or acquired after the date hereof.
“Trading
Day” means a day on which the principal Trading Market is open for trading.
“Trading
Market” means any of the following markets or exchanges on which the Common Stock is listed or quoted for trading on the date
in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock
Exchange, the Pink Open Market, OTCQB or the OTCQX (or any successors to any of the foregoing).
“Transaction
Documents” means this Agreement, the Certificate of Designation, all exhibits and schedules thereto and hereto and any other
documents or agreements executed in connection with the transactions contemplated hereunder.
“Transfer
Agent” means Issuer Direct Corporation, the current transfer agent of the Company, with a mailing address of 1981 Murray Holladay
Road, Suite 100 Salt Lake City, Utah 84117, and any successor transfer agent of the Company.
ARTICLE
II.
PURCHASE
AND SALE
2.1
Closing. On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the
execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly,
agree to purchase, up to an aggregate of $499,997.24 of Preferred Shares. Each Purchaser shall deliver to the Company, via wire
transfer immediately available funds (or such other consideration as agreed to by the Company) equal to such Purchaser’s Subscription
Amount as set forth on the signature page hereto executed by such Purchaser, and the Company shall deliver to the Company each Purchaser’s
respective Preferred Shares, as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items
set forth in Section 2.2(b) deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and
2.3, the Closing shall take place remotely by electronic transfer of the Closing documentation.
2.2
Deliveries.
(a)
On or prior to the Closing Date (except as indicated below), the Company shall deliver or cause to be delivered to each Purchaser the
following:
(i)
this Agreement duly executed by the Company;
(ii)
subject to Section 2.1, the Company shall have provided each Purchaser with the Company’s wire instructions;
(iii)
a certificate evidencing that number of Preferred Shares equal to such Purchaser’s Subscription Amount divided by the Per Share
Purchase Price, which Preferred Shares shall be registered in the name of such Purchaser; and
(iv)
evidence of the filing and acceptance of the Certificate of Designation from the Secretary of State of Nevada.
(b)
On or prior to the Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:
(i)
this Agreement duly executed by such Purchaser; and
(ii)
such Purchaser’s Subscription Amount by wire transfer to the account specified in writing by the Company (or such other consideration
as agreed to by the Company).
2.3
Closing Conditions.
(a)
The obligations of the Company hereunder in connection with the Closing are subject to the following conditions being met:
(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality, in all respects)
on the Closing Date of the representations and warranties of the Purchasers contained herein (unless as of a specific date therein, in
which case they shall be accurate in all material respects (or, to the extent representations or warranties are qualified by materiality,
in all respects) as of such date);
(ii)
all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been
performed; and
(iii)
the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.
(b)
The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:
(i)
the accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse
Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company contained herein (unless
as of a specific date therein, in which case they shall be accurate in all material respects (or, to the extent representations or warranties
are qualified by materiality or Material Adverse Effect, in all respects) as of such date);
(ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;
(iii)
the delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;
(iv)
there shall have been no Material Adverse Effect with respect to the Company; and
(v)
from the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company’s
principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing.
ARTICLE
III.
REPRESENTATIONS
AND WARRANTIES
3.1
Representations and Warranties of the Company. Except as set forth in the Disclosure Schedules, which Disclosure Schedules shall
be deemed a part hereof and shall qualify any representation or otherwise made herein to the extent of the disclosure contained in the
corresponding section of the Disclosure Schedules, the Company hereby makes the following representations and warranties to each Purchaser:
(a)
Subsidiaries. All of the direct and indirect subsidiaries of the Company are set forth in the SEC Reports. The Company owns, directly
or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all of the issued
and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive
and similar rights to subscribe for or purchase securities. If the Company has no subsidiaries, all other references to the Subsidiaries
or any of them in the Transaction Documents shall be disregarded.
(b)
Organization and Qualification. The Company and each of the Subsidiaries is an entity duly incorporated or otherwise organized,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power
and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any
Subsidiary is in violation nor default of any of the provisions of its respective certificate or articles of incorporation, bylaws or
other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good
standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned
by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise)
of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in
any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material
Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking
to revoke, limit or curtail such power and authority or qualification.
(c)
Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors or the Company’s stockholders in connection herewith or therewith
other than in connection with the Required Approvals. This Agreement and each other Transaction Document to which it is a party has been
(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will
constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except (i) as
limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application
affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance,
injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable
law.
(d)
No Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby
do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles
of incorporation, bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or
assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, anti-dilution or similar adjustments,
acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by
which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the Required Approvals, conflict
with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or
governmental authority to which the Company or a Subsidiary is subject (including federal and state securities laws and regulations),
or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect.
(e)
Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any
notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other
Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, other than: (i) the notice
and/or application(s) to each applicable Trading Market for the issuance and sale of the Securities and the listing of the Conversion
Shares for trading thereon in the time and manner required thereby, (ii) the filing of Form D with the Commission, (iii) such filings
as are required to be made under applicable state securities laws, and (iv) as it relates to the conversion of Preferred Shares to Common
Stock, stockholder approval for the removal of the Exchange Cap (collectively, the “Required Approvals”).
(f)
Issuance of the Securities. The Securities are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company.
The Preferred Shares and the Conversion Shares, when issued in accordance with the terms of the Transaction Documents, will be validly
issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company. The Company shall reserve from its duly authorized
capital stock a number of shares of Common Stock necessary for issuance as the Preferred Shares.
(g)
Capitalization. The capitalization of the Company is set forth in the SEC Reports. Except as set forth in the SEC Reports, no
Person has any right of first refusal, preemptive right, right of participation, or any similar right to participate in the transactions
contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities and as set forth in the SEC
Reports, there are no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating
to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe
for or acquire, any shares of Common Stock or the capital stock of any Subsidiary, or contracts, commitments, understandings or arrangements
by which the Company or any Subsidiary is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents
or capital stock of any Subsidiary. The issuance and sale of the Securities will not obligate the Company or any Subsidiary to issue
shares of Common Stock or other securities to any Person (other than the Purchasers). Except as set forth in the SEC Reports, there are
no outstanding securities or instruments of the Company or any Subsidiary with any provision that adjusts the exercise, conversion, exchange
or reset price of such security or instrument upon an issuance of securities by the Company or any Subsidiary. Except as set forth in
the SEC Reports, there are no outstanding securities or instruments of the Company or any Subsidiary that contain any redemption or similar
provisions, and there are no contracts, commitments, understandings or arrangements by which the Company or any Subsidiary is or may
become bound to redeem a security of the Company or such Subsidiary. The Company does not have any stock appreciation rights or “phantom
stock” plans or agreements or any similar plan or agreement. All of the outstanding shares of capital stock of the Company are
duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws,
and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities.
Except for the Required Approvals, no further approval or authorization of any stockholder, the Board of Directors or others is required
for the issuance and sale of the Securities. Except as set forth in the SEC Reports, there are no stockholders agreements, voting agreements
or other similar agreements with respect to the Company’s capital stock to which the Company is a party or, to the knowledge of
the Company, between or among any of the Company’s stockholders.
(h)
SEC Reports; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof (the foregoing
materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the
“SEC Reports”). As of their respective dates, the SEC Reports complied in all material respects with the requirements
of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of
a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein,
in the light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the
SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with
respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally
accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as may be
otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain
all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated
Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the
case of unaudited statements, to normal, immaterial, year-end audit adjustments.
(i)
Certain Fees. No brokerage or finder’s fees or commissions are or will be payable by the Company or any Subsidiary to any
broker, financial advisor or consultant, finder, other placement agent, investment banker, bank or other Person with respect to the transactions
contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims
made by or on behalf of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions
contemplated by the Transaction Documents.
(j)
Listing and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and
the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration
of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as set forth in the SEC Reports, the Company has not, in the 12 months preceding the date hereof, received
notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance
with the listing or maintenance requirements of such Trading Market. Except as set forth in the SEC Reports, the Company is, and has
no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements.
The Common Stock is currently eligible for electronic transfer through the Depository Trust Company or another established clearing corporation
and the Company is current in payment of the fees to the Depository Trust Company (or such other established clearing corporation) in
connection with such electronic transfer.
(k)
No Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2,
neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers
or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities
to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of the
Securities, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company
are listed or designated.
(l)
Acknowledgment Regarding Purchasers’ Purchase of Securities. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated
thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar
capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers’ purchase of the Securities. The Company further represents to each Purchaser that the Company’s
decision to enter into this Agreement and the other Transaction Documents has been based solely on the independent evaluation of the
transactions contemplated hereby by the Company and its representatives.
(m)
Regulation M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly,
any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate
the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or, paid any compensation for soliciting purchases of, any
of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other securities
of the Company.
(n)
Private Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, no
registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers as contemplated
hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market.
(o)
No General Solicitation. Neither the Company nor any Person acting on behalf of the Company has offered or sold any of the Securities
by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and
certain other “accredited investors” within the meaning of Rule 501 under the Securities Act.
(p)
No Disqualification Events. With respect to the Securities to be offered and sold hereunder in reliance on Rule 506 under the
Securities Act, none of the Company, any of its predecessors, any affiliated issuer, any director, executive officer, other officer of
the Company participating in the offering hereunder, any beneficial owner of 20% or more of the Company’s outstanding voting equity
securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule 405 under the Securities Act)
connected with the Company in any capacity at the time of sale (each, an “Issuer Covered Person” and, together, “Issuer
Covered Persons”) is subject to any of the “Bad Actor” disqualifications described in Rule 506(d)(1)(i) to (viii)
under the Securities Act (a “Disqualification Event”), except for a Disqualification Event covered by Rule 506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine whether any Issuer Covered Person is subject to a Disqualification
Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule 506(e), and has furnished to the
Purchasers a copy of any disclosures provided thereunder.
(q)
Other Covered Persons. The Company is not aware of any person (other than any Issuer Covered Person) that has been or will be
paid (directly or indirectly) remuneration for solicitation of purchasers in connection with the sale of any Securities.
(r)
Notice of Disqualification Events. The Company will notify the Purchasers in writing, prior to the Closing Date of (i) any Disqualification
Event relating to any Issuer Covered Person and (ii) any event that would, with the passage of time, reasonably be expected to become
a Disqualification Event relating to any Issuer Covered Person.
3.2
Representations and Warranties of the Purchasers. Each Purchaser, for itself and for no other Purchaser, hereby represents and
warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case
they shall be accurate as of such date):
(a)
Organization; Authority. Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership, limited
liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance
by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary corporate,
partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to
which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof,
will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except:
(i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.
(b)
Understandings or Arrangements. Such Purchaser is acquiring the Securities as principal for its own account and has no direct
or indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities. Such
Purchaser is acquiring the Securities hereunder in the ordinary course of its business. Such Purchaser understands that the Securities
are “restricted securities” and have not been registered under the Securities Act or any applicable state securities law
and is acquiring such Securities as principal for his, her or its own account and not with a view to or for distributing or reselling
such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no present intention
of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or
indirect arrangement or understandings with any other persons to distribute or regarding the distribution of such Securities in violation
of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser’s right
to sell such Securities pursuant to a registration statement or otherwise in compliance with applicable federal and state securities
laws).
(c)
Purchaser Status. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each
date on which it converts any Preferred Shares, it will be an “accredited investor” as defined in Rule 501(a)(1), (a)(2),
(a)(3), (a)(7), (a)(8), (a)(9), (a)(12), or (a)(13) under the Securities Act.
(d)
Experience of Such Purchaser. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.
(e)
Access to Information. Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including
all exhibits and schedules thereto) and the SEC Reports and has been afforded, (i) the opportunity to ask such questions as it has deemed
necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the
Securities and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition,
results of operations, business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the
opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that
is necessary to make an informed investment decision with respect to the investment.
(f)
Certain Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, such Purchaser has
not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed any
purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser
first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material
terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser’s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser’s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.
(g)
General Solicitation. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other
communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or
presented at any seminar or, to the knowledge of such Purchaser, any other general solicitation or general advertisement.
(h)
Restrictions Regarding Purchaser’s Trading Activity. Anything in this Agreement or elsewhere herein to the contrary notwithstanding,
it is understood and acknowledged by the Purchaser that: (i) the Purchasers have been asked by the Company and the Purchasers agreed,
to desist from purchasing or selling short, securities of the Company, or “derivative” securities based on securities issued
by the Company; (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short
Sales or “derivative” transactions, before or after the closing of this or future private placement transactions, may negatively
impact the market price of the Company’s publicly-traded securities; and (iii) any Purchaser, and counter-parties in “derivative”
transactions to which any such Purchaser is a party, directly or indirectly, presently may not have a “short” position in
the Common Stock. The Purchasers further acknowledge that (y) the Purchasers may not engage in hedging activities at various times during
the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Conversion Shares
deliverable with respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing
stockholders’ equity interests in the Company at and after the time that the hedging activities are being conducted. The Purchasers
acknowledge that such aforementioned hedging activities constitute a breach of the Transaction Documents.
The
Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such Purchaser’s
right to rely on the Company’s representations and warranties contained in this Agreement or any representations and warranties
contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement
or the consummation of the transactions contemplated hereby. Notwithstanding the foregoing, for the avoidance of doubt, nothing contained
herein shall constitute a representation or warranty, or preclude any actions, with respect to locating or borrowing shares in order
to effect Short Sales or similar transactions in the future.
ARTICLE
IV.
OTHER
AGREEMENTS OF THE PARTIES
4.1
Removal of Legends.
(a)
The Preferred Shares and Conversion Shares may only be disposed of in compliance with state and federal securities laws. In connection
with any transfer of Preferred Shares or Conversion Shares other than pursuant to an effective registration statement or Rule 144, to
the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may require
the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company,
the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require
registration under the Securities Act.
(b)
The Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Preferred Shares or Conversion
Shares in the following form:
NEITHER
THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE OR EXERCISABLE HAS BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933,
AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS
OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON CONVERSION
OR EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED BROKER-DEALER OR OTHER LOAN
WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER
LOAN SECURED BY SUCH SECURITIES.
(c)
Certificates evidencing the Conversion Shares shall not contain any legend (including the legend set forth in Section 4.1(b) hereof):
(i) while a registration statement covering the resale of such security is effective under the Securities Act, if any, or (ii) if such
legend is not required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued
by the staff of the Commission). The Company shall cause its counsel to issue a legal opinion to the Transfer Agent or the Purchaser
promptly if required by the Transfer Agent to effect the removal of the legend hereunder, or if requested by a Purchaser, respectively.
If all or any portion of a Preferred Share is converted into shares of Common Stock at a time when there is an effective registration
statement to cover the resale of the Conversion Shares, or if such Conversion Shares may be sold under Rule 144 or if such legend is
not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued
by the staff of the Commission) then such Conversion Shares shall be issued free of all legends. The Company agrees that following such
time as such legend is no longer required under this Section 4.1(c), the Company will, no later than the earlier of (i) two (2) Trading
Days and (ii) the number of Trading Days comprising the Standard Settlement Period (as defined below) following the delivery by a Purchaser
to the Company or the Transfer Agent of a certificate representing Conversion Shares issued with a restrictive legend (such date, the
“Legend Removal Date”), deliver or cause to be delivered to such Purchaser a certificate representing such shares
that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions to the
Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Conversion Shares subject to legend removal hereunder
shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser’s prime broker with the Depository
Trust Company System as directed by such Purchaser. As used herein, “Standard Settlement Period” means the standard
settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect to the Common Stock
as in effect on the date of delivery of a certificate representing shares issued with a restrictive legend.
4.2
Furnishing of Information. Until the time that no Purchaser owns Securities, the Company covenants to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof
pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.
4.3
Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security
(as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would
require the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of
the Securities for purposes of the Exchange Cap as well as rules and regulations of any Trading Market such that it would require stockholder
approval prior to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent
transaction.
4.4
Conversion and Exercise Procedures. Each of the form of Notice of Conversion included in the Certificate of Designation set forth
the totality of the procedures required of the Purchasers in order to convert the Preferred Shares.
4.5
Use of Proceeds. Except as set forth on Schedule 4.5 attached hereto, the Company shall use the net proceeds from the sale
of the Securities hereunder for working capital purposes and shall not use such proceeds for the redemption of any Common Stock or Common
Stock Equivalents.
4.6
Reservation of Common Stock. The Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance
pursuant to the Transaction Documents in such amount as may then be required to fulfill its obligations in full under the Transaction
Documents.
4.7
Listing of Common Stock. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock
on the Trading Market on which it is currently listed. The Company shall, if applicable: (i) in the time and manner required by the principal
Trading Market submit an additional shares listing application covering the Conversion Shares, and (ii) take all steps necessary to cause
such shares of Common Stock to be approved for listing or quotation on such Trading Market as soon as possible thereafter. The Company
agrees to maintain the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established
clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other established
clearing corporation in connection with such electronic transfer.
4.8
Form D; Blue Sky Filings. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation
D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably
determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under
applicable securities or “Blue Sky” laws of the states of the United States, and shall provide evidence of such actions promptly
upon request of any Purchaser.
4.9
Restrictions on Conversions and Exercises. Each Purchaser agrees and acknowledges that the Preferred Shares may not be converted
into Conversion Shares unless and until such time as the Company has lifted the Exchange Cap. Buyer further agrees and acknowledges that
Buyer shall bear the economic risk of loss associated with holding the Preferred Shares pending the satisfaction of the conditions set
forth in this Section 4.9.
ARTICLE
V.
MISCELLANEOUS
5.1
Termination. This Agreement may be terminated by any Purchaser, as to such Purchaser’s obligations hereunder only and without
any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the
Closing has not been consummated on or before the fifth (5th) Trading Day following the date hereof; provided, however,
that no such termination will affect the right of any party to sue for any breach by any other party (or parties).
5.2
Fees and Expenses. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and
expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees (including,
without limitation, any fees required for same-day processing of any instruction letter delivered by the Company and any conversion or
exercise notice delivered by a Purchaser), stamp taxes and other taxes and duties levied in connection with the delivery of any Securities
to the Purchasers.
5.3
Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written,
with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.
5.4
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of: (a) the time of transmission, if such notice or communication is
delivered via email attachment at the email address as set forth on the signature pages attached hereto at or prior to 5:30 p.m. (New
York City time) on a Trading Day, (b) the next Trading Day after the time of transmission, if such notice or communication is delivered
via email attachment at the email address as set forth on the signature pages attached hereto on a day that is not a Trading Day or later
than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if
sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required
to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto.
5.5
Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument
signed, in the case of an amendment, by the Company and Purchasers which purchased at least 50.1% in interest of the Preferred Shares
based on the initial Subscription Amounts hereunder (or, prior to the Closing, the Company and each Purchaser) or, in the case of a waiver,
by the party against whom enforcement of any such waived provision is sought, provided that if any amendment, modification or waiver
disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser
(or group of Purchasers) shall also be required. No waiver of any default with respect to any provision, condition or requirement of
this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner
impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the
rights and obligations of any Purchaser relative to the comparable rights and obligations of the other Purchasers shall require the prior
written consent of such adversely affected Purchaser. Any amendment effected in accordance with this Section 5.5 shall be binding upon
each Purchaser and holder of Securities and the Company.
5.6
Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof.
5.7
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and
permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent
of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom
such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the
transferred Securities, by the provisions of the Transaction Documents that apply to the “Purchasers.”
5.8
No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise
set forth in this Section 5.8.
5.9
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents
shall be governed by and construed and enforced in accordance with the internal laws of the State of Nevada, without regard to the principles
of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and defense of
the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective
affiliates, directors, officers, shareholders, partners, members, employees or agents) shall be commenced exclusively in the state and
federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and
federal courts sitting in the City of New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith
or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction
Documents), and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to
the jurisdiction of any such court, that such Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby
irrevocably waives personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof
via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices
to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted by law. If any party shall
commence a Proceeding to enforce any provisions of the Transaction Documents, then, the prevailing party in such Proceeding shall be
reimbursed by the non-prevailing party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation,
preparation and prosecution of such Proceeding.
5.10
Survival. The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.
5.11
Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party,
it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery
of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such “.pdf” signature page were an original thereof.
5.12
Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to
be invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall
remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared
invalid, illegal, void or unenforceable.
5.13
Replacement of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed,
the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation),
or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also
pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such replacement Securities.
5.14
Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that
monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction
Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that
a remedy at law would be adequate.
5.15
Payment Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.
5.16
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding
Business Day.
5.17
Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise
the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against
the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse
and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock that occur after the
date of this Agreement.
(Signature
Pages Follow)
IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.
NextTrip, INC. |
|
Address
for Notice: |
|
|
|
|
By: |
|
|
3900
Paseo Del Sol, |
Name: |
William
Kerby |
|
Santa
Fe, New Mexico 87507 |
Title: |
Chief
Executive Officer |
|
|
|
|
|
|
|
|
|
E-Mail:
bill.kerby@nexttrip.com |
|
|
|
|
With a copy to (which shall not constitute notice): |
|
|
Snell & Wilmer LLP |
|
|
Attn: Christopher L. Tinen, Esq. |
|
|
12230 El Camino Real, Suite 300 |
|
|
San Diego, California 92130 |
|
|
E-Mail: ctinen@swlaw.com |
|
|
[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK
SIGNATURE
PAGE FOR PURCHASER FOLLOWS]
[PURCHASER
SIGNATURE PAGES TO SECURITIES PURCHASE AGREEMENT]
IN
WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized signatories
as of the date first indicated above.
Name
of Purchaser: ________________________________________________________
Signature
of Authorized Signatory of Purchaser: _________________________________
Name
of Authorized Signatory: _______________________________________________
Title
of Authorized Signatory: ________________________________________________
Email
Address of Authorized Signatory: _________________________________________
Address
for Notice to Purchaser:
Address
for Delivery of Securities to Purchaser (if not same as address for notice):
Subscription
Amount: $_________________
Preferred
Shares: _________________ Beneficial Ownership Blocker ☐ 4.99% or ☐ 9.99%
EIN
Number: ____________________
☐
Notwithstanding anything contained in this Agreement to the contrary, by checking this box (i) the obligations of the above-signed to
purchase the securities set forth in this Agreement to be purchased from the Company by the above-signed, and the obligations of the
Company to sell such securities to the above-signed, shall be unconditional and all conditions to Closing shall be disregarded, (ii)
the Closing shall occur on the second (2nd) Trading Day following the date of this Agreement and (iii) any condition to Closing
contemplated by this Agreement (but prior to being disregarded by clause (i) above) that required delivery by the Company or the above-signed
of any agreement, instrument, certificate or the like or purchase price (as applicable) shall no longer be a condition and shall instead
be an unconditional obligation of the Company or the above-signed (as applicable) to deliver such agreement, instrument, certificate
or the like or purchase price (as applicable) to such other party on the Closing Date.
EXHIBIT
A
Form
of Certificate of Designation
Exhibit
10.4
DEBT
CONVERSION AGREEMENT
This
Debt Conversion Agreement (the “Agreement”) is entered into effective as of as of December 31, 2024 by and between
the investor on the signature page hereto (“Investor”) and NextTrip, Inc., a Nevada corporation (the “Company”),
with reference to the following facts:
WHEREAS, Investor has loaned
certain funds to the Company as described in those certain unsecured promissory notes dated February 29, 2024, March 18, 2024 and April
23, 2024 (the “Loan Agreements”), of which the Company and Investor desire to convert $500,000 (the “Debt”)
into shares of the Company’s newly created Series L Nonvoting Convertible Preferred Stock (the “Preferred Stock”),
with such rights as governed under that certain Certificate of Designation of Series L Nonvoting Convertible Preferred Stock (the “Certificate
of Designation”) attached hereto as Exhibit A and incorporated by reference herein.
NOW, THEREFORE, for good and
valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Investor and the Company agree as follows:
1. Conversion to Preferred
Stock. Effective as of the date hereof, $500,000 of the Debt shall be converted into shares of Preferred Stock at a price per share
of $3.02 for an aggregate number 165,562 shares of Preferred Stock (the “Shares”). Upon execution of this Agreement,
the Company shall file the Certificate of Designation with the Secretary of State of the State of Nevada and, once filed, issue Shares
to the Investor, and the Investor shall acknowledge the repayment of said portion of the Debt under the Loan Agreement. Investor acknowledges
and agrees that the conversion of the Preferred Stock into Common Stock of the Company is subject to stockholder approval as required
under Nasdaq rules and as provided in the Certificate of Designation.
2.
Investor Representations. The Company is issuing the Shares to Investor in reliance upon the following representations made by
Investor:
(a)
Investor acknowledges and agrees that the Shares are characterized as “restricted securities” under the Securities Act of
1933 (as amended and together with the rules and regulations promulgated thereunder, the “Securities Act”) and that,
under the Securities Act and applicable regulations thereunder, such securities may not be resold, pledged or otherwise transferred without
registration under the Securities Act or an exemption therefrom. Investor acknowledges and agrees that (i) the Shares are being offered
in a transaction not involving any public offering in the United States within the meaning of the Securities Act, and the Shares have
not yet been registered under the Securities Act, and (ii) such Shares may be offered, resold, pledged or otherwise transferred only
in a transaction registered under the Securities Act, or meeting the requirements of Rule 144, or in accordance with another exemption
from the registration requirements of the Securities Act (and based upon an opinion of counsel if the Company so requests) and in accordance
with any applicable securities laws of any State of the United States or any other applicable jurisdiction.
(b)
Investor acknowledges and agrees that (i) the registrar or transfer agent for the Shares will not be required to accept for registration
of transfer any shares except upon presentation of evidence satisfactory to the Company that the restrictions on transfer under the Securities
Act have been complied with and (ii) any Shares in the form of definitive physical certificates will bear a restrictive legend.
(c)
Investor acknowledges and agrees that: (a) the Shares have not been registered under the Securities Act, or under any state securities
laws, and are being offered and sold in reliance upon federal and state exemptions for transactions not involving any public offering;
(b) Investor is acquiring the Shares solely for its own account for investment purposes, and not with a view to the distribution thereof
in a transaction that would violate the Securities Act or the securities laws of any State of the United States or any other applicable
jurisdiction; (c) Investor is a sophisticated purchaser with such knowledge and experience in business and financial matters that it
is capable of evaluating the merits and risks of purchasing the Shares; (d) Investor has had the opportunity to obtain from the Company
such information as desired in order to evaluate the merits and the risks inherent in holding the Shares; (e) Investor is able to bear
the economic risk and lack of liquidity inherent in holding the Shares; (f) Investor is an “accredited investor” within the
meaning of Rule 501(a) under the Securities Act; and (g) and (g) Investor either has a pre-existing personal or business relationship
with the Company or its officers, directors or controlling persons, or by reason of Investor’s business or financial experience,
or the business or financial experience of their professional advisors who are unaffiliated with and who are not compensated by the Company,
directly or indirectly, have the capacity to protect their own interests in connection with the purchase of the Common Stock.
(d)
Investor’s investment in the Company pursuant to this Common Stock is consistent, in both nature and amount, with Investor’s
overall investment program and financial condition.
3.
Miscellaneous.
(a)
This Agreement shall be construed and enforced in accordance with the laws of the State of Nevada.
(b)
This Agreement constitutes the entire agreement between the parties and supersedes all prior oral or written negotiations and agreements
between the parties with respect to the subject matter hereof. No modification, variation or amendment of this Agreement (including any
exhibit hereto) shall be effective unless made in writing and signed by both parties.
(c)
Each party to this Agreement hereby represents and warrants to the other party that it has had an opportunity to seek the advice of its
own independent legal counsel with respect to the provisions of this Agreement and that its decision to execute this Agreement is not
based on any reliance upon the advice of any other party or its legal counsel. Each party represents and warrants to the other party
that in executing this Agreement such party has completely read this Agreement and that such party understands the terms of this Agreement
and its significance. This Agreement shall be construed neutrally, without regard to the party responsible for its preparation.
(d)
Each party to this Agreement hereby represents and warrants to the other party that (i) the execution, performance and delivery of this
Agreement has been authorized by all necessary action by such party; (ii) the representative executing this Agreement on behalf of such
party has been granted all necessary power and authority to act on behalf of such party with respect to the execution, performance and
delivery of this Agreement; and (iii) the representative executing this Agreement on behalf of such party is of legal age and capacity
to enter into agreements which are fully binding and enforceable against such party.
(e)
This Agreement may be executed in any number of counterparts and may be delivered by facsimile transmission, all of which taken together
shall constitute a single instrument.
This
Agreement is entered into and effective as of the date first written above.
COMPANY:
|
|
INVESTOR: |
|
|
|
|
|
NextTrip,
Inc. |
|
|
|
|
|
|
|
|
By: |
|
|
|
|
Frank
Orzechowski, CFO |
|
William Kerby |
Exhibit
A
Certificate
of Designation
Exhibit
10.5
DEBT
CONVERSION AGREEMENT
This
Debt Conversion Agreement (the “Agreement”) is entered into effective as of as of December 31, 2024 by and between
the investor on the signature page hereto (“Investor”) and NextTrip, Inc., a Nevada corporation (the “Company”),
with reference to the following facts:
WHEREAS,
Investor has loaned certain funds to the Company as described in those certain promissory notes dated November 1, 2024 and December 3,
2024 (the “Loan Agreements”), of which the Company and Investor desire to convert $350,000 (the “Debt”)
into shares of the Company’s newly created Series M Nonvoting Convertible Preferred Stock (the “Preferred Stock”),
with such rights as governed under that certain Certificate of Designation of Series M Nonvoting Convertible Preferred Stock (the “Certificate
of Designation”) attached hereto as Exhibit A and incorporated by reference herein.
NOW,
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Investor and the Company
agree as follows:
1.
Conversion to Preferred Stock. Effective as of the date hereof, $350,000 of the Debt shall be converted into shares of Preferred
Stock at a price per share of $3.02 for an aggregate number 115,894 shares of Preferred Stock (the “Shares”). Upon
execution of this Agreement, the Company shall file the Certificate of Designation with the Secretary of State of the State of Nevada
and, once filed, issue Shares to the Investor, and the Investor shall acknowledge the repayment of said portion of the Debt under the
Loan Agreement. Investor acknowledges and agrees that the conversion of the Preferred Stock into Common Stock of the Company is subject
to stockholder approval as required under Nasdaq rules and as provided in the Certificate of Designation.
2.
Investor Representations. The Company is issuing the Shares to Investor in reliance upon the following representations made by
Investor:
(a)
Investor acknowledges and agrees that the Shares are characterized as “restricted securities” under the Securities Act of
1933 (as amended and together with the rules and regulations promulgated thereunder, the “Securities Act”) and that,
under the Securities Act and applicable regulations thereunder, such securities may not be resold, pledged or otherwise transferred without
registration under the Securities Act or an exemption therefrom. Investor acknowledges and agrees that (i) the Shares are being offered
in a transaction not involving any public offering in the United States within the meaning of the Securities Act, and the Shares have
not yet been registered under the Securities Act, and (ii) such Shares may be offered, resold, pledged or otherwise transferred only
in a transaction registered under the Securities Act, or meeting the requirements of Rule 144, or in accordance with another exemption
from the registration requirements of the Securities Act (and based upon an opinion of counsel if the Company so requests) and in accordance
with any applicable securities laws of any State of the United States or any other applicable jurisdiction.
(b)
Investor acknowledges and agrees that (i) the registrar or transfer agent for the Shares will not be required to accept for registration
of transfer any shares except upon presentation of evidence satisfactory to the Company that the restrictions on transfer under the Securities
Act have been complied with and (ii) any Shares in the form of definitive physical certificates will bear a restrictive legend.
(c)
Investor acknowledges and agrees that: (a) the Shares have not been registered under the Securities Act, or under any state securities
laws, and are being offered and sold in reliance upon federal and state exemptions for transactions not involving any public offering;
(b) Investor is acquiring the Shares solely for its own account for investment purposes, and not with a view to the distribution thereof
in a transaction that would violate the Securities Act or the securities laws of any State of the United States or any other applicable
jurisdiction; (c) Investor is a sophisticated purchaser with such knowledge and experience in business and financial matters that it
is capable of evaluating the merits and risks of purchasing the Shares; (d) Investor has had the opportunity to obtain from the Company
such information as desired in order to evaluate the merits and the risks inherent in holding the Shares; (e) Investor is able to bear
the economic risk and lack of liquidity inherent in holding the Shares; (f) Investor is an “accredited investor” within the
meaning of Rule 501(a) under the Securities Act; and (g) and (g) Investor either has a pre-existing personal or business relationship
with the Company or its officers, directors or controlling persons, or by reason of Investor’s business or financial experience,
or the business or financial experience of their professional advisors who are unaffiliated with and who are not compensated by the Company,
directly or indirectly, have the capacity to protect their own interests in connection with the purchase of the Common Stock.
(d)
Investor’s investment in the Company pursuant to this Common Stock is consistent, in both nature and amount, with Investor’s
overall investment program and financial condition.
3.
Miscellaneous.
(a)
This Agreement shall be construed and enforced in accordance with the laws of the State of Nevada.
(b)
This Agreement constitutes the entire agreement between the parties and supersedes all prior oral or written negotiations and agreements
between the parties with respect to the subject matter hereof. No modification, variation or amendment of this Agreement (including any
exhibit hereto) shall be effective unless made in writing and signed by both parties.
(c)
Each party to this Agreement hereby represents and warrants to the other party that it has had an opportunity to seek the advice of its
own independent legal counsel with respect to the provisions of this Agreement and that its decision to execute this Agreement is not
based on any reliance upon the advice of any other party or its legal counsel. Each party represents and warrants to the other party
that in executing this Agreement such party has completely read this Agreement and that such party understands the terms of this Agreement
and its significance. This Agreement shall be construed neutrally, without regard to the party responsible for its preparation.
(d)
Each party to this Agreement hereby represents and warrants to the other party that (i) the execution, performance and delivery of this
Agreement has been authorized by all necessary action by such party; (ii) the representative executing this Agreement on behalf of such
party has been granted all necessary power and authority to act on behalf of such party with respect to the execution, performance and
delivery of this Agreement; and (iii) the representative executing this Agreement on behalf of such party is of legal age and capacity
to enter into agreements which are fully binding and enforceable against such party.
(e)
This Agreement may be executed in any number of counterparts and may be delivered by facsimile transmission, all of which taken together
shall constitute a single instrument.
This
Agreement is entered into and effective as of the date first written above.
COMPANY:
|
|
INVESTOR: |
|
|
|
|
|
NextTrip,
Inc. |
|
|
|
|
|
|
|
|
By: |
|
|
|
|
Frank
Orzechowski, CFO |
|
|
Exhibit
A
Certificate
of Designation
Exhibit 10.6
PROMISSORY
NOTE
For
value received, the undersigned, NextTrip, Inc. at address 3900 Paseo del Sol, Santa Fe NM 87507 (the
“Borrower”), promises to pay (the “Lender”), the sum of $1,000,000 plus an interest rate of 15%
per annum prepaid interest.
The
Parties further agree that all Interest on the loan will be prepaid in the form of $150,000 of NextTrip Inc. Preferred I shares. (NOTE:
The Preferred I share is convertible at the holder’s option into NextTrip Inc. Common shares at a price of $3.02 per share).
The
Lender will fund the Borrower as follows:
i) | $500,000
on or before December 19th, 2024 |
AND
ii) | $500,000
on or before January 15th, 2025. |
Any
unpaid principal shall be payable in full the earlier of the date the company completes a financing of $5 million or greater, OR by December
19th, 2025 (the “Due Date”).
| B. | Application
of Payments |
Payment
on this Note shall be in a lump sum by the Due Date.
If
any payment obligation under this Note is not paid when due, then the remaining unpaid principal balance and interest become due immediately
at the option of the Lender.
The
Borrower reserves the right to prepay this Note (in whole or in part) prior to the Due Date with no prepayment penalty.
If
any payment obligation under this Note is not paid when due, the Borrower promises to pay all costs of collection, including reasonable
attorney fees, whether or not a lawsuit is commenced as part of the collection process.
If
any of the following events of default occur, this Note and any other obligations of the Borrower to the Lender, shall become due immediately,
without demand or notice:
| 1) | the
failure of the Borrower to pay the principal and premium when due. |
| 2) | the
liquidation, dissolution, incompetency, or death of the Borrower. |
| | |
| 3) | the
filing of bankruptcy proceedings involving the Borrower as a debtor. |
| | |
| 4) | the
application for the appointment of a receiver for the Borrower. |
| | |
| 5) | the
making of a general assignment for the benefit of the Borrower’s creditors. |
| | |
| 6) | the
insolvency of the Borrower. |
| | |
| 7) | a
misrepresentation by the Borrower to the Lender for the purpose of obtaining or extending
credit; or |
| | |
| 8) | the
sale of a material portion of the business or assets of the Borrower. |
V. | SEVERABILITY
OF PROVISIONS |
If
any one or more of the provisions of this Note are determined to be unenforceable, in whole or in part, for any reason, the remaining
provisions shall remain fully operative.
All
payments of principal and premium on this Note shall be paid in the legal currency of the United States. The Borrower waives presentment
for payment, protest, and notice of protest and demand of this Note.
No
delay in enforcing any right of the Lender under this Note, or assignment by Lender of this Note, or failure to accelerate the debt evidenced
hereby by reason of default in the payment of a monthly installment or the acceptance of a past-due installment shall be construed as
a waiver of the right of Lender to thereafter insist upon strict compliance with the terms of this Note without notice being given to
Borrower. All rights of the Lender under this Note are cumulative and may be exercised concurrently or consecutively at the Lender’s
option.
This
note may not be amended without the written approval of the holder/lender.
NextTrip
will agree to file a resale registration statement within 30 days of clearing its Registration statement with Benchmark Securities.
This
Note shall be construed in accordance with the laws of the State of New Mexico.
In
addition to paying the principal and premium amount of this note by the due date, NextTrip, Inc. shall award the Lender:
i) | 250,000
common stock warrants with an exercise price of $4.00 AND 250,000 common stock Cashless warrants
with an exercise price of $4.00 on the initial $500,000 loan, |
AND
ii) | 250,000
common stock warrants with an exercise price of $4.00 AND 250,000 common stock Cashless warrants
with an exercise price of $4.00 on the second $500,000 loan. |
This
Note shall be signed by Denis Suggs and William R. Kerby.
[SIGNATURE
PAGE FOLLOWS]
IN
WITNESS WHEREOF, this Agreement has been executed and delivered in the manner prescribed by law as of the date first written above.
Lender: |
|
Borrower: NextTrip, Inc. |
|
|
|
|
|
William R Kerby |
Printed Individual/Representative Name |
|
Printed Individual/Representative Name |
|
|
|
|
|
|
Lender Signature |
|
Borrower Signature |
|
|
|
|
|
CEO |
Title, If Applicable |
|
Title, If Applicable |
Exhibit
10.7
PROMISSORY
NOTE
December
31, 2024
FOR
$220,000 (Two Hundred Twenty Thousand Dollars) RECEIVED, the undersigned, NextTrip,
Inc., a Nevada corporation, at 3900 Paseo del Sol, Santa Fe, New Mexico 87507 (the “Maker” or the
“Company”), hereby unconditionally promises to pay to the order of (the “Payee”), the
principal and the premium thereon as provided in this Promissory Note (the “Note”), pursuant to the terms and
conditions set forth herein.
PAYMENT
OF PRINCIPAL. The principal amount of this Note is Two Hundred Twenty Thousand Dollars ($220,000) (the “Principal Amount”)
and is due and payable in full in a lump sum on or prior to one year from the date of execution of this Note (the “Maturity
Date”), together with all other amounts payable under this Note. If any payment obligation under this Note is not paid when
due, any remaining unpaid balance of the Principal Amount and the Premium Amount (defined below) becomes due immediately, unless otherwise
agreed by the Payee.
PREMIUM
AMOUNT. On or prior to the Maturity Date, Maker shall deliver to Payee Fifteen Percent (15%) of the Principal Amount, Thirty-Three
Thousand Dollars ($33,000) (the “Premium Amount”), together with the Principal Amount, in accordance with the terms
of payment and conversion set out in the following section.
PAYMENT
OF PRINCIPAL AMOUNT AND PREMIUM AMOUNT. The Principal Amount shall be paid on or prior to the Maturity Date in immediately payable
United States funds. The Premium amount shall be paid on or prior to the Maturity Date by Maker’s delivery to Payee of Ten Thousand
Nine Hundred Twenty-Eight (10,928) shares of Series K Preferred Stock of the Company (the “Conversion Shares”). The
number of Conversion Shares has been determined by dividing the Premium Amount by a preferred stock per share price equal to Three and
2/100 Dollars ($3.02), and rounding up to the next even number of shares.
WARRANT.
As additional consideration for Payee’s extension of the loan pursuant to this Note, the Company shall issue to the Payee a
warrant to purchase Two Hundred Twenty Thousand (220,000) shares of the Company’s Common Stock (the “Warrant”).
PREPAYMENT.
The Maker shall have the right at any time and from time to time to prepay the Principal Amount and the Premium Amount, in part or
in full, as set out in this Note; provided however, that notwithstanding any prepayment, the Principal Amount and Premium Amount shall
be due in full and shall not be prorated or otherwise reduced because such amounts were paid and/or delivered prior to the Maturity Date.
GOVERNING
LAW. This Note shall be governed by, and construed in accordance with, the laws of the State of Nevada.
DISPUTE
RESOLUTION. In case of disputes in connection with this Agreement, the parties agree to seek non-binding mediation, which shall be
conducted remotely by a single mediator before a retired judge of a federal District Court or state court of the State of Texas, or some
similarly qualified, mutually agreeable individual. The parties shall bear the costs of such mediation equally. If a mediator is not
appointed within thirty (30) days of the initial notice of dispute, or if any such mediation does not produce a settlement, the dispute
shall be resolved by binding and final arbitration conducted in Austin, Texas which shall be in accordance with the rules and procedures
of the Commercial Arbitration Rules of the American Arbitration Association, and, to the maximum extent applicable, the Federal Arbitration
Act (Title 9 of the United States Code) then in effect with respect to commercial disputes in Travis County, Texas, by a sole arbitrator
selected by the parties (or by the American Arbitration Association if the parties cannot agree.
IN
WITNESS WHEREOF, Maker has executed this Promissory Note as of the day and year first above written.
Maker:
NextTrip, Inc. |
|
Payee: |
|
|
|
|
|
By: |
|
|
By: |
|
|
|
|
|
|
|
Bill
Kerby, CEO |
|
|
Roy
Mullin, Manager |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denis
Suggs, Manager |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ronald
Robinson, Manager |
Exhibit
10.8
REGISTRATION
RIGHTS AGREEMENT
THIS
REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of December __, 2024, is entered into by and among
NEXTTRIP, INC., a Nevada corporation (the “Company”), and (the “Investor”
and collectively together with its respective permitted assigns, the “Investors”). Capitalized terms used herein and
not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and among the parties
hereto, dated as of the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase
Agreement”).
WHEREAS:
A. Upon
the terms and subject to the conditions of the Purchase Agreements, the Company has agreed to issue to the Investor shares of the Company’s
Common Stock and shares of the Company’s Preferred Stock (collectively, the “Initial Shares”). The Initial Shares
are collectively referred to herein as the “Shares.”
B. To
induce the Investors to enter into the Purchase Agreements, the Company has agreed to provide certain registration rights under the U.S.
Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively, the “Securities
Act”), and applicable state securities laws.
NOW,
THEREFORE, in consideration of the promises and the mutual covenants contained herein and other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the Company and the Investors hereby agree as follows:
For
purposes of this Agreement, the following terms shall have the following meanings:
(a) “Person”
means an individual, partnership, corporation, limited liability company, business trust, joint stock company, trust, unincorporated
association, joint venture or any other entity or organization.
(b) “Purchase
Agreements” shall mean that certain Promissory Note and Warrant sold and issued to the Investor and dated contemporaneously
herewith.
(c) “Register,”
“Registered,” and “Registration” refer to a registration effected by preparing and filing one or
more registration statements of the Company in compliance with the Securities Act and providing for offering securities on a continuous
basis, and the declaration or ordering of effectiveness of such registration statement(s) by the U.S. Securities and Exchange Commission
(the “SEC”).
(d) “Registrable
Securities” means the Shares and any Common Stock issued or issuable with respect to the Shares as a result of any stock split
or subdivision, stock dividend, recapitalization, exchange or similar event. Registrable Securities shall cease to be Registrable Securities
upon the date on which the Investors shall have resold all the Registrable Securities covered by the Registration Statement.
(e) “Registration
Expenses” means all registration and filing fee expenses incurred by the Company in effecting any registration pursuant to
this Agreement, including (i) all registration, qualification, and filing fees, printing expenses, and any other fees and expenses associated
with filings required to be made with the SEC, FINRA or any other regulatory authority, (ii) all fees and expenses in connection with
compliance with or clearing the Registrable Securities for sale under any securities or “Blue Sky” laws, (iii) all printing,
duplicating, word processing, messenger, telephone, facsimile and delivery expenses, and (iv) all fees and disbursements of counsel for
the Company and of all independent certified public accountants of the Company (including the expenses of any special audit and cold
comfort letters required by or incident to such performance).
(f) “Registration
Statement” means any registration statement of the Company filed with, or to be filed with, the SEC under the Securities Act,
that Registers Registrable Securities, including the related prospectus, amendments and supplements to such registration statement, including
pre- and post-effective amendments, and all exhibits and all material incorporated by reference in such registration statement as may
be necessary to comply with applicable securities laws. “Registration Statement” shall also include a New Registration Statement,
as amended when each became effective, including all documents filed as part thereof or incorporated by reference therein, and including
any information contained in a prospectus subsequently filed with the SEC.
(g) “Selling
Expenses” means all underwriting discounts and selling commissions applicable to the sale of Registrable Securities and all
similar fees and commissions relating to the Investors’ disposition of the Registrable Securities.
(a) Mandatory
Registration. The Company shall, as promptly as reasonably practicable and in any event no later than thirty (30) days after the
current Form S-1 on file is declared effective by the SEC and the Alumni ELOC is declared effective , will prepare and file for sale
and issuance of any of the Shares in accordance with the provisions of the Purchase Agreements (the “Filing Deadline”),
prepare and file with the SEC an initial Registration Statement (the “Initial Registration Statement”) covering the
resale of all Registrable Securities. Before filing the Registration Statement, the Company shall furnish to the Investor a copy of the
Registration Statement. The Investor and their counsel shall have at least three Business Days prior to the anticipated filing date of
a Registration Statement to review and comment upon such Registration Statement and any amendment or supplement to such Registration
Statement and any related prospectus, prior to its filing with the SEC. Subject to any SEC comments, such Registration Statement shall
include the plan of distribution substantially in the form attached hereto as Exhibit A. The Company shall (a) use commercially
reasonable efforts to address in each such document prior to being so filed with the SEC such comments as the Investor or its counsel
reasonably proposed by the Investor, and (b) not file any Registration Statement or related prospectus or any amendment or supplement
thereto containing information regarding the Investor to which Investor reasonably objects, unless such information is required to comply
with any applicable law or regulation. The Investors shall furnish all information reasonably requested by the Company and as shall be
reasonably required in connection with any registration referred to in this Agreement.
(b) Effectiveness.
The Company shall use its reasonable best efforts to have the Initial Registration Statement and any amendment declared effective
by the SEC at the earliest possible date but no later than the earlier of the 75th calendar day following the initial filing date of
the Initial Registration Statement if the SEC notifies the Company that it will “review” the Initial Registration Statement
and (b) the fifth Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that the
Initial Registration Statement will not be “reviewed” or will not be subject to further review (the “Effectiveness
Deadline”). The Company shall notify the Investor by e-mail as promptly as practicable, and in any event, within 24 hours,
after the Registration Statement is declared effective or is supplemented and shall provide the Investor with copies of any related prospectus
to be used in connection with the sale or other disposition of the securities covered thereby. The Company shall use reasonable best
efforts to keep the Initial Registration Statement continuously effective pursuant to Rule 415 promulgated under the Securities Act and
available for the resale by the Investors of all of the Registrable Securities covered thereby at all times until the earliest to occur
of the following events: (i) the date on which the Investors shall have resold all the Registrable Securities covered thereby; and (ii)
the date on which the Registrable Securities may be resold by the Investors without registration and without regard to any volume or
manner-of-sale limitations by reason of Rule 144, without the requirement for the Company to be in compliance with the current public
information requirement under Rule 144 under the Securities Act or any other rule of similar effect (the “Registration Period”).
The Initial Registration Statement (including any amendments or supplements thereto and prospectuses contained therein) shall not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements
therein, in light of the circumstances in which they were made, not misleading.
(c) Sufficient
Number of Shares Registered. In the event the number of shares available under the Initial Registration Statement at any time is
insufficient to cover the Registrable Securities, the Company shall, to the extent necessary and permissible, amend the Initial Registration
Statement or file a new registration statement (together with any prospectuses or prospectus supplements thereunder, a “New
Registration Statement”), so as to cover all of such Registrable Securities as soon as reasonably practicable, but in any event
not later than ten Business Days after the necessity therefor arises (the “New Registration Filing Deadline”). The
Company shall use its reasonable best efforts to have such amendment and/or New Registration Statement become effective as soon as reasonably
practicable following the filing thereof but no later than the earlier of the 75th calendar day following the initial filing date of
the New Registration Statement if the SEC notifies the Company that it will “review” the New Registration Statement and (b)
the fifth Business Day after the date the Company is notified (orally or in writing, whichever is earlier) by the SEC that the New Registration
Statement will not be “reviewed” or will not be subject to further review (the earlier of such dates, the “New Registration
Effectiveness Deadline”). The provisions of Section 2(a) and (b) shall apply to the New Registration Statement,
except as modified hereby.
(d) Liquidated
Damages. If (i) the Initial Registration Statement has not been filed by the Filing Deadline, (ii) the Initial Registration Statement
has not been declared effective by the Effectiveness Deadline, (iii) the New Registration Statement has not been filed by the New Registration
Filing Deadline, (iv) the New Registration Statement has not been declared effective by the New Registration Effectiveness Deadline or
(v) after any Registration Statement has been declared effective by the SEC, sales cannot be made pursuant to such Registration Statement
for any reason (including without limitation by reason of a stop order, or the Company’s failure to update such Registration Statement),
but excluding any Allowed Delay (as defined below) or, if the Registration Statement is on Form S-1, for a period of 20 days following
the date on which the Company files a post-effective amendment to incorporate the Company’s Annual Report on Form 10-K (a “Maintenance
Failure”), then the Company will make pro rata payments to each Investor then holding Registrable Securities, as liquidated
damages and not as a penalty, in an amount equal to 1.0% of the aggregate amount paid pursuant to the Purchase Agreement by such Investor
for such Registrable Securities then held by such Investor for each 30-day period or pro rata for any portion thereof during which the
failure continues (the “Blackout Period”). Such payments shall constitute the Investors’ exclusive monetary
remedy for such events, but shall not affect the right of the Investors to seek injunctive relief. The amounts payable as liquidated
damages pursuant to this paragraph shall be paid in cash no later than five (5) Business Days after each such 30-day period following
the commencement of the Blackout Period until the termination of the Blackout Period (the “Blackout Period Payment Date”).
Interest shall accrue at the rate of 1.0% per month on any such liquidated damages payments that shall not be paid by the Blackout Period
Payment Date until such amount is paid in full. Notwithstanding the above, in no event shall the aggregate amount of liquidated damages
(or interest thereon) paid under this Agreement to any Investor exceed, in the aggregate, 5.0% of the aggregate purchase price of the
Shares purchased by such Investor under the Purchase Agreement. Notwithstanding anything in this Section 2(d) to the contrary,
during any periods that the Company is unable to meet its obligations hereunder with respect to the registration of the Registrable Securities
because any Investor fails to furnish information required to be provided pursuant to Section 2(a) or Section 4(a) within
three Business Days of the Company’s request, any liquidated damages that would otherwise accrue as to such Investor only shall
be tolled until such information is delivered to the Company.]
(e) Allowable
Delays. On no more than two occasions and for not more than 30 consecutive days or for a total of not more than 60 days in any 12
month period, the Company may delay the effectiveness of the Initial Registration Statement or any other Registration Statement, or suspend
the use of any prospectus included in any Registration Statement, in the event that the Company determines in good faith that such delay
or suspension is necessary to (A) delay the disclosure of material non-public information concerning the Company, the disclosure of which
at the time is not, in the good faith opinion of the Company, in the best interests of the Company or (B) amend or supplement the affected
Registration Statement or the related prospectus so that such Registration Statement or prospectus shall not include an untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the
case of the prospectus in light of the circumstances under which they were made, not misleading (an “Allowed Delay”);
provided, that the Company shall promptly (a) notify each Investor in writing of the commencement of an Allowed Delay, but shall not
(without the prior written consent of an Investor) disclose to such Investor any material non-public information giving rise to an Allowed
Delay, (b) advise the Investors in writing to cease all sales under the Registration Statement until the end of the Allowed Delay and
(c) use commercially reasonable efforts to terminate an Allowed Delay as promptly as practicable.
(f) Rule
415; Cutback. If at any time the SEC takes the position that the offering of some or all of the Registrable Securities in any Registration
Statement is not eligible to be made on a delayed or continuous basis under the provisions of Rule 415 under the Securities Act (provided,
however, the Company shall be obligated to use reasonable best efforts to advocate with the SEC for the registration of all of the Registrable
Securities) or requires any Investor to be named as an “underwriter,” the Company shall (i) promptly notify each holder of
Registrable Securities thereof and (ii) make commercially reasonable efforts to persuade the SEC that the offering contemplated by such
Registration Statement is a valid secondary offering and not an offering “by or on behalf of the issuer” as defined in Rule
415 and that none of the Investors is an “underwriter.” The Investors shall have the right to select one legal counsel, at
such Investor’s expense, to review and oversee any registration or matters pursuant to this Section 2(f), including participation
in any meetings or discussions with the SEC regarding the SEC’s position and to comment on any written submission made to the SEC
with respect thereto. No such written submission with respect to this matter shall be made to the SEC to which any Investor’s counsel
reasonably objects. In the event that, despite the Company’s reasonable best efforts and compliance with the terms of this Section
2(f), the SEC refuses to alter its position, the Company shall (i) remove from such Registration Statement such portion of the Registrable
Securities (the “Cut Back Shares”) and/or (ii) agree to such restrictions and limitations on the registration and
resale of the Registrable Securities as the SEC may require to assure the Company’s compliance with the requirements of Rule 415
(collectively, the “SEC Restrictions”); provided, however, that the Company shall not name any Investor as an “underwriter”
in such Registration Statement without the prior written consent of such Investor (provided that, in the event an Investor withholds
such consent, the Company shall have no obligation hereunder to include any Registrable Securities of such Investor in any Registration
Statement covering the resale thereof until such time as the SEC no longer requires such Investor to be named as an “underwriter”
in such Registration Statement or such Investor otherwise consents in writing to being so named). Any cut-back imposed on the Investors
pursuant to this Section 2(f) shall be allocated among the Investors on a pro rata basis and shall be applied first to any of
the Registrable Securities of such Investor as such Investor shall designate, unless the SEC Restrictions otherwise require or provide
or the Investors otherwise agree. No liquidated damages shall accrue as to any Cut Back Shares until such date as the Company is able
to effect the registration of such Cut Back Shares in accordance with any SEC Restrictions applicable to such Cut Back Shares (such date,
the “Restriction Termination Date”). From and after the Restriction Termination Date applicable to any Cut Back Shares,
all of the provisions of this Section 2 (including the Company’s obligations with respect to the filing of a Registration
Statement and its obligations to use reasonable efforts to have such Registration Statement declared effective within the time periods
set forth herein and the liquidated damages provisions relating thereto) shall again be applicable to such Cut Back Shares; provided,
however, that the date by which the Company is required to file the Registration Statement with respect to such Cut Back Shares shall
be the tenth day following the Restriction Termination Date and the date by which the Company is required to have the Registration Statement
effective with respect to such Cut Back Shares shall be the 55th day immediately after the Restriction Termination Date.
| 3. | RELATED
COMPANY OBLIGATIONS. |
With
respect to the Registration Statement and whenever any Registrable Securities are to be Registered pursuant to Section 2, including
on the Initial Registration Statement or on any New Registration Statement, the Company shall use its reasonable best efforts to effect
the registration of the Registrable Securities in accordance with the intended method of disposition thereof and, pursuant thereto, the
Company shall have the following obligations:
(a) Notifications.
The Company will promptly notify the Investors promptly of the time when any subsequent amendment to the Initial Registration Statement
or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective
or where a receipt has been issued therefor or any subsequent supplement to a prospectus has been filed and of any request by the SEC
for any amendment or supplement to the Registration Statement, any New Registration Statement or any prospectus or for additional information.
(b) Amendments.
The Company will prepare and file with the SEC any amendments, post-effective amendments or supplements to the Initial Registration
Statement, any New Registration Statement or any related prospectus, as applicable, that, (a) as may be necessary to keep such Registration
Statement effective for the Effectiveness Period and to comply with the provisions of the Securities Act and the Securities Exchange
Act of 1934, as amended (the “Exchange Act”) with respect to the distribution of all of the Registrable Securities
covered thereby, or (b) in the reasonable opinion of the Investors and the Company, as may be necessary or advisable in connection with
any acquisition or sale of Registrable Securities by the Investors.
(c) Investor
Review. The Company will not file any amendment or supplement to the Registration Statement, any New Registration Statement or any
prospectus, other than documents incorporated by reference, relating to the Investors, the Registrable Securities or the transactions
contemplated hereby unless (A) the Investors and their counsel shall have been advised and afforded the opportunity to review and comment
thereon at least three (3) Business Days prior to filing with the SEC and (B) the Company shall have given reasonable due consideration
to any comments thereon received from the Investors or their counsel.
(d) Copies
Available. The Company will furnish to any Investor whose Registrable Securities are included in any Registration Statement and its
counsel copies of the Initial Registration Statement, any prospectus thereunder (including all documents incorporated by reference therein),
any prospectus supplement thereunder, any New Registration Statement and all amendments to the Initial Registration Statement or any
New Registration Statement that are filed with the SEC during the Registration Period (including all documents filed with or furnished
to the SEC during such period that are deemed to be incorporated by reference therein), each letter written by or on behalf of the Company
to the SEC or the staff of the SEC, and each item of correspondence from the SEC or the staff of the SEC, in each case relating to such
Registration Statement (other than any portion thereof which contains information for which the Company has sought confidential treatment)
and such other documents as Investor may reasonably request in order to facilitate the disposition of the Registrable Securities owned
by Investor that are covered by such Registration Statement, in each case as soon as reasonably practicable upon such Investor’s
request and in such quantities as such Investor may from time to time reasonably request; provided, however, that the Company shall not
be required to furnish any document to the Investor to the extent such document is available on EDGAR.
(e) Notification
of Stop Orders; Material Changes. The Company shall use commercially reasonable efforts to (i) prevent the issuance of any stop order
or other suspension of effectiveness and, (ii) if such order is issued, obtain the withdrawal of any such order as soon as practicable.
The Company shall advise the Investors promptly (but in no event later than 24 hours) and shall confirm such advice in writing, in each
case: (i) of the Company’s receipt of notice of any request by the SEC or any other federal or state governmental authority for
amendment of or a supplement to the Registration Statement or any prospectus or for any additional information; (ii) of the Company’s
receipt of notice of the issuance by the SEC or any other federal or state governmental authority of any stop order suspending the effectiveness
of the Initial Registration Statement or prohibiting or suspending the use of any prospectus or prospectus supplement, or any New Registration
Statement, or of the Company’s receipt of any notification of the suspension of qualification of the Registrable Securities for
offering or sale in any jurisdiction or the initiation or contemplated initiation of any proceeding for such purpose; and (iii) of the
Company becoming aware of the happening of any event, which makes any statement of a material fact made in any Registration Statement
or any prospectus untrue or which requires the making of any additions to or changes to the statements then made in any Registration
Statement or any prospectus in order to state a material fact required by the Securities Act to be stated therein or necessary in order
to make the statements then made therein (in the case of any prospectus, in light of the circumstances under which they were made) not
misleading, or of the necessity to amend any Registration Statement or any prospectus to comply with the Securities Act or any other
law. The Company shall not be required to disclose to the Investors the substance of specific reasons of any of the events set forth
in clause (i) to (iii) of the immediately preceding sentence (each, a “Suspension Event”), but rather, shall only
be required to disclose that the event has occurred. If at any time the SEC, or any other federal or state governmental authority shall
issue any stop order suspending the effectiveness of any Registration Statement or prohibiting or suspending the use of any prospectus
or prospectus supplement, the Company shall use its reasonable best efforts to obtain the withdrawal of such order at the earliest practicable
time. The Company shall furnish to the Investors, without charge, a copy of any correspondence from the SEC or the staff of the SEC,
or any other federal or state governmental authority to the Company or its representatives relating to the Initial Registration Statement,
any New Registration Statement or any prospectus, or prospectus supplement as the case may be. In the event of a Suspension Event set
forth in clause (iii) of the first sentence of this Section 3(e), the Company will use its commercially reasonable efforts to
publicly disclose such event as soon as reasonably practicable, or otherwise resolve the matter such that sales under Registration Statements
may resume; provided, however, that if the Company has a bona fide business purpose for not making such information public, the Company
may suspend the use of all Registration Statements for up to 60 consecutive calendar days; provided, further, that the Company may not
suspend the use of all Registration Statements more than twice, or for more than 90 total calendar days, in each case during any twelve-month
period.
(f) Confirmation
of Effectiveness. If reasonably requested by an Investor at any time in respect of any Registration Statement, the Company shall
deliver to such Investor a written confirmation from Company’s counsel of whether or not the effectiveness of such Registration
Statement has lapsed at any time for any reason (including, without limitation, the issuance of a stop order) and whether or not such
Registration Statement is currently effective and available to the Company for sale of Registrable Securities.
(g) Listing.
The Company shall use best efforts to cause all Registrable Securities covered by a Registration Statement to be listed on [the Nasdaq
Global Market].
(h) Compliance.
The Company shall otherwise use best efforts to comply with all applicable rules and regulations of the SEC under the Securities Act
and the Exchange Act, including, without limitation, Rule 172 under the Securities Act, file any final prospectus, including any supplement
or amendment thereof, with the SEC pursuant to Rule 424 under the Securities Act, promptly inform the Investor in writing if, at any
time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the
Investor is required to deliver a prospectus in connection with any disposition of Registrable Securities and take such other actions
as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder, and make available to its security
holders, as soon as reasonably practicable, but not later than the Availability Date (as defined below), an earnings statement covering
a period of at least 12 months, beginning after the effective date of each Registration Statement, which earnings statement shall satisfy
the provisions of Section 11(a) of the Securities Act, including Rule 158 promulgated thereunder (for the purpose of this subsection
3(h), “Availability Date” means the 45th day following the end of the fourth fiscal quarter that includes
the effective date of such Registration Statement, except that, if such fourth fiscal quarter is the last quarter of the Company’s
fiscal year, “Availability Date” means the 90th day after the end of such fourth fiscal quarter).
(i) Blue-Sky.
The Company shall register or qualify or cooperate with the Investor and their counsel in connection with the registration or qualification
of such Registrable Securities for the offer and sale under the securities or blue sky laws of such jurisdictions reasonably requested
by the Investor; provided, however, that the Company shall not be required in connection therewith or as a condition thereto to (i) qualify
to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section 3(i), (ii) subject
itself to general taxation in any jurisdiction where it would not otherwise be so subject but for this Section 3(i), or (iii)
file a general consent to service of process in any such jurisdiction.
(j) Rule
144. With a view to making available to the Investors the benefits of Rule 144 (or its successor rule) and any other rule or regulation
of the SEC that may at any time permit the Investors to sell shares of Common Stock to the public without registration, the Company covenants
and agrees to: (i) make and keep adequate current public information available, as those terms are understood and defined in Rule 144,
until the earlier of (A) six months after such date as all of the Registrable Securities may be sold without restriction by the holders
thereof pursuant to Rule 144 or any other rule of similar effect or (B) such date as there are no longer Registrable Securities; and
(ii) file with the SEC in a timely manner all reports and other documents required of the Company under the Exchange Act; (iii) furnish
electronically to each Investor upon request, as long as such Investor owns any Registrable Securities, (A) a written statement by the
Company that it has complied with the reporting requirements of the Exchange Act, (B) a copy of or electronic access to the Company’s
most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q, and (C) such other information as may be reasonably requested
in order to avail such Investor of any rule or regulation of the SEC that permits the selling of any such Registrable Securities without
registration.
(k) Cooperation.
The Company shall cooperate with the holders of the Registrable Securities to facilitate the timely preparation and delivery of certificates
or uncertificated shares representing the Registrable Securities to be sold pursuant to such Registration Statement or Rule 144 free
of any restrictive legends and representing such number of shares of Common Stock and registered in such names as the holders of the
Registrable Securities may reasonably request to the extent permitted by such Registration Statement or Rule 144 to effect sales of Registrable
Securities ; for the avoidance of doubt, the Company may satisfy its obligations hereunder without issuing physical stock certificates
through the use of The Depository Trust Company’s Direct Registration System.
| 4. | OBLIGATIONS
OF THE INVESTORS. |
(a) Investor
Information. Each Investor shall provide a completed Investor Questionnaire in the form attached hereto as Exhibit B in connection
with the registration of the Registrable Securities. If the Company has not received such completed Questionnaire from an Investor within
three business days of the Company’s request, the Company may file the Registration Statement without including such Investor’s
Registrable Securities.
(b)
Suspension of Sales. Each Investor, severally and not jointly with any other Investor, agrees that, upon receipt of any notice
from the Company of the existence of Suspension Event as set forth in Section 3(e), the Investor will immediately discontinue
disposition of Registrable Securities pursuant to any Registration Statement covering such Registrable Securities until the Investor’s
receipt of a notice from the Company confirming the resolution of such Suspension Event and that such dispositions may again be made.
(c)
Investor Cooperation. Each Investor, severally and not jointly with any other Investor, agrees to cooperate with the Company as
reasonably requested by the Company in connection with the preparation and filing of any amendments and supplements to any Registration
Statement or New Registration Statement hereunder, unless such Investor has notified the Company in writing of its election to exclude
all of its Registrable Securities from such Registration Statement.
| 5. | EXPENSES
OF REGISTRATION. |
All
Registration Expenses incurred in connection with registrations pursuant to this Agreement shall be borne by the Company. All Selling
Expenses relating to securities registered on behalf of the Investors shall be borne by the Investors pro rata on the basis of the number
of Registrable Securities so registered.
(a) To
the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investors, each Person,
if any, who controls the Investors, the members, the directors, officers, partners, employees, members, managers, agents, representatives
and advisors of the Investors and each Person, if any, who controls the Investors within the meaning of the Securities Act or the Exchange
Act (each, an “Indemnified Person”), against any losses, obligation, claims, damages, liabilities, contingencies,
judgments, fines, penalties, charges, costs (including, without limitation, court costs and costs of preparation), reasonable and documented
attorneys’ fees, amounts paid in settlement or reasonable and documented expenses, (collectively, “Claims”)
reasonably incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken
from the foregoing by or before any court or governmental, administrative or other regulatory agency or body or the SEC, whether pending
or threatened, whether or not an indemnified party is or may be a party thereto (“Indemnified Damages”), to which
any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect thereof)
arise out of or are based upon: (i) any untrue statement or alleged untrue statement or omission or alleged omission of any material
fact contained in any Registration Statement, any preliminary prospectus or final prospectus, or any amendment or supplement thereof,
or (ii) any violation or alleged violation by the Company or any of its Subsidiaries of the Securities Act, Exchange Act or any other
state securities or other “blue sky” laws of any jurisdiction in which Registrable Securities are offered or any rule or
regulation promulgated thereunder applicable to the Company or its agents and relating to action or inaction required of the Company
in connection with such registration of the Registrable Securities (the matters in the foregoing clauses (i) and (ii) being, collectively,
“Violations”). The Company shall reimburse each Indemnified Person promptly as such expenses are incurred and are
due and payable, for any reasonable out-of-pocket legal fees or other reasonable and documented expenses incurred by them in connection
with investigating or defending any such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement
contained in this Section 6(a): (A) shall not apply to a Claim by an Indemnified Person arising out of or based upon a Violation
which occurs in reliance upon and in conformity with information furnished in writing to the Company by the Investors or such Indemnified
Person specifically for use in such Registration Statement or prospectus and was reviewed and approved in writing by such Investor or
such Indemnified Person expressly for use in connection with the preparation of any Registration Statement, any prospectus or any such
amendment thereof or supplement thereto, if such in each case if the foregoing was timely made available by the Company; (B) with respect
to any superseded prospectus, shall not inure to the benefit of any such Person from whom the Person asserting any such Claim purchased
the Registrable Securities that are the subject thereof (or to the benefit of any other Indemnified Person) if the untrue statement or
omission of material fact contained in the superseded prospectus was corrected in the revised prospectus, as then amended or supplemented,
and the Indemnified Person was promptly advised in writing not to use the outdated, defective or incorrect prospectus prior to the use
giving rise to a violation; (C) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the
prior written consent of the Company, which consent shall not be unreasonably withheld, conditioned or delayed. Such indemnity shall
remain in full force and effect regardless of any investigation made by or on behalf of the Indemnified Person and shall survive the
transfer of the Registrable Securities by the Investor pursuant to Section 8.
(b) In
connection with the Initial Registration Statement, any New Registration Statement or any prospectus, the Investors, severally and not
jointly, agree to indemnify, hold harmless and defend, the Company, each of its directors, each of its officers who signed the Initial
Registration Statement or signs any New Registration Statement, each Person, if any, who controls the Company within the meaning of the
Securities Act or the Exchange Act (each, an “Indemnified Party”), against any losses, claims, damages, liabilities
and expense (including reasonable attorney fees) resulting from any Violation, in each case to the extent, and only to the extent, that
such Violation occurs in reliance upon and in conformity with information about an Investor furnished in writing by such Investor to
the Company and reviewed and approved in writing by such Investor or such Indemnified Person expressly for use in connection with the
preparation of the Registration Statement, any New Registration Statement, any prospectus or any such amendment thereof or supplement
thereto. In no event shall the liability of an Investor be greater in amount than the dollar amount of the proceeds (net of all expense
paid by such Investor in connection with any claim relating to this Section 6 and the amount of any damages such Investor has
otherwise been required to pay by reason of such untrue statement or omission) received by such Investor upon the sale of the Registrable
Securities included in such Registration Statement giving rise to such indemnification obligation. Such indemnity shall remain in full
force and effect regardless of any investigation made by or on behalf of such Indemnified Party and shall survive the transfer of the
Registrable Securities by any Investor pursuant to Section 8.
(c) Promptly
after receipt by an Indemnified Person or Indemnified Party under this Section 6 of notice of the commencement of any action or
proceeding (including any governmental action or proceeding) involving a Claim, such Indemnified Person or Indemnified Party shall, if
a Claim in respect thereof is to be made against any indemnifying party under this Section 6, deliver to the indemnifying party
a written notice of the commencement thereof, and the indemnifying party shall have the right to participate in, and, to the extent the
indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense thereof
with counsel mutually satisfactory to the indemnifying party and the Indemnified Person or the Indemnified Party, as the case may be,
and upon such notice, the indemnifying party shall not be liable to the Indemnified Person or the Indemnified Party for any legal or
other expenses subsequently incurred by the Indemnified Person or the Indemnified Party in connection with the defense thereof; provided,
however, that an Indemnified Person or Indemnified Party (together with all other Indemnified Persons and Indemnified Parties that may
be represented without conflict by one counsel) shall have the right to retain its own counsel with the reasonable fees and expenses
to be paid by the indemnifying party, if, in the reasonable opinion of counsel retained by the indemnifying party, the representation
by such counsel of the Indemnified Person or Indemnified Party and the indemnifying party would be inappropriate due to actual or potential
differing interests between such Indemnified Person or Indemnified Party and any other party represented by such counsel in such proceeding.
The Indemnified Party or Indemnified Person shall cooperate with the indemnifying party in connection with any negotiation or defense
of any such action or claim by the indemnifying party and shall furnish to the indemnifying party all information reasonably available
to the Indemnified Party or Indemnified Person which relates to such action or claim. The indemnifying party shall keep the Indemnified
Party or Indemnified Person fully apprised as to the status of the defense or any settlement negotiations with respect thereto. No indemnifying
party shall be liable for any settlement of any action, claim or proceeding effected without its written consent, provided, however,
that the indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the
consent of the Indemnified Party or Indemnified Person, consent to entry of any judgment or enter into any settlement or other compromise
unless such judgment or settlement (i) imposes no liability or obligation on, (ii) includes as an unconditional term thereof the giving
of a complete, explicit and unconditional release from the party bringing such indemnified claims of all liability of the Indemnified
Party or Indemnified Person in respect to or arising out of such claim or litigation in favor of, and (iii) does not include any admission
of fault, culpability, wrongdoing, or wrongdoing or malfeasance by or on behalf of, the Indemnified Party or Indemnified Person.. Following
indemnification as provided for hereunder, the indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified
Person with respect to all third parties, firms or corporations relating to the matter for which indemnification has been made. The failure
to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve
such indemnifying party of any liability to the Indemnified Person or Indemnified Party under this Section 6, except to the extent
that the indemnifying party is prejudiced in its ability to defend such action.
(d) The
indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the investigation
or defense, as and when bills are received or Indemnified Damages are incurred. Any Person receiving a payment pursuant to this Section
6 which person is later determined to not be entitled to such payment shall return such payment (including reimbursement of expenses)
to the person making it.
(e) The
indemnity agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified Party or Indemnified
Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant to the law.
To
the extent any indemnification by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum
contribution with respect to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted
by law; provided, however, that: (i) no seller of Registrable Securities guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act) shall be entitled to contribution from any seller of Registrable Securities who was not guilty of
fraudulent misrepresentation; and (ii) contribution by any seller of Registrable Securities shall be limited in amount to the net amount
of proceeds (net of all expenses paid by such holder in connection with any claim relating to this Section 7 and the amount of
any damages such holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged
omission) received by such seller from the sale of such Registrable Securities giving rise to such contribution obligation.
| 8. | ASSIGNMENT
OF REGISTRATION RIGHTS. |
The
Company shall not assign this Agreement or any rights or obligations hereunder (whether by operation of law or otherwise) without the
prior written consent of the Investors holding a majority of the Registrable Securities then outstanding (determined as if all of the
Warrants then outstanding have been exercised without regard to any limitations on the exercise of such Warrants); provided, however,
that in any transaction, whether by merger, reorganization, restructuring, consolidation, financing or otherwise, whereby the Company
is a party and in which the Registrable Securities are converted into the equity securities of another Person, from and after the effective
time of such transaction, such Person shall, by virtue of such transaction, be deemed to have assumed the obligations of the Company
hereunder, the term “Company” shall be deemed to refer to such Person and the term “Registrable Securities” shall
be deemed to include the securities received by the Investor in connection with such transaction unless such securities are otherwise
freely tradable by the Investor after giving effect to such transaction, and the prior written consent of the Investors holding a majority
of the Registrable Securities then outstanding (determined as if all of the Warrants then outstanding have been exercised without regard
to any limitations on the exercise of such Warrants) shall not be required for such transaction.
An
Investor may transfer or assign its rights hereunder, in whole or from time to time in part, to one or more Persons in connection with
the transfer of not fewer than all of the Registrable Securities (including Registrable Securities issuable upon exercise of Warrants)
by such Investor to such Person, provided that such Investor complies with all laws applicable thereto, and the provisions of the Purchase
Agreement, and provides written notice of assignment to the Company promptly after such assignment is effected, and such Person agrees
in writing to be bound by all of the provisions contained herein.
The provisions of this Agreement shall be binding upon and inure
to the benefit of the Investor and its successors and permitted assigns.
| 9. | AMENDMENTS
AND WAIVERS. |
The
provisions of this Agreement, including the provisions of this sentence, may be amended, modified or supplemented, or waived only by
a written instrument executed by (i) the Company and (ii) the holders of a majority of the then outstanding Registrable Securities (determined
as if all of the Warrants then outstanding have been exercised without regard to any limitations on the exercise of such Warrants), provided
that any party may give a waiver as to itself and provided further that any amendment, modification, supplement or waiver that disproportionately
and adversely affects the rights and obligations of any Investor relative to the comparable rights and obligations of the other Investors
shall require the prior written consent of such adversely affected Investor or each Investor, as applicable. Notwithstanding the foregoing,
a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of one or more
Investors and that does not adversely directly or indirectly affect the rights of other Investors may be given by Investors holding all
of the Registrable Securities to which such waiver or consent relates.
(a) Notices.
Any notices or other communications required or permitted to be given hereunder shall be in writing and shall be deemed to be given (a)
when delivered if personally delivered to the party for whom it is intended, (b) when delivered, if sent by electronic mail during normal
business hours of the recipient, and if not sent during normal business hours, then on the recipient’s next business day, (c) three
days after having been sent by certified or registered mail, return-receipt requested and postage prepaid, or (d) one business day after
deposit with a nationally recognized overnight courier, freight prepaid, specifying next business day delivery, with written verification
of receipt:
i. If to the Company, addressed as follows:
William
Kerby
Chief
Executive Officer
NextTrip,
Inc.
3900
Paseo del Sol
Santa
Fe, New Mexico 87507
Phone:
(954) 526-9688
with
a copy (which shall not constitute notice):
[__________________ ]
[Address]
Attention:
Email:
ii. If
to any Investor, at its e-mail address or address set forth on its signature page to the Purchase Agreement or to such e-mail address,
or address as subsequently modified by written notice given in accordance with this Section 10.
Any
Person may change the address to which notices and communications to it are to be addressed by notification as provided for herein.
(b) Consent
to Electronic Notice. Each Investor consents to the delivery of any stockholder notice pursuant to the Delaware General Corporation
Law (the “DGCL”), as amended or superseded from time to time, by electronic mail pursuant to Section 232 of the DGCL
(or any successor thereto) at the e-mail address set forth below the Investor’s name on the signature page or Exhibit A, as updated
from time to time by notice to the Company. To the extent that any notice given by means of electronic mail is returned or undeliverable
for any reason, the foregoing consent shall be deemed to have been revoked until a new or corrected e-mail address has been provided,
and such attempted electronic notice shall be ineffective and deemed to not have been given. Each party agrees to promptly notify the
other parties of any change in its e-mail address, and that failure to do so shall not affect the foregoing.
(c) Waiver.
No waiver of any term, provision or condition of this Agreement, whether by conduct or otherwise, in any one or more instances, shall
be deemed to be, or be construed as, a further or continuing waiver of any such term, provision or condition or as a waiver of any other
term, provision or condition of this Agreement.
(d) Governing
Law. The provisions of the Purchase Agreements are incorporated by reference herein mutatis mutandis.
(e) Headings.
The titles, subtitles and headings in this Agreement are for convenience of reference and shall not form part of, or affect the interpretation
of, this Agreement.
(f) Counterparts.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and
shall become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile or
pdf signature including any electronic signatures complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com shall be
considered due execution and shall be binding upon the signatory thereto with the same force and effect as if the signature were an original,
not a facsimile or pdf (or other electronic reproduction of a) signature.
(g) Further
Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute
and deliver all such other agreements, certificates, instruments and documents as the other party may reasonably request in order to
carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.
(h) Contract
Interpretation. This Agreement is the joint product of each Investor and the Company and each provision hereof has been subject to
the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
(i) No
Third Party Beneficiaries. Nothing in this Agreement, express or implied, is intended to confer on any Person other than the parties
to this Agreement any rights, remedies, claims, benefits, obligations or liabilities under or by reason of this Agreement, and no Person
that is not a party to this Agreement (including, without limitation, any partner, member, shareholder, director, officer, employee or
other beneficial owner of any party to this Agreement, in its own capacity as such or in bringing a derivative action on behalf of a
party to this Agreement) shall have any standing as a third party beneficiary with respect to this Agreement or the transactions contemplated
hereby.
(j) Severability.
If any part or provision of this Agreement is held unenforceable or in conflict with the applicable laws or regulations of any jurisdiction,
the invalid or unenforceable part or provisions shall be replaced with a provision which accomplishes, to the extent possible, the original
business purpose of such part or provision in a valid and enforceable manner, and the remainder of this Agreement shall remain binding
upon the parties hereto.
(k) Non-Recourse.
Notwithstanding anything that may be expressed or implied in this Agreement, the Company covenants, agrees and acknowledges that no recourse
under this Agreement or any documents or instruments delivered in connection with this Agreement shall be had against any current or
future director, officer, employee, stockholder, general or limited partner or member of the Investors or of any affiliates or assignees
thereof, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation
or other applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed
on or otherwise be incurred by any current or future director, officer, employee, stockholder, general or limited partner or member of
the Investors or of any affiliates or assignees thereof, as such for any obligation of the Investors under this Agreement or any documents
or instruments delivered in connection with this Agreement for any claim based on, in respect of or by reason of such obligations or
their creation.
(l) Specific
Performance. In addition to any and all other remedies that may be available at law in the event of any breach of this Agreement,
each Investor shall be entitled to specific performance of the agreements and obligations of the Company hereunder and to such other
injunction or other equitable relief as may be granted by a court of competent jurisdiction.
(m) Cumulative
Remedies. The remedies provided herein are cumulative and not exclusive of any remedies provided by law.
[Signature
Page Follows]
IN
WITNESS WHEREOF, the parties have caused this Registration Rights Agreement to be duly executed as of date first written above.
|
COMPANY: |
|
|
|
|
NEXTTRIP, INC. |
|
|
|
|
By: |
|
|
Name:
|
William
Kerby |
|
Title:
|
Chief
Executive Officer |
|
|
|
|
INVESTOR: |
|
|
|
|
By:
|
|
|
Name: |
|
|
Title:
|
|
[Signature Page to Registration
Rights Agreement]
Exhibit
A
PLAN
OF DISTRIBUTION
The
selling stockholders, which as used herein includes donees, pledgees, transferees or other successors-in-interest selling shares of common
stock or interests in shares of common stock received after the date of this prospectus from a selling stockholder as a gift, pledge,
partnership distribution or other transfer, may, from time to time, sell, transfer or otherwise dispose of any or all of their shares
of common stock or interests in shares of common stock on any stock exchange, market or trading facility on which the shares are traded
or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices related
to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices.
The
selling stockholders may use any one or more of the following methods when disposing of shares or interests therein:
|
● |
distributions
to members, partners, stockholders or other equity holders of the selling stockholders; |
|
|
|
|
● |
ordinary
brokerage transactions and transactions in which the broker-dealer solicits purchasers; |
|
|
|
|
● |
block
trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block as
principal to facilitate the transaction; |
|
|
|
|
● |
purchases
by a broker-dealer as principal and resale by the broker-dealer for its account; |
|
|
|
|
● |
an
exchange distribution in accordance with the rules of the applicable exchange; |
|
|
|
|
● |
privately
negotiated transactions; |
|
|
|
|
● |
short
sales and settlement of short sales entered into after the effective date of the registration statement of which this prospectus
is a part; |
|
|
|
|
● |
through
the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise; |
|
|
|
|
● |
broker-dealers
may agree with the selling stockholders to sell a specified number of such shares at a stipulated price per share; |
|
|
|
|
● |
a
combination of any such methods of sale; and |
|
|
|
|
● |
any
other method permitted pursuant to applicable law. |
The
selling stockholders may, from time to time, pledge or grant a security interest in some or all of the shares of common stock owned by
them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares
of common stock, from time to time, under this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable
provision of the Securities Act, amending the list of selling stockholders to include the pledgee, transferee or other successors in
interest as selling stockholders under this prospectus. The selling stockholders also may transfer the shares of common stock in other
circumstances, in which case the transferees, pledgees or other successors in interest will be the selling stockholders for purposes
of this prospectus.
In
connection with the sale of our common stock or interests therein, the selling stockholders may enter into hedging transactions with
broker-dealers or other financial institutions, which may in turn engage in short sales of the common stock in the course of hedging
the positions they assume. The selling stockholders may also sell shares of our common stock short and deliver these securities to close
out their short positions, or loan or pledge the common stock to broker-dealers that in turn may sell these securities. The selling stockholders
may also enter into option or other transactions with broker-dealers or other financial institutions or the creation of one or more derivative
securities which require the delivery to such broker-dealer or other financial institution of shares offered by this prospectus, which
shares such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect
such transaction).
The
aggregate proceeds to the selling stockholders from the sale of the common stock offered by them will be the purchase price of the common
stock less discounts or commissions, if any. Each of the selling stockholders reserves the right to accept and, together with their agents
from time to time, to reject, in whole or in part, any proposed purchase of common stock to be made directly or through agents. We will
not receive any of the proceeds from this offering.
The
selling stockholders also may resell all or a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities
Act, provided that they meet the criteria and conform to the requirements of that rule, or another available exemption from the registration
requirements under the Securities Act.
The
selling stockholders and any underwriters, broker-dealers or agents that participate in the sale of the common stock or interests therein
may be “underwriters” within the meaning of Section 2(a)(11) of the Securities Act (it being understood that the selling
stockholders shall not be deemed to be underwriters solely as a result of their participation in this offering). Any discounts, commissions,
concessions or profit they earn on any resale of the shares may be underwriting discounts and commissions under the Securities Act. Selling
stockholders who are “underwriters” within the meaning of Section 2(a)(11) of the Securities Act will be subject to the prospectus
delivery requirements of the Securities Act.
To
the extent required, the shares of our common stock to be sold, the names of the selling stockholders, the respective purchase prices
and public offering prices, the names of any agent, dealer or underwriter, and any applicable commissions or discounts with respect to
a particular offer will be set forth in an accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration
statement that includes this prospectus.
In
order to comply with the securities laws of some states, if applicable, the common stock may be sold in these jurisdictions only through
registered or licensed brokers or dealers. In addition, in some states the common stock may not be sold unless it has been registered
or qualified for sale or an exemption from registration or qualification requirements is available and is complied with.
We
have advised the selling stockholders that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares
in the market and to the activities of the selling stockholders and their affiliates. In addition, to the extent applicable, we will
make copies of this prospectus (as it may be supplemented or amended from time to time) available to the selling stockholders for the
purpose of satisfying the prospectus delivery requirements of the Securities Act. The selling stockholders may indemnify any broker-dealer
that participates in transactions involving the sale of the shares against certain liabilities, including liabilities arising under the
Securities Act.
We
have agreed to indemnify the selling stockholders against liabilities, including liabilities under the Securities Act and state securities
laws, relating to the registration of the shares offered by this prospectus.
We
have agreed with the selling stockholders to use commercially reasonable efforts to cause the registration statement of which this prospectus
constitutes a part to become effective and to remain continuously effective until the earlier of: (i) the date on which the selling stockholders
shall have resold or otherwise disposed of all the shares covered by this prospectus and (ii) the date on which the shares covered by
this prospectus no longer constitute “Registrable Securities” as such term is defined in the Registration Rights Agreement,
such that they may be resold by the selling stockholders without registration and without regard to any volume or manner-of-sale limitations
and without current public information pursuant to Rule 144 under the Securities Act or any other rule of similar effect.
Exhibit
B
Investor
Questionnaire1
The
undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate:
QUESTIONNAIRE
1. Name.
|
(a) |
Full
Legal Name of Investor |
|
|
|
|
|
|
|
(b) |
Full
Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities are held: |
|
|
|
|
|
|
|
(c) |
Full
Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power to vote
or dispose of the securities covered by this Questionnaire): |
|
|
|
|
|
|
2.
Address for Notices to Investor:
|
|
|
|
|
|
Telephone: |
|
|
E-Mail:
______________________________________________________________________________________ |
|
Contact
Person: |
|
1
Best practice is to collect completed Investor Questionnaires along with executed signature pages.
3.
Broker-Dealer Status:
|
(a) |
Are
you a broker-dealer? |
Yes
☐ No ☐
|
(b) |
If
“yes” to Section 3(a), did you receive your Registrable Securities as compensation for investment banking services to
the Company? |
Yes
☐ No ☐
|
Note: |
If
“no” to Section 3(b), the Commission’s staff has indicated that you should be identified as an underwriter in the
Registration Statement. |
|
(c) |
Are
you an affiliate of a broker-dealer? |
Yes
☐ No ☐
|
(d) |
If
you are an affiliate of a broker-dealer, do you certify that you purchased the Registrable Securities in the ordinary course of business,
and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings, directly or
indirectly, with any person to distribute the Registrable Securities? |
Yes
☐ No ☐
|
Note: |
If
“no” to Section 3(d), the Commission’s staff has indicated that you should be identified as an underwriter in the
Registration Statement. |
4.
Beneficial Ownership of Securities of the Company Owned by the Investor.
Except
as set forth below in this Item 4, the undersigned is not the beneficial or registered owner of any securities of the Company other than
the securities issuable pursuant to the Purchase Agreement.
| (a) | Type
and Amount of other securities beneficially owned by the Investor: |
5.
Relationships with the Company:
Except
as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners of 5%
of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship with
the Company (or its predecessors or affiliates) during the past three years.
State
any exceptions here:
The
undersigned agrees to promptly notify the Company of any material inaccuracies or changes in the information provided herein that may
occur subsequent to the date hereof at any time while the Registration Statement remains effective; provided, that the undersigned shall
not be required to notify the Company of any changes to the number of securities held or owned by the undersigned or its affiliates.
By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items 1 through 5 and
the inclusion of such information in the Registration Statement and the related prospectus and any amendments or supplements thereto.
The undersigned understands that such information will be relied upon by the Company in connection with the preparation or amendment
of the Registration Statement and the related prospectus and any amendments or supplements thereto.
IN
WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice and Questionnaire to be executed and delivered either
in person or by its duly authorized agent.
PLEASE
EMAIL A .PDF COPY OF THE COMPLETED AND EXECUTED QUESTIONNAIRE TO:
v3.24.4
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionEnd date of current fiscal year in the format --MM-DD.
+ References
+ Details
Name: |
dei_CurrentFiscalYearEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:gMonthDayItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14a -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
NextTrip (NASDAQ:NTRP)
過去 株価チャート
から 12 2024 まで 1 2025
NextTrip (NASDAQ:NTRP)
過去 株価チャート
から 1 2024 まで 1 2025